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1 Summary 	  	  
Immunodeficiencies are severe diseases, which are inherited or acquired after 
cytotoxic treatment or radiotherapy. Hematopoietic stem cell transplantation (HSCT) 
has become a common treatment for patients suffering from immunodeficiency, but 
especially the re-establishment of a functional T cell pool is often delayed and 
patients suffer from infections and relapse of malignancies. The generation of an 
adequate T cell pool can be achieved by de novo generation and peripheral 
expansion of donor T cells. However, T cell development after pretransplantational 
treatment is often impaired due to damage of the thymic environment. To improve 
thymic engraftment and preserve the thymic microenvironment, current treatments 
involve application of cytokines, which have often severe side effects. Therefore it is 
important to find alternative ways to improve T cell reconstitution after HSCT. 
LTi cells are members of the family of innate lymphoid cells group 3 (ILC3s), 
which promote lymphoid tissue generation and are involved in tissue remodelling in 
primary and secondary lymphoid organs. In my study, I wanted to investigate the 
impact of ILC3s and secondary lymphoid organs on T cell reconstitution after HSCT. 
Therefore immunodeficient Rag2-/-γc-/- mice, which have reduced numbers of ILC3s 
and severe defects in LN development and K14 TSLP+/- Rag2-/- γc-/- mice with 
increased numbers of ILC3s were compared before and after transplantation with 
hematopoietic stem cells or mature T cells. 
Characterization of the recipient mice showed that TSLP overexpression in   
Rag2-/-γc-/- mice increases the number of double negative thymocytes DN2 and 
DN3s, and improves the thymic architecture with the development of mTECs and 
Aire expression. Reconstitution of the hematopoietic system with fetal liver (FL) 
HSCs from TSLPR-/- mice showed that TSLP overexpression results in an 
accelerated T cell reconstitution in the thymus and peripheral organs. The 
reconstitution of B cells did not differ between Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- 
mice, suggesting that the reconstitution itself was equally efficient. 
T cells depend on IL-7, as this cytokine promotes T cell proliferation and survival. 
I could show that the IL-7 expression was significantly higher in the spleen of       
K14 TSLP+/- Rag2-/-γc-/- compared to Rag2-/-γc-/- mice most likely as a result of higher 
numbers of dendritic cells (DCs) expressing IL-7. Finally, I could demonstrate that 
TSLP overexpression increases T cell proliferation in secondary lymphoid organs. 
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Taken together, these data suggest, that TSLP overexpression accelerates T cell 
reconstitution by improving de novo T cell development in the thymus and T cell 
expansion in secondary lymphoid organs. 
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2. Introduction 
 
2.1 The Immune System 
 
The human body is constantly exposed to a variety of potentially harmful 
microorganisms such as bacteria, fungi and viruses and has to discriminate between 
self and non-self cells. To protect the organism, the immune system with an innate 
and adaptive branch has developed, whereas the latter is only found in vertebrates. 
The innate immune system is the first line of defence in all animals and is able to 
react within minutes or hours to pathogen- and danger- associated molecular 
patterns (PAMPs and DAMPs), typical components of microorganisms. Cells of the 
innate immune system include professional (e.g. dendritic cells) as well as non-
professional antigen presenting cells (APC) (endothelial and epithelial cells) and 
phagocytic cells like macrophages (MΦ). The release of cytokines and chemokines 
by innate immune cells and endothelial or epithelial cells is important to recruit and 
activate the second branche, the adaptive immune system. Contrary to innate 
immune cells, cells of the adaptive immune system, namely T and B lymphocytes 
are able to recognize antigens (Ags) due to the expression of highly specific Ag 
receptors, which are generated by random recombination of gene segments. The 
number of B and T cells that recognize a given foreign Ag is small, on the order of 1 
cell per million. The high diversification of the T and B cell repertoire through 
recombination, however, ensures clonal and highly specific immune responses 
towards a broad spectrum of different Ags.  
T and B cells develop in primary lymphoid organs such as thymus and bone 
marrow (BM), respectively. T cells contribute to cell - mediated immune response. 
CD8+ cytotoxic T cells can eliminate intracellular pathogens, whereas CD4+ T helper 
cells help other immune cells through the secretion of cytokines. There are two 
major subsets, T helper (Th) 1 and Th2. While Th1 cells mediate cellular immunity 
by stimulating MΦ and stimulating proliferation of CD8+ cytotoxic T cells, Th2 cells 
support B cell proliferation and antibody (Ab) class switch1. Continuing studies 
identified also new subsets of CD4+ T cells, which include Th9, Th17 and Th22 
named after their key effector cytokine secretion2.  
The recognition of Ags by CD4+ and CD8+ T cells are different. CD4+ T cells 
recognize extracellular Ags presented by MHC class II, whereas CD8+ cytotoxic T 
cells recognize intracellular Ags complexed with MHC class I. CD4+ T cell activation 
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leads to the production of cytokines, which in turn activate other cells of the immune 
system1. B cells on the other hand recognize native Ags and secrete 
immunoglobulins (Ig) Abs with two functional parts: the Fab part of Igs recognizes 
extracellular pathogens, whereas the Fc part activates other host cells Fc receptors 
(humoral immune response). B cell activation and maturation is possible via two 
different pathways: The thymus - dependent (TD) and thymus - independend (TI) B 
cell activation. During TD B cell activation, Th2 cells primed for a specific Ag by 
APCs activate B cells by cytokine secretion, if the B cell presents the same Ag. This 
results in B cell division and maturation into an Ab producing plasma blast. 
A hallmark of the adaptive immune system is the formation of immunological 
memory. Following reactivation with the same Ag peptide, lymphocytes mount a 
faster and more efficient immune response. Important places for lymphocytes are 
secondary lymphoid organs including spleen and lymph nodes (LNs) because they 
provide special niches for mounting an immune response but also for maintenance 
of immune homeostasis. Exposure to most pathogens elicit both innate and adaptive 
immune responses, which help to clear the infection and prevent chronic 
inflammation1,3. 	  	  	  
2.2. Reconstitution of the adaptive immune system 
 
2.2.1 Immunodeficiencies and hematopoietic stem cell transplantation 
 
Immunodeficiency diseases are either inherited or acquired diseases, in which 
the immune system is compromised and fails to fight infections. Inherited or primary 
immunodeficiencies are caused by mutations that control the differentiation and 
activities of immune cells. These mutations can occur on different levels during cell 
development. Mutations in the Ikaros gene, for instance, affect already lymphocyte 
progenitors4, whereas recombination activating gene (Rag) deficiency results in the 
arrest of T and B cell development because of a failure to rearrange the Ag receptor 
genes. Moreover, defects in surface molecules like CD40L or common γ chain or in 
cytokine production can prevent their essential interaction with other immune cells to 
mount an immune response5. Acquired or secondary immunodeficiencies include 
HIV infection and chemotherapy. Hematopoietic stem cell transplantation (HSCT) 
has become a common therapeutic treatment for patients suffering from 
immunodeficiency like severe combined Immunodeficiency or after radiation – and 
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chemotherapy of hematologic malignancies such as different types of leukemia6. It 
involves the transplantation of autologous hematopoietic stem cells (HSC’s from the 
patients themselves) or allogenic stem cells (HSC’s from another donor), which can 
be harvested from BM or umbilical cord blood (UCB). HSCs can also be obtained by 
the mobilization of these cells from the BM into the peripheral blood by treatment 
with granulocyte colony-stimulating factor (G-CSF). 
In 2012, more than 33 000 patients in Europe were reported to receive HSCT, of 
which 42% were performed allogeneic and 58% autologous. The main indications for 
HSCT were lymphoid neoplasias (57%) followed by leukemia (32%), solid tumors 
(5%) and nonmalignant disorders (6%) (Fig. 1)7. 
 
 
 
Figure 1: Proportions of HSCT in Europe in 2012 
(A) Proportion of HSC transplant type in Europe in 2012. (B) Proportions of disease 
indication for HSCT in Europe in 2012. Adapted from Passweg et al., Bone marrow 
transplantation (2014)7 
 
The successful outcome of HSCT depends on several parameters like stage and 
progress of the underlying disease, pretransplantational conditions like chemo- or 
radiation therapy, age of the patient and genetic disparity of donor and recipient7-9. 
The re-establishment of the functional immune system in the patient after HSCT is a 
major clinical issue, and improving the adaptive immune system is crucial for a 
successful outcome of HSCT. 
While the innate immune system including monocytes, granulocytes and natural 
killer (NK) cells recovers quickly after HSCT, the restoration of the adaptive immune 
system is a long - lasting and often insufficient process10-12. Delayed reconstitution of 
adaptive immunity bears, especially in the first two years after HSCT13,14, a high risk 
for opportunistic fungal (aspergillus spp) as well as bacterial and viral infections 
(Cytomegalovirus (CMV), Epstein-Barr virus (EBV), Varizella zoster virus (VZV), 
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influenza) and even relapse of malignancies15. Another high risk for HSCT patients 
are late bacterial infections caused by defective Ab production and defective class 
switch due to failure in B cell development16. The generation of an adequate T cell 
pool can be achieved by either peripheral expansion of donor T cells, which bears a 
higher risk for graft versus host disease (GVHD) or de novo T cell generation. 
However, the development from a hematopoietic precursor into a T cell is insufficient 
after HSCT because treatments like chemo- or radiotherapy damages the thymic 
environment and perturbs normal T cell development. Current immunomodulary 
treatments try to improve thymic engraftment or to preserve the thymic 
microenvironment with cytokines, such as keratinocyte growth factor (KGF)17-19, IL-
220, IL-721, growth hormones22  or blockade of sex hormones23. Other therapies 
involve the transplantation of ex-vivo isolated cells such as T cells 24 or co-
transplantation of mesenchymal stem cells (MSC)25. 
Although there are a number of treatments available to accelerate immune 
reconstitution and to improve the outcome of HSCT, regaining fast and efficient 
immune competence is still a matter of ongoing research. It is therefore essential to 
gain further insights into immunological processes involved in the reconstitution of 
the adaptive immune system after HSCT.  
 
 
2.2.2 Models for reconstitution of the adaptive immune system 
 
As described, there are several difficulties to efficiently reconstitute the adaptive 
immune system after HSCT in humans. However, ethical issues prevent extensive 
research on these obstacles. Therefore, mouse models are needed to provide 
insight into molecular and cellular mechanisms during HSC engraftment. Since adult 
BM and fetal liver (FL) are rich in HSCs, common assays to study murine HSC 
activity and their engraftment is the transplantation of BM or embryonic FL cells via 
intravenous (i.v.) injection into either lethally irradiated wild type (WT) mice or 
immunodeficient mice such as Rag-/- or Rag-/-γc-/-26. However, such immunodeficient 
mutant mice have an abnormal development of thymus and LNs27, which leads to 
less efficient engraftment and function of donor cells. Therefore, new and better 
animal models would be beneficial to study HSC engraftment and to improve HSCT. 
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2.3 Development and differentiation of adaptive immune cells 
 
2.3.1 B cell development in the bone marrow 
 
B cells originate from hematopoietic precursors, which can give rise to lymphoid 
progenitors (CLP) in the BM of adult mice. B cell development requires several 
recombination steps of the gene segments on the immunoglobuline locus V 
(variable), D (diversity) and J (joining) thus leading to randomly arranged B cell 
receptors (BCR). This process is initiated by the expression of Rag1 and Rag2. In 
addition to Rag1 and Rag2, B cell development is coordinated by transcription 
factors such as Pax - 528 and cytokines such as stem cell factor (SCF), fms-related 
tyrosine kinase 3 Ligand (Flt3L) and IL-729-34. Further B cell developmental stages 
are discriminated by the expression of surface molecules shown in Fig. 2. After 
rearranging a functional BCR, B cells undergo selection processes within the BM to 
remove potential auto-reactive B cells. B cells, which recognize self-antigens in the 
BM are clonally deleted35, become anergic36 or start to rearrange their light chain 
locus (receptor editing)37. B cells with a functional and non-auto-reactive BCR leave 
the BM and acquire further maturation in the periphery. 
 
 
Figure 2: B cell development in the Bone marrow. Adapted from Ceredig and Rolink, 
Nature reviews Immunology, (2002)38 
 	  
M
edulla
CD19+
CD117+
CD25-
IL-7R_+
IgM-
CD19+
CD117+
CD25-
IL-7R_+
IgM-
CD19+
CD117-
CD25+
IL-7R_+
IgM-
CD19+
CD117-
CD25+
IL-7R_-
IgM-
CD19+
CD117-
CD25-
IL-7R_-
IgM+++
Pro-B Pre-B-I Pre-B-II Immature
Pre- BCR BCR
DH - JH VH - DJH Vgh - DJgh 
 
Introduction 
	   12	  
2.3.2 Peripheral B cells 	  
Immature B cells, which leave the BM, enter the blood stream and recirculate 
through peripheral lymphoid tissues. During their migration, B cells undergo further 
maturation processes with the upregulation of IgD and downregulation of IgM. B 
cells in the spleen can be separated into CD21high CD23- marginal zone (MZ) B cells 
and CD21+ CD23+ follicular B (fol B) cells. MZ B cells are located in the marginal 
zone of the white pulp in the spleen. They express polyreactive and therefore less 
specific BCRs and high levels of Toll like receptors (TLR), comparable to DCs39. This 
allows them to react fast to a broad range of blood borne Ags and hence contribute 
to early immune responses. After Ag encounter MZ B cells become activated in a TD 
or TI pathway40. Whereas MZ B cells are exclusively detectable in the murine spleen, 
Fol B cells can also be found in the B cell areas of the LNs and Peyer’s patches (PP), 
the lymphoid follicles in the intestine. Fol B cells mediate TD high-affinity immune 
responses to protein Ags. Thereby, Ags recognized by IgM on the surface of naïve B 
cells are internalized, processed and presented via MHC II to T cells. T cells, which 
were primed by the same Ag produce cytokines which lead to B cell differentiation 
and maturation into Ab-secreting cells. Crosslinking CD40 on B cells with CD40L on 
T cells induces point mutations of the rearranged V region (somatic hypermutation), 
which creates additional diversity within the highly Ag specific B cell clone and 
isotype switch to either IgG, IgA or IgE. Afterwards, fol B cells can further 
differentiate either into short-lived plasma blasts or into plasma cells, which migrate 
to the BM and persist as long-lived plasma cells41.  
B-1 cells are another subtyp of peripheral B cells, which are mainly found in the 
peritoneal and pleural cavities. During their migration through the blood and 
lymphoid organs, they contribute to TI immune responses e.g. against bacterial Ags 
such as phosphorylcholine41.	  	  	  
2.3.3 T cell development in the thymus 
 
The thymus is the primary lymphoid organ that is specialized for T cell 
development and generation of a highly diverse T cell repertoire that recognizes 
foreign Ags42. It is organized into a subcapsular region, cortex, cortico-medullary 
junction (CMJ) and medulla, and gives major contribution to cell-mediated immunity 
in the periphery. The thymus needs to be continuously seeded by lymphoid 
progenitors from the blood. These newly immigrating thymocytes migrate through 
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the different thymic regions where they undergo several maturation steps until they 
develop into mature T cells (Fig. 3). 
 
   
         
 
Figure 3: Thymocyte development and trafficking in the thymus. Hematopoietic 
precursors enter the thymus at the cortico-medullary junction. Chemotactic migration guides 
the double negative thymocytes through the cortex. Positive T cell selection in the cortex 
followed by negative selection in the medulla establishes a self-tolerant T cell pool with broad 
antigen specificity, which finally emigrate from the thymus into the periphery (DN: double 
negative; DP: double positive; SP: Single positive; cTEC: cortical thymic epithelial cell; 
mTEC: medullary thymic epithelial cell). Adapted from Takahama, Nature reviews 
Immunology, (2006)43 	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  Thymic stromal compartment 	  
The stromal compartment of the thymus is a 3-dimensial network structured into a 
cortical and medullary region, whose stromal cells are phenotypically and also 
functionally different. Thymic epithelial cells (TECs) are the major component of the 
thymic stromal compartment, but it includes also mesenchymal cells and cells of 
hematopoietic origin like DCs and macrophages. This network builds a 
microenvironment essential to promote and support survival, differentiation, 
maturation and selection of thymocytes44,45. Various extra- as well as intracellular 
markers help to discriminate cortical epithelial cells (cTECs) from medullary thymic 
epithelial cells (mTECs). Major markers to characterize the TEC subsets of the 
murine thymus are cytokeratins (CK) such as CK8 and CK18 expressed by cTECs 
and CK5 and CK14 expressed by mTECs. Both cTECs and mTECs share 
expression of epithelial cell adhesion molecule (EpCAM, CD326), MHC II molecules 
and lack CD45, a transmembrane protein expressed by hematopoietic cells. 
Characteristic for cTECs is the surface molecule Ly51 whereas the reactivity with 
Ulex europaeus agglutinin I (UEA-1) is a typical feature of mTECs46,47. In addition, 
mature mTECs express the intracellular transcription factor Autoimmune Regulator 
(Aire). Aire is responsible for the transcription of a broad spectrum of self-Ags, which 
are usually only present in the periphery like e.g. insulin48,49. These so-called tissue 
restricted Ags (TRA) are produced by mTECs and presented to developing 
thymocytes by either mTECs or by thymic DCs via cross-presentation50. This 
mechanism is crucial for central tolerance51, as T cells, which recognize self-Ags are 
potentially auto-reactive and undergo therefore negative selection.  
 
 
   Thymocyte development 
 
After lymphoid progenitors enter at the CMJ, thymocytes pass through the cortex, 
where they progress through intermediate developmental stages. The first stage is a 
CD3- CD4- CD8- triple negative phenotype, which is followed by different expression 
levels of c-kit, CD25 and CD44, characterizing the phenotype of double negative 
states one to four (DN1-DN4). DN1: c-kithigh CD25- CD44+, DN2: c-kithigh CD25+ 
CD44+, DN3: c-kitlow CD25+ CD44-, DN4: c-kitlow CD25- CD44- 38,52. At the DN3 state, 
Rag 1 and 2 are expressed, which catalyse the rearrangement of the β, γ and δ loci. 
Successful rearrangement of the Tcrb locus and later the assembling of the T cell 
receptor β (TCRβ) and pre-TCRα chains result in the expression of the pre-TCR 
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complex on the cell surface and drives the cell further into a CD4+ CD8+ double 
positive (DP) stage. Rearrangement of the α-chain locus leads to a complete 
randomly created, unique Ag-specific TCRαβ receptor. At the DP stage, the TCR is 
tested for its recognition of self-peptide/self-MHC present on cTECs and DCs. 
Current models propose that self-Ag induced positive or negative selection is defined 
by an apparent affinity threshold of the interaction of TCR and co-receptor with a self 
peptide-MHC complex. Thereby cells with a TCR below the threshold undergo 
apoptosis (death by neglect), whereas cells above the threshold, hence having a 
high affinity towards self-MHC become negatively selected53. 
After the first round of selection, only 3-5% of the DP thymocytes have a low-
affinity interaction, and therefore receive survival and further differentiation signals to 
progress to the single positive (SP) stage and to migrate further into the medulla.  
Additional rounds of negative selection to eliminate potential auto-reactive T cells 
from the system accompany the final maturation process. Thereby, TCR with a too 
high affinity for self-Ags, which are presented by mTECs and DCs, are eliminated.  
The medulla is also the site for development of regulatory T cells (Tregs)54. This T 
cell subset is able to suppress an immune response by inhibiting proliferation of 
effector T cells and promotes tolerance to self-antigens. 
T cell development is also associated with distinct transcription factor and 
cytokine ensembles. Transcription factors, such as Ikaros, GATA3 and T-cell-factor 
(TCF) -1 control the expression of important genes and guide the developing 
thymocytes from one stage to the next55. Notch1 signals are required to differentiate 
hematopoietic cells into T cells56 and support Vβ-DJβ recombination57. Important 
cytokines during T cell development are Stem cell factor (SCF) and IL-7 by 
promoting proliferation, differentiation and survival of DNs33,58,59. 
 	  
  Thymocyte - TEC interaction 
 
The crosstalk between stromal cells and hematopoietic cells is crucial for the 
development and differentiation of thymocytes. Specifically the CC-chemokine ligand 
21 (CCL21) and 25 (CCL25) were reported to play significant roles in thymus 
colonialization60-62. The presence of CXC-chemokine ligand 12 (CXCL12) or its 
receptor CXC-chemokine receptor 4 (CXCR4) is also involved in thymic seeding but 
to a lesser extend than CCL21 and CCL25 and is rather related to T cell expansion 
during embryogenesis63,64. The migration of thymocytes through the cortex, follows 
defined rules in such a way, that the thymocytes make their developmental changes 
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in distinct cortical regions65. Cortical DP cells show an increase in CCR7 expression, 
whereby mTECs are the major source of its ligands CCL19 and CCL21. Therefore, 
DP thymocytes are attracted by chemotaxis to the medulla, whereas deficiency for 
CCR7 leads to the accumulation of positively selected thymocytes in the cortex. 
Negatively selected DP thymocytes undergo apoptosis irrespectively of chemotactic 
attraction66. Another role of the CCL19-CCR7 axis was discovered by Ueno et al., in 
which CCL19 promotes the egress of mature T cells out of the thymus67, 
emphasizing again the importance of thymocyte - TEC crosstalk for T cell 
development. Beside the requirement of lymphocyte - TEC interaction for thymocyte 
development, TEC development relies also on interaction with thymocytes. It was 
reported that arrest in thymocyte development at stage DN1 leads to a failure of 
normal cortical as well as medulllary compartment68. Furthermore, it was 
demonstrated that mTEC development, differentiation and maturation is strongly 
dependent on signals provided by hematopoietic cells in the thymus69,70. The 
interaction of mTECs with thymocytes is mediated by nuclear factor kappa-light-
chain-enhancer of activated B-cells (NF-κB) signaling71,72. Signals through various 
TNF superfamily members, which are expressed by mTECs, play key roles in the 
maturation and differentiation of mTECs73,74. Rossi and colleagues identified 
receptor activator for NF-κB (Rank) in situ during embryogenesis as an important 
mediator for mTEC development. By the engagement with the ligand (RankL), which 
is present on CD3- CD4+ cells, namely lymphoid tissue inducer (LTi) cells, mTECs 
develop into a mature state concomitant with the expression of CD80 and Aire75. 
However, Rorc-/- mice, which lack LTi cells, also have Aire+ mTECS. This indicated 
the involvement of another cell type in regulating mTEC development during 
embryogenesis. Indeed, γδ T cell progenitors (Vγ5+ dendritic epidermal T cells; 
DETC) express RankL thereby contributing to mTEC growth and maturation76. In 
adults, LTi cells as well as  γδ T cell progenitors are severely reduced in their 
frequency, as αβ T cells outnumber them. As soon as αβ T cells develop, they take 
over the function as mTEC inducer with expression of several other molecules e.g. 
CD40L and lymphotoxin, which were revealed to also regulate the development and 
differentiation of mature mTECs77-81 (Fig. 4). 
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Figure 4: mTEC development and Aire induction/maintenance in fetal and adult 
mice. In fetal mice, receptor activator of NK-kB ligand (RankL) interaction provided by Vγ5+ 
γδ T cell progenitors and LTi cells, induces the development of mature mTECS with 
expression of Aire and CD80. Under steady state conditions in adults, signals like LTα, 
CD40L and RankL are provided by αβ T cells which engage the respective receptor resulting 
in a mature CD80+ Aire+ mTEC.  
	  	  	  
2.3.4 Peripheral T cells 
 
The majority of peripheral T cells are positive for αβ TCR and express either CD4 
or CD8. While the effector function of CD8+ T cells is characterized by their 
cytotoxicity against target cells, CD4+ T cells have divers functions as helper T cells 
and are characterized by their production of cytokines. The major Th subsets are 
Th1, Th2, Th17 and Tregs. T helper (Th) 1 cells develop in response to IL-12 and 
IFN82,83  and are described to produce IFN-γ in a positive feedback loop as well as IL-
2 and tumor necrosis-factor (TNF) - β. They are important in protection against 
intracellular pathogens83, but are also involved in unwanted inflammatory diseases 
like rheumatoid arthritis or intestinal inflammation84,85. Th2 differentiation is driven 
mainly by IL-486 and TSLP87,88. Th2 cells produce IL-4, IL-5, IL-9, IL-10 and IL-13 
and are often associated with humoral immune response. Therefore, Th2 immunity 
is important to resist extracellular pathogens such as helminthes or nematodes89. 
However, elevated Th2 responses are also associated with chronic inflammatory 
diseases such as allergy and asthma90.  
Th17 cells produce IL-17 and IL-22 and are associated with autoimmune diseases 
but also with the clearance of bacterial and fungal infections82. Tregs are a subset of 
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CD4+ T cells, which either develop in the thymus (naturally occurring Tregs: nTregs) 
or are generated in the periphery (pTregs) from naïve T cells after TCR stimulation in 
the presence of TGF-β and IL-2. Tregs express forkhead box P3 (FoxP3), are 
immuno-suppressive, and maintain self-tolerance as well as immune homeostasis91. 
To distinguish nTregs from pTregs, the Ikaros family member Helios and Neuropilin-
1 (Nrp1) were suggested as potential markers92-94. 
Peripheral T cells either have a naïve or memory phenotype. Naïve T cells are 
CD44low and express CCR7 and L-selectin (CD62L), an adhesion molecule, which 
enables them to enter LNs via high endothelial venules (HEV). Indeed, the majority 
of naïve T cells are found within secondary lymphoid organs, where they encounter 
foreign Ags followed by differentiation into effector T cells95. Effector T cells migrate 
to peripheral sites where they encounter Ags and mount Ag-specific immune 
responses. The majority of effector T cells undergo apoptosis to maintain immune 
homeostasis. Only a minor subset differentiates into long-lived memory cells, which 
home to lymphoid as well as non-lymphoid tissue where they can be reactivated 
upon recurrent Ag encounter96. Memory T cells have an activated phenotype and are 
identified by CD44high expression97. Survival, proliferation as well as homeostasis of 
naïve T cells are dependent on the interaction of TCR with self-peptide / MHC and 
several cytokines, whereas current studies indicate that maintenance of memory T 
cells does not require TCR / self-peptide interaction. 
Common cytokine receptor γ - chain (γc)-dependent cytokines like IL-2, IL-7 and 
IL-15 support proliferation and survival of naïve as well as memory T cells. While 
both IL-7 and IL-15 control the survival of CD8+ T cells, with IL-7 playing the major 
role98,99, IL-15 is redundant for the proliferation and survival of CD4+ T cells100. IL-7 is 
an important factor to induce slow homeostatic proliferation in CD4+ and CD8+, 
whereas IL-2 and IL-15 lead to rather rapid proliferaton101. In addition to IL-7 and IL-
15, IL-2 is an important cytokine produced by activated T cells for T cell growth and 
proliferation. Especially Treg expansion is heavily depended on IL-2 and mice 
deficient in IL-2 signaling suffer from autoimmune diseases102. 
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2.4 The lymph node  	  	  
LNs are encapsulated secondary lymphoid organs, which are important to initiate 
immune responses. They are organized into two compartments, the cortex and the 
medulla. The cortex can be further separated into an outer cortical area with B cell 
follicles and the paracortical area with mainly T cells and DCs. 
The medulla contains macrophages, Ab secreting plasma cells and the efferent 
lymphatics through which lymphocytes leave the LNs (Fig. 5)103,104. A dense network 
of reticular fibres and the secretion of their chemokines maintain the 
compartmentalization into B and T cell areas. Follicular dendritic cells (FDC) in the B 
cell zone, which are also present in the spleen, are the major source of B cell 
survival factors such as BAFF and APRIL and secrete CXCL13 to attract and 
preserve B cells105,106. T cells on the other hand are associated with T zone reticular 
cells (TRC), which produce CCL19 and CCL21. These cytokines are recognized by 
CCR7 expressed on naïve T cells and DCs and are important for motility107, survival 
as well as antigen uptake by DCs108. Beside its crucial role in initiating immune 
responses, LNs provide also an environment for lymphocyte homeostasis by 
producing growth and survival factors109, which will be further described in 2.4.1. 
Ags from peripheral tissues and Ag-loaded DCs enter the LN via afferent lymphatic 
vessels. Naïve lymphocytes can enter the LN directly via HEVs and encounter Ags 
expressed by APCs in the respective compartments of the LN. After Ag exposure B 
cells undergo intense proliferation and form germinal centers, in which B cells 
undergo important modifications such as somatic hypermutation, affinity maturation 
and isotype switching. These steps result in the generation of mature high affinity B 
cells. 
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Figure 5: Lymph node architecture: Lymph enters through afferent lymphatic vessels, 
whereas naïve lymphocytes enter the LN via HEVs. Lymph fluid is drained through cortex 
and medulla, where cells of the immune system are activated to mount an immune response 
against foreign antigens. The lymph and lymphocytes leave the LN through efferent 
lymphatic vessels.  	  
 
 
2.4.1 Lymph node stromal cells  	  
Lymph node stromal cells (LNSC) are cells of mesenchymal origin, which provide 
the network within the LN to sustain immune homeostasis. Four different cell types 
can be identified by the expression of CD31 and the glycoprotein podoplanin (gp38): 
T zone reticular cells (TRC) (also known as follicular reticular cells), which are CD31- 
gp38+, lymphatic endothelial cells (LEC), which are CD31+ gp38+, blood endothelial 
cells (BEC), which are CD31+ gp38-, and finally a subset of double negative stromal 
cells (DNSC)109. BECs and LECs surround blood vessels and lymphatic vessels, 
respectively. They are important for lymphocyte migration from the blood into the LN 
by the expression of chemokines and adhesion molecules. TRC and LECs were 
identified as a main source of IL-7, which promotes survival of naïve T cells109,110. 
Furthermore, IL-7 producing TRCs and LECs were reported to be essential for virus-
induced LN remodelling and LN regeneration after avascular transplantation111. 
Beside IL-7, TRCs produce CCL19 and CCL21, which are recognized by CCR7 
expressed on the surface of naïve T cells. These cytokines are chemoattractants for 
T cells and DCs promoting leukocyte traffic and T cell - DC interactions112. Just 
recently, it was found that IL-15, which is critical for proliferation and maintenance of 
CD8+ T cells as well as NK cells and NKT cells, is expressed not only by BECs but 
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also by TRCs and DNSCs. This suggests a role for IL-15 in T cell homeostasis113. 
The idea that TRC support immune homeostasis is further supported by some 
evidence that they can express and present peripheral Ags to naïve T cells and 
hence may contribute to peripheral tolerance114,115. The function of the forth subset 
of LN stromal cells, the DNSC is not revealed yet116 but their global gene expression 
closely resembles the one of TRCs117. 
 
 
2.4.2 Lymph node development  	  
The first LN anlagen emerge early during embryogenesis. It was shown that 
signaling through lymphotoxin β receptor (LTβR) mediated by LTα1β2 is crucial for 
the development of lymphoid tissues, as mice deficient for either LTα or its receptor 
have neither LN nor PP. Similarly, LTβ -deficient mice also lack PP and peripheral 
LN except cervical and mesenteric LNs (mLNs). This suggested that another ligand 
than LTα1β2 is involved in their formation. Indeed, it was found that mice double 
deficient for LTβ  and another LTβR ligand LIGHT had even lower numbers of 
mLN118-120. LTα1β2 and LTβR is the main pathway involved in peripheral LN 
generation. Studies from other genetic mouse models revealed further important 
receptor ligand interactions for LN development. Mice with deficiency for either Rank 
or RankL completely lack LNs, whereas deficiency for CXCR5 or its ligand CXCL13 
just leads to a reduction of LNs. Additionally, intracellular molecules like inhibitor of 
DNA binding 2 (Id2), Ikaros and the transcription factor retinoid related orphan 
receptor γ (RORγt) play essential roles in the formation of LNs. Both factors are 
crucial for LTi cell development and the deficiency of Id2 or RORγt results in 
complete lack of LNs and PPs121-124.  	  	  	  
  Lymphoid tissue inducer cells  
 
LTi cells are cells of the hematopoietic system and first identified as CD4+, CD3- 
and IL-7Rα+ in fetal and newborn blood, LN and spleen125. As they were also found 
as one of the first cells colonizing lymphoid tissues, they were discussed as initiators 
of lymphoid organogenesis. The proof came from two independent transfer 
experiments in mice lacking lymphoid tissue. Adoptive transfer of LTi cells isolated 
from fetal spleen into CXCR5-/- induced PP development126, whereas LTi cells form 
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fetal intestine transferred into Id2 deficient mice resulted in the generation of nasal-
associated lymphoid tissue. These experiments demonstrated that LTi cells are in 
fact capable to rescue lymphoid organogenesis121. However, the mechanism of 
development for the different lymphoid tissues like LNs or PP might differ and 
involves other cellular interactions. 
LN organogenesis relies on the interaction of LTi cells with organizer stromal 
cells127,128. LTα1β2, which is induced on LTi cells by triggering IL-7Rα and Rank129, 
interacts with LTβR on organizer cells and activates NFκB pathways. NFκB 
activation results in the expression of adhesion molecules Vcam, Icam and MadCam 
on stromal cells and the production of CXCL13, CCL19 and CCL21130,131. As LTi 
cells express the respective chemokine receptors, this leads to attraction and 
retention of further LTi cells and amplification of their interaction with stromal cells. 
IL-7 and RankL expression, which are provided by stromal cells induce the 
expression of LTα1β2 on freshly migrated LTi cells, resulting in enhanced LTβR 
triggering on stromal cells, which closes the positive feedback loop132. Recruitment 
and colonialization of other hematopoietic cells to the initial cell cluster leads finally 
to the formation of lymphoid tissue (Fig. 6).  
 
 
 
 
Figure 6: Model for LN development: LTi cells interact with stromal organizer cells via 
LTα1β2  - LTβR. Activated NFκB pathways lead to chemokine secretion and further 
recruitment of LTi cells. Final lymphocyte colonialization leads to the generation of a 
functional LN. Adapted from Mebius, Nature reviews Immunology, (2003)133 
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2.5 The family of innate lymphoid cells 	  
2.5.1 ILC subsets 
	  
Innate lymphoid cells (ILC) are a heterogeneous family of immune cells, which 
recently came into research focus of numerous research groups. ILCs are thought to 
be integrators of the innate and adaptive immune system, orchestrating homeostasis, 
immunity and inflammation134,135. All members of the ILC family share a classic 
lymphoid morphology and lack the characteristical surface-molecule expression of 
other immune cells and are therefore referred to as lineage marker negative (Lin-). In 
contrast to T and B cells, ILCs also lack the expression of Rag and cannot acquire 
Ag specificity136. They express the common cytokine receptor γ chain (γc) and 
depend on cytokines that signal via this receptor. All ILC family members are 
dependent on the transcriptional repressor Id2137 and require different transcription 
factors and cytokines for the development. The function of ILCs is very diverse. They 
play crucial roles in the development of lymphoid tissue, tissue repair, maintenance 
of organ homeostasis and contribute to immunity against pathogens. On the other 
hand, ILCs are also reported to have a role in the promotion of inflammation and 
cancer progression134,135. As ILC subgroups are regulated by transcriptional factors 
and exert effector functions similar to Th subsets, the nomenclature of ILCs is based 
on their Th counterpart. Therefore, ILCs are grouped into i) Group 1 ILC, ii) Group 2 
ILC and iii) Group 3 ILC. 
Group ILC1 consist of the conventional natural killer (cNK) cells and the ILC1s. 
Both cell types are dependent on the T-box transcription factor (T-bet) and are 
capable to secrete IFN-γ . ILC2s are characterized by their developmental 
dependence on IL-7, GATA3, RORα and TCF1 and their production of Th2 
cytokines IL-4, IL-5 and IL-13 upon stimulation. Several studies identified ILC2s as a 
critical mediator of allergic diseases and protective immune cells in helminth 
infections. Group 3 ILCs are dependent on the transcription factors RORγt and 
cytokines such as IL-7, SCF and TSLP138,139135 for their development. ILC3s are 
further subdivided into three different cell types: LTi cells in fetal and neonatal tissue 
and the natural cytotoxicity receptor (NCR) NKp46+ and NKp46- cells, which were 
discovered in adults. While NKp46+ ILC3s are CD4-, CD4+ and CD4- subpopulations 
exist in the NKp46- ILC3 compartment. All ILC3 subtypes can secrete IL-17 and IL-
22 with NKp46- also being able to secrete IFN-γ under certain conditions135 (Fig. 7).  
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Figure 7: Family of innate lymphoid cells: Illustration of the developmental 
requirements and cytokine production of the different ILC subsets. Adapted from Spits et al., 
Nature reviews Immunology, (2013)135 and Artis and Spits, Nature (2015)136 
	  	  	  
2.5.2 Immune functions of ILC3s in adults  
 
LTi cells were originally named after their function to induce lymphoid tissues 
during embryogenesis. Several studies described cells with a similar phenotype also 
in the adult system140, named as LTi - like cell141. However, a new nomenclature 
introduced the terminus NCR- ILC3s for adult RORγt+ ILC3s, which lack NKp46 
expression and resemble very likely the LTi - like cells135. Adult ILC3s exert a broad 
spectrum of functions, which range from tissue remodeling142,143 and maintenance of 
immune homeostasis to pathological properties144-147.  
 IL-17 and IL-22 are cytokines not only produced by T cells but also by ILC3s. 
Studies in mice showed an attribution of IL-17 and IL-22 in psoriasisform plaque 
formation, an inflammatory skin disease. Indeed, analysis of Rag2-/-γc-/-, RORγt-/- and 
Rag-/- mice suggest that ILC3s play a substantial role in psoriasisform plaque 
 
Introduction 
	   25	  
formation, since Rag-/- mice had more sever inflammatory symptoms than Rag2-/- γc-/- 
and RORγt-/- mice146. Further roles for ILC3s in inflammation were shown in the 
intestine of mice145,147. Here, ILC3s were reported to induce colitis through 
production of pro - inflammatory cytokines IL-17 and IFN-γ, driven by TNF-α and IL-
23 producing DCs. This could be confirmed by Thy1 depletion or IL7R-α blocking 
respectively, since reducing ILC3 numbers abrogated colitis145,147. The role of ILC3s 
in promoting immune homeostasis and tissue repair is often mediated by the 
secretion of IL-22134,144,148. In the intestine IL-22 secretion upregulates anti-microbial 
peptide expression by intestinal epithelial cells149 and improves epithelial barrier 
function, which is involved in immune defence against pathogenic bacterial 
colonialization150,151. Mice deficient for IL-22 show higher susceptibility to intestinal 
pathogens and intestinal inflammation152. In addition, ILC3s were found to interact 
with intestinal CD11c+ DCs via membrane bound α1β2, which is known to be crucial 
for IgA production153. Promoting an immunologically tolerogenic state in the intestine 
is important to prevent unwanted inflammation and ILC3s seem to play a substantial 
role in maintaining tolerance. ILC3s process and present antigens via MHC II to T 
cells154,155. Hepwoth et al. observed that ILC3 depletion resulted in dysregulated 
immune responses against commensal bacteria leading to low - grade inflammation. 
This effect occurred independently of IL-17 or IL-22 and was due to missing MHC - T 
cell interaction between ILC3s and CD4+ T cells154. In contrast, other groups could 
not detect spontaneous inflammation in mice lacking MHC II on ILC3155,156, which 
argues for additional factors such as microbiota for triggering inflammation in these 
mice. A recent study described another mechanism of ILC3s to promote tolerance in 
the intestine by production of GM-CSF, which increases the function of intestinal 
DCs and Tregs157. However, the host protective effects of ILC3s are not limited to 
the intestinal environment, since ILC3s were also an important source of IL-17 in the 
lung to mount an immune response against fungal infections158. Tissue remodelling 
functions like wound healing and repair of damaged tissue is also ascribed to ILC3s. 
In an infection model with lymphocytic choriomeningitis virus (LCMV), infected TRCs 
of the LN were targeted by virus-specific CD8+ T cells. This resulted in the 
destruction of the secondary organ integrity. Restoration of the TRC network was 
due to proliferation of LTi cells and their interaction through LTβR with lymphoid 
stromal cells142. Furthermore, it was reported that IL-22 from ILC3s protects the 
intestinal stem cell niche after pretransplantational conditioning and is critical for 
reducing tissue damage during GVHD159. In line with this, Dudakov et al. observed a 
similar effect in the thymus. After total body irradiation, IL-22 production and 
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upregulation of RankL from radio resistant ILC3s resulted in regeneration of the 
thymic environment in an IL-23 dependent manner160.  
 
 	  
2.6 TSLP  	  
Thymic stromal lymphopoietin (TSLP) is a member of the Interleukin (IL) -2 like 
cytokine family, which was first discovered in the supernatant of the murine thymic 
stromal cell line Z210R.1. It was shown to promote the differentiation of FL cells into 
B cell lineage and also the growth of pre - B cells in vitro161. Murine TSLP is a protein 
of 140 amino acids (aa) harbouring a four-helix bundle with three potential sides for 
N-linked glycosylation162. Purification of TSLP upon expression in mammalian cells 
resolved a 23-kD major isoform (140aa) and an 18-kD minor species162. 
Human TSLP gene encodes a protein of 159 amino acids and has poor homology 
with murine TSLP (43% amino acid residues)163,164. However, a set of disulfide 
bonds between 6 cysteines is conserved between human and mouse163. TSLP 
exerts similar biological functions in both species. It is predominantly produced by 
cells of non - hematopoietic origin like epithelial cells in lung, skin and 
gastrointestinal tract165-167 and it was shown that multiple cell types of the adaptive 
and innate immune system are capable to respond to TSLP.  
 
 
2.6.1 TSLP receptor and signaling 
 
The TSLP receptor (TSLPR) also known as cytokine receptor - like factor 2 (CRLF2), 
is a heterodimer and consists of the TSLP - receptor chain, which binds TSLP with 
low affinity and IL-7-Receptor α chain. It has a N-terminal region outside the plasma 
membrane, a single hydrophobic transmembrane domain and an extracellular 
domain, which is also the ligand - binding domain168-170. It is likely that alternative 
splicing results in the two observed murine TSLP - receptor forms of 359 and 370 
amino acids169,171,172. 
TSLPR stimulation activates multiple signal transduction pathways via kinases180 
such as Janus and Src kinases. These kinases regulate the activity of signal 
transducers and activators of transduction (STAT) e.g. STAT5, promoting activation 
and cell proliferation173-175. Similar to TSLP, also mouse and human TSLPR share 
only low amino acid identity (39%). The TSLPR is expressed in mouse and man by 
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various cells of the hematopoietic system, like T and B cells, natural killer (NK) cells, 
monocytes, mast cells, basophils, eosinophils and DCs. The various target cells for 
TSLP reflect the potential role of this cytokine in a wide range of diseases, including 
allergy, cancer and intestinal inflammation176. 
 
 
2.6.2 Role of TSLP in lymphopoiesis 	  
TSLP was initially described to support murine B cell development161. Further studies 
revealed an effect of TSLP on pre B cells and the support of differentiation from 
uncommitted fetal liver and BM precursor into B cell lineage162,177 as well as their 
further differentiation into mature B220+ IgM+ B cells178. The effect of TSLP on B cell 
maturation was also observed in human and can even substitute the effect of IL-7 
deficiency177,179. In addition to its role in B cell development, TSLP was also 
described to affect T cell development. TSLP can drive thymopoiesis independently 
of IL-7 and favours especially the proliferation of DN1 and DN2 thymocytes in vitro180 
and in situ. In vivo, daily injections of recombinant TSLP in WT and γc -/- mice 
resulted in an increase in T cell populations in thymus and periphery181. However, in 
adult TSLPR-/- mice, there is no reduction in DN, double positive or single positive T 
cells. Furthermore, TSLPR-/- mice have neither a deficiency in B cell precursor in the 
bone marrow (BM) nor in the peripheral B cell compartment. Therefore, TSLP seems 
to be redundant in T and B cell development and maintenance under steady state 
coditions181,182, but is essential for their development in the absence of IL-7 180. 
 	  
2.6.3 Activity of TSLP on dendritic cells 
 
DCs were identified to be a potent source of TSLP after Toll like receptor (TLR) 
stimulation183,184. On the other hand, several studies in human and mice identified 
myeloid DCs as a major responder to TSLP. Treating DCs with TSLP improved their 
survival and maturation such as upregulation of MHC II and co-stimulatory 
molecules CD40, CD80 and CD86. These TSLP - conditioned DCs can polarize 
CD4+ T cells towards the Th2 subset and can induce homeostatic proliferation of 
naïve CD4+ T cells, which acquire characteristics of a central memory phenotype185. 
Through interaction of TSLP primed DCs, also CD8+ T cells become activated and 
undergo expansion. After co - culture with DCs, stimulated with TSLP and CD40L, 
CD8+ T cells increase IFN-γ production and gain cytolytic potential186. 
 
Introduction 
	   28	  
2.6.4 Regulation of TSLP 
 
Numerous studies using primary human epithelial cells were designed to 
understand the regulation of TSLP. It was shown that TSLP expression is induced 
upon stimulation with IL-1β, TNF, different TLR like polyI:C and LPS as well as 
bacterial peptidoglycans. It appeared that the activation of the TSLP promoter after 
IL-1β and TNF-α treatment is mediated by an upstream NFκB site187,188, but could 
also be activated via the MAPK pathway189. TSLP conditioned DCs were shown to 
induce the differentiation of naïve CD4+ T cells into Th2 cells, which produce IL-4, IL-
13 and TNF-α 87,190. TSLP expression can be further induced by the Th2 cytokines 
IL-4 and IL-13 as well as dsRNA. This indicates a positive feedback loop to amplify 
Th2 inflammation e.g. during viral infections 191,192. The nuclear receptor subtypes 
Retinoic X receptors α and  β (RXRα/β) seem to be negative regulators of TSLP, 
since mice deficient for RXR α and RXR β in epidermal keratinocytes expressed 
higher amounts of TSLP and developed cutaneous inflammation193. RXR can form a 
heterodimer with vitamin D receptor (VDR). Application of vitamin D3 results in 
increased TSLP expression in keratinocytes, whereas application of vitamin D3 on 
the skin of RXR-/- mice or mice deficient for VDR does not increase TSLP 
expression194,195. There is evidence that RXR mediates TSLP repression via the 
inhibition of NFκB, rather than direct binding of RXR to the TSLP promoter196. 
Aberrant Notch signaling in the skin results in a loss of barrier function. As a result 
TSLP is systemically released in large amounts leading to atopic dermatitis - like 
symptoms197,198. Taken together, these results suggest, that inflammation, epithelial 
damage and skin barrier dysfunction positively regulate TSLP expression. 
 
 
 
Aim of the study 
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3 Aim of the study  	  
 
Reconstitution of the adaptive immune system after HSCT is a major clinical issue, 
as the re - establishment of a functional T cell pool is delayed and even years after 
transplantation, patients suffer from infections and relapse of malignancies. 
Pretransplantational treatments with cytotoxic drugs and radiotherapy destroy the 
thymic microenvironment, which leads to impaired T lymphocyte development. 
Studies in fetal mice demonstrated that ILC3s as well as γδ T cell progenitors exhibit 
a supportive function in the maturation process of mTECs before birth, which assures 
adequate T cell development75,76. It remains unclear whether ILC3s also indirectly 
play a beneficial role in de novo T cell development in immunodeficient settings. 
Rag2-/-γc-/- mice are devoid of T, B and NK cells and therefore represent a mouse 
model for combined immunodeficiency in humans. In addition, these mice are devoid 
of LNs, PPs and ILCs. In Rag2-/-γc-/- mice overexpressing TSLP (referred to as K14 
TSLP+/- Rag2-/- γc-/-mice) ILC3 numbers are increased and almost all LNs are present. 
In my project, I wanted to investigate the role of increased ILC3 numbers and LNs on 
the reconstitution of the adaptive immune system after HSCT in immunodeficient 
mice. In order to address this question, Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- mice 
were transplanted with FL cells or mature T cells from TSLPR-/- mice and analysed 
for the efficiency of reconstitution in primary and secondary lymphoid organs. 
 
Materials and methods 
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4 Materials and methods  	  
4.1 Materials 	  
4.1.1 Reagents and chemicals 	  
Acetone Sigma-Aldrich 
Agarose Sigma-Aldrich 
Amphotericin B Sigma-Aldrich 
2’-Deoxyguanosine monohydrate Sigma-Aldrich 
2-Mercaptoethanol Gibco 
2-Propanol (CH3CH(OH)CH3) Merck KgaA 
2x SensiMix SYBR Hi-ROX Bioline 
Albumin from bovine serum (BSA) Sigma-Aldrich 
Alum (Aluminium potassium sulphate, AlK(SO4)2) Sigma-Aldrich  
Ammonium chloride (NH4Cl) Sigma-Aldrich 
Anti-CD4 microbeads Miltenyi Biotec 
Anti-PE microbeads Miltenyi Biotec 
4-Bromo-2-chlorophenol Sigma-Aldrich 
Brefeldin A (BFA) Sigma Aldrich 
Calciumchloride Merck KgaA 
Carboxyfluorescein succinimidyl ester (CFSE) Molecular Probes 
Ciproxine Bayer (0.2%) 
Collagenase D Roche 
4’, 6-Diamidino-2-pheylindole (DAPI)  AppliChem 
Deoxyadenosine triphosphate (dATP)  Sigma-Aldrich 
Deoxycytidine triphosphate (dCTP)  Sigma-Aldrich 
Deoxyguanosine triphosphate (dGTP)  Sigma-Aldrich 
Deoxythymidine triphosphate (dTTP)  Sigma-Aldrich 
Di-ethanolamine (C4H11NO2)  Sigma-Aldrich 
Di-nitrophenyl phosphate (dNPP)  Sigma-Aldrich 
Di-potassium hydrogen phosphatate (K2HPO4)   Merck KgaA    
Di-sodium hydrogen phosphatate (Na2HPO4 x 2 H2O)  Merck KgaA 
Di-thiothreitol (DTT)  AppliChem 
DMEM (1x) GlutaMaxTM-I  Gibco 
DNase I  Roche 
Materials and methods 
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EDTA disodium salt dihydrate  AppliChem 
Fluoromount-G™ eBioscience  
Ethanol (C2H5OH)  Merck KgA 
Fetal calf serum (FCS, heat-inactivated)  Gibco 
D (+) – Glucose monohydrate  Merck 
Gentamycin   Life technologies 
GlycoBlue™  Life technologies 
Hydrochloric acid (HCl)  Sigma-Aldrich 
Insulin Transferrin Selenium  Gibco 
Ionomycin  AxonLab 
Iscove`s modified Dulbecco`s medium (IMDM)  Sigma-Aldrich 
Kanamycin  Sigma-Aldrich 
Liberase  Roche 
Methanol  Merck KgA 
Magnesium chloride hexahydrate (MgCl2 x 6 H2O)  AppliChem 
Nonessential amino acids (NEAA)  Gibco (100 x) 
Nuclease free H2O  life technologies 
O.C.T™  Tissue-Tek® 
Oligo dT   Promega 
Phosphate buffered saline (PBS)  Biochrom AG 
Penicillin Streptomycin (Pen/Step)  Gibco 
Percoll  GE Healthcare 
Paraformaldehyde (PFA)  AppliChem 
Phorbol-12-myristat-13-acetat (PMA, C36H56O8)  Sigma-Aldrich 
Potassium bicarbonate (KHCO3)  Sigma-Aldrich 
Potassium chloride (KCL)  AppliChem 
Primatone  Sigma-Aldrich 
Proteinase K  Roche 
Saponin  Sigma-Aldrich 
Sodium acide (NaN3)  Merck KgaA 
Sodium chloride (NaCL)  AppliChem 
Sodium dodecyl sulfate (SDS)  BioRad 
Sodium hydrogen carbonate (NaHCO3)   Merck KgaA 
Sodium hydroxide (NaOH)  Merck KgaA 
SuperScriptTM III Reverse Transcriptase Invitrogen 
Taq Polymerase  Sigma-Aldrich 
Tris (C4H11NO3)   Carl Roth GmbH 
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TRI-Reagent® Sigma-Aldrich  
Tween-20 AppliChem 
 
4.1.2 Buffers, solutions and media 
 
1x PBS 137 mM NaCl 
 2.7 mM KCl 
 10 mM Na2HPO4 x 2 H2O 
 2 mM KH2PO4 
 in dH2O 
 
1x TE buffer 10 mM Tris 
 1 mM EDTA 
 in dH2O 
      
DMEM (1x) GlutaMaxTM-I (+) 4.5 g/L D-Glucose 
 (-) Pyruvate 
 
dNTP mix 10 mM sATP   
 10 mM sCTP 
 10 mM sGTP 
 10 mM sTTP 
 in nuclease free H2O 
 
ELISA buffer (NP-OVA ELISA) 1 % BSA  
 0.2 % Tween-20 
 in 1x PBS 
 
ELISA wash buffer (NP-OVA ELISA) 0.1 % Tween-20 
 in H2O 
 
Erythrolysis buffer 0.15 M NH4Cl 
 10 mM KHCO3 
 0.1 mM EDTA 
 in dH2O (pH 7.2 – 7.4) 
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Fixation buffer 1x PBS 
 4 % PFA 
 
FACS buffer 1x PBS 
 3 % FCS 
  
IMDM (SF) IMDM (powder) 
 3.02 g NaHCO3 
 1 % Pen/Step 
 1 % Ciproxine 
 0.1 % Kanamycin 
 1 % Insulin Transferrin  Selenium 
 0.3 % Primatone 
 1 % NEAA 
 0.1 % 2-mercaptoethanol 
 
IMDM 5 % FCS IMDM (SF) 
 5 % FCS 
 
IMDM 10 % FCS IMDM (SF) 
 10 % FCS 
 
Lysis buffer  100 mM Tris (pH 8.0) 
(for DNA isolation from mouse biopsies) 200 mM NaCl   
 5 mM EDTA (pH 8.0)  
 0.2 % SDS   
 in dH2O  
 
Permebabilization buffer for intracellular staining 0.5 % Saponin 
 10 mM NaN3 
 in FACS buffer 
 
Stromal cell isolation buffer DMEM (1x) GlutaMaxTM-I 
 2 % FCS 
 1.2 mM CaCl2 
 1 % Pen/Step 
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Substrate buffer (NP-OVA ELISA) 0.1 g MgCl2 x 6 H2O 
 10 mM NaN3   
 10 % C4H11NO2  
 in dH2O (pH 9.8)   
 
Thymus organ culture (TOC) medium IMDM 
 10% FCS 
 10-5 nM β-mercaptoethanol 
 1 % Kanamycin 
  
 
4.1.3 Cytokines, TLR ligands, peptides, proteins 	  
IL-7, recombinant Peprotech 
IL-23, recombinant eBioscience 
SCF, recombinant Peprotech 
TSLP, recombinant R&D 
RankL home made 
 
4-Hydroxy-3-nitrophenylacetyl NP- (18)-OVA  Biosearch Technologies Inc. 
 
 
4.1.4 Antibodies (Abs) 	  
Abs for flow cytometry analyses (directed against murine proteins) 
 
Specificity Clone 
Aire 5H12 
CD3ε  17A2, 145-2C11    
CD4  RM4-4, RM4-5 and GK1.5 
CD8α 53-6.7      
CD11b  M1/70 
CD11c  N418     
CD19  6D5     
CD21 7G6 
CD23  B3B4 
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CD24 M1/59 
CD25 (IL-2Rα) PC61      
CD31 390 
CD35 8C12 
CD40 1C10     
CD44 IM7  
CD45 30-F11 
CD45R (B220) RA3-6B2     
CD54 (ICAM-1) 3E2 
CD62L  MEL-14      
CD69  H1.2F3  
CD80  16-10A1 
CD86 GL1   
CD90.2 (Thy1.2) 30-H12 
CD103 2E7 
CD106 (VCAM-1) 429 
CD117 (ckit) 2B8 
CD127 (IL-7Rα)  A7R34  
CD196 (CCR6) 140706 
CD278 (ICOS) C398.4A   
CD326 (EpCAM) G8.8     
Foxp3 FJK-16s 
GATA-3 TWAJ 
GmCSF MP1-22E9 
Gp38 (Podoplanin) 8.1.1  
Gr-1  RB6-8C5     
Helios 22F6 
IFNγ  XMG1.2     
IgM II/41 
IL-5 TRFK5 
IL-13 eBio13A 
IL-17 TC11-18H10 
IL-22 1H8PWSR 
Ly51 6C3 
MHC II  M5/114.15.2,  
NKp46  29A1.4 
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NK1.1  PK136 
RORγt  AFKJS-9, B2D 
STAT5 47  
TCRβ  H57-597 
TCRγδ  GL3, UC7-13D5 
TER-119 TER-119 
UEA-1 
 
All reagents were purchased from BD Bioscience, eBioscience, Biolegend, R&D 
systems or Vector Laboratories. Primary monoclonal Abs (mAbs) were conjugated to 
either fluorescein isothycyanate (FITC), phycoerythrin (PE), allophycocyanin (APC), 
Alexa Fluor® 700, brilliant violet 421, 510, or 605 (BV421TM, BV510TM BV605TM,), 
phycoerythrin cyanine 7 (PECy7), peridinin chlorophyll (PerCP)-eFluor 710, Percp-
Cy5.5, allophycocyanin cyanine 7 (APC-Cy7), or Texas Red®. 
Biotin-conjugated primary mAbs were detected using secondary anti-rat polyclonal 
Abs conjugated to Streptavidin/APC-Cy7, Streptavidin/BV421TM, 
Streptavidin/BV510TM or Streptavidin Percp-Cy5.5. Blocking of Fc receptors was 
performed using anti-mouse FcγRII/III mAb (clone 2.4G2, purified supernatant, home 
made). 
 
 
Abs used for ELISA (NP-OVA) 
For coating of plates: 
Purified anti-mouse IgM (unlabeled) M41 (A. Rolink, University of 
 Basel) 
Purified anti-mouse IgG (unlabeled) 15H6 (SouthernBiotech) 
 
For detection: 
Biotin-conjugated goat anti-mouse IgG Caltag Laboratories 
Alkaline phosphatase (AKP) – Streptavidin Roche 
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Abs used for Immunofluorescence 
 
Aire 5H12 
CK5 Rabbit PRB-160B  
  (Covalence, Princeton, NJ) 
CK8-Cy5 TROMA-1 
(Developmental Studies 
Hybridoma Bank, University of 
Iowa)     
goat-αRabbit-Alexa 555  Molecular Probes 
 
 
4.1.5 Primers for quantitative real time PCR (qRT PCR) 
 
 
Primer Sequence 
Aire forward	   5’TGTGCCACGACGGAGGTGAG3’ 
Aire reverse	   5’GGTTCTGTTGGACTCTGCCCTG3’ 
β -actin forward 5’CAATAGTGATGACCTGGCCGT3’ 
β -actin reverse 5’AGAGGGAAATCGTGCGTGAC3’ 
CCL19 forward	   5’CCTGGGTGGATCGCATCATCCG3’ 
CCL19 reverse	   5’AGAGCATCAGGAGGCCTGGTCCT3’ 
CCL21 forward	   5’AGCTATGTGCAAACCCTGAGGA3’ 
CCL21 reverse	   5’TTCCAGACTTAGAGGTTCCCCG3’ 
CCL25 forward 5’GTTACCAGCACAGGATCAAAT3’ 
CCL25 reverse 5’GGAAGTAGAATCTCACAGCA3’ 
CD80 forward 5’CCTGGGAAAAACCCCCAGAA3’ 
CD80 reverse 5’ACAACGATGACGACGACTGT3’ 
CxCL12 forward 5’AAATCCTCAACACTCCAAAC3’ 
CxCL12 reverse 5’GCTTTCTCCAGGTACTCTTG3’ 
EpCAM forward 5’TGAGGACCTACTGGATCATC3’ 
EpCAM reverse 5’TATCGAGATGTGAACGCCTC3’ 
FGF 10 forward	   5’AGGGGAAACTCTATGGCTCAAAAG3’ 
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Primer	   Sequence 
FGF 10 reverse 5’GCCACATACATTTGCCTGCC3’ 
IL-7 forward 5’GATAGTAATTGCCCGAATAATGAACCA3’ 
IL-7 reverse 5’GTTTGTGTGCCTTGTGATACTGTTAG3’  
IL-15 forward 5’GACGGGATCCTGCTGTGTTT3’ 
IL-15 reverse 5’AGGTGGATTCTTTCCTGACCTC3’ 
IL-22 forward 5’GAGTCAGTGCTAAGGATCAG3’ 
IL-22 reverse 5’TCAGAGACATAAACAGCAGG3’ 
KGF forward	   5’CATGCTTCCACCTCGTCTGT3’ 
KGF reverse	   5’CAGTTCACACTCGTAGCCGT3’ 
PDGFRα forward 5’AAGACCTGGGCAAGAGGAAC3’ 
PDGFRα reverse	   5’GAACCTGTCTCGATGGCACT3’ 
RankL forward	   5’CCTGTACTTTCGAGCGCAGA3’ 
RankL reverse 5’CCAGAGTCGAGTCCTGCAAA3’ 
SCF forward 5’AAGGAGATCTGCGGGAATCC3’ 
SCF reverse 5’CGGCGACATAGTTGAGGGTTA3’ 
TBP forward 5’GGCACCACCCCCTTGTACCCT3’ 
TBP reverse 5’ACGCAGTTGTCCGTGGCTCT3’ 
XCL1 forward 5’ATGGGTTGTGGAAGGTGTGG3’ 
XCL1 reverse 5’AGCCGCTGGGTTTGTAAGTT3’ 	  	  	  
4.1.6 Kits 	  
Foxp3 staining buffer set  eBioscience    
LIVE/DEAD® Fixable Aqua Dead Cell Stain Kit  Molecular Probes 
RNeasy Micro Kit Qiagen 
RNeasy Mini kit Qiagen 
RT2 HT first strand kit Qiagen 
RT2 PCR Arrays  Qiagen 
SensiMix SYBR Hi-ROX Kit Bioline     
SuperScriptTM III Reverse Transcriptase Invitrogen 
Zombie AquaTM Fixable Viability Kit  BioLegend 
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4.1.7 Tools and instruments 	  
Asys Expert Plus Microplate Reader Biochrom 
AutoMACS Pro Miltenyi Biotec 
Cell strainer (70 µm / 100 µm) Falcon 
Cell counter CASY INNOVATIS Roche 
Eppendorf centrifuge 5810 R, 5415 R, 5417 R Eppendorf 
Eppendorf Mastercycler Gradient Eppendorf 
ELISA plate reader ASYS Expert Plus 
Flow cytometer BD FACSAria Ilu BD Bioscience 
Flow cytometer BD FACSCanto II BD Bioscience 
BD LSR Fortessa BD Biosciences 
gentleMACS™ Octo Dissociator Miltenyi Biotec 
MAXI sorb 96 well plates for ELISA Nunc  
Microscope DMI 4000  Leica     
Micro tube 1.3 mL K3E Sarstedt 
Nanodrop 2000c Thermo Scientific 
Nucleopore Track-Etch Membrane Millipore 
(poresize: 0.8 µm) 
Rotorgene RT PCR machine (RG-3000A) Corbett Research 
Zirconia beads BioSpec Products 
 
 
4.1.8 Software 	  
FlowJo 9.7.6    
GraphPad Prism 6    
ImageJ   
Microsoft Office for Mac 14.4.3   
 
 
4.1.9 Mice 
C57BL/6 were purchased from Janvier (Saint Berthevin Cedex, France). TSLPR-/-181, 
K14 TSLP+/- Rag2-/-γc-/-180, RORγ-/-199, Rag2-/-200(Jackson), were previously described. 
Rag2-/-γc-/- on C57BL/6 background were provided by Jörg Kirberg,MPI Freiburg, 
Germany. All mice were kept under specific-pathogen free (SPF) conditions. The 
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animal experiments received the approval of the Cantonal Veterinary Office of the 
city of Basel, Switzerland. 
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4.2 Methods 
 
4.2.1 Genotyping  
 
Isolation of DNA 
For isolation of genomic DNA, biopsies were digested in 500 µL lysis buffer 
containing 100 µg/mL Proteinase K (at least 3 h at 55 °C while shaking at 700 rpm on 
a heat block). 500 µL H2O was added for further dilution and stored at 4 ºC. 
 
TSLP PCR 
Primer TSLP Fwd: 5’ GGAGCCTCTTCATCCTGCAA 3’ 
Primer TSLP Rev: 5’ TCCGGGCAAATGTTTTGTCG 3’ 
 
PCR reaction mix: 
2.5 µl  10x buffer  
0.5 µl  TSLP fwd primer (10 µM) 
0.5 µl  TSLP rev primer (10 µM) 
0.5 µl  dNTPs (10 mM)   
0.1 µl    Taq Polymerase (Sigma) 
 20 µl   dH2O 
   1 µl  genomic DNA 
 
PCR program for amplification:  
 
step 1  94 ºC  5’ 
step 2  94 ºC  30” 
step 3  63 ºC  30” 
step 4  72 ºC  30”          step 2 - 4   31 x 
step 5  72 ºC  10’ 
step 6  20 ºC  hold 
 
product length:   
TSLP: ~252 base pairs (bp) 
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4.2.2 Cell isolation  
Lamina propria lymphocytes (LPL) from colon and small intestine (SI) were 
isolated by enzymatic digestion. Briefly, SI was opened longitudinally, feces were 
removed, and SI was cut into 2 cm pieces. After incubation in 25 mL of 30 mM EDTA 
solution in Ca2+- and Mg2+- free PBS for 30’ on ice, the tube was shaken 
vigourously and washed with PBS several times until PBS was clear without debris. 
Tissue was cut in smaller pieces and incubated in pre – warmed DMEM plus 0.025 
mg/mL DNaseI (Roche) and1 mg/mL Collagenase D (Roche) at 37 ºC. After 15 min, 
tissue pieces were pipetted up and down and supernatant was filtered through a 100 
µm filter into a collection tube containing 15 mL DMEM, 5% FCS, 2mM EDTA. 
Incubation steps were repeated 3 times with fresh Collagenase D. After the last 
digestion step, cell suspension was pelleted, resuspended in 5 mL 40 % Percoll, 
underlaid with 3 mL 80 % Percoll and centrifuged for 30’ at 20 ºC (1800 rpm, 
acceleration 4, brake 1). Cells of the interphase were collected and washed once 
with PBS. 
Colon (w/o cecum) was opened longitudinally, feces were removed, and colon 
was cut into 1 cm pieces. Tissue pieces were incubated in 25 mL of 5 mM EDTA plus 
10 mM HEPES solution in Ca2+- and Mg2+- free PBS for 20 min at 200 rpm shaking 
at 37 ºC. Incubation steps were repeated 3 times in fresh EDTA/HEPES solution 
followed by a washing step with DMEM. Tissue was transferred to gentle MACS tube 
with 5 mL pre-warmed DMEM, 0.025 mg/mL DNaseI, 1 mg/mL Collagenase D, 0.25 
mg/mL Collagenase VIII and incubated for 2x 30’ at 37 ºC interrupted by 2 cycles of 
tissue dissociation with gentleMACS™ Octo Dissociator (Miltenyi Biotech). Cell 
suspension was filtered through a 100 µm filter into a collection tube containing 15 
mL DMEM, 5% FCS, 2mM EDTA, peletted, resuspended in 2 mL 40 % Percoll 
underlaid with 1.2 mL 80 % Percoll and centrifuged for 30’ at 20 ºC (1800 rpm, 
acceleration 4, brake 1). Cells of the interphase were collected (total LP 
lymphocytes). 
 
Thymocytes and splenocytes were either gained by mashing the tissue through a 
metal grid (Ø 0.8 mm) in FACS buffer or by cutting the tissue and digesting it 
enzymatically by 4 rounds with DMEM, 0.025 mg/mL DNaseI, 1 mg/mL Collagenase 
D at 37 ºC as described earlier. Erythrocytes were lysed with erythrolysis buffer (2’ at 
RT). 
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Thymic ILC3s were isolated by enzymatic digestion as described. For WT and 
RORγt-/- mice, thymocytes were depleted with a Lin cocktail (CD3ε, CD8α, CD11c, 
B220, CD19 TCRαβ, TCRγδ, GR-1, NK1.1) by MACS before staining for ILC3 marker, 
whereas total thymi were analysed in case of Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- 
mice. 
 
Bone marrow (BM) was recovered by crushing the bones of femurs and tibias in 
FACS buffer. Erythrocytes were lysed with erythrolysis buffer (2’ at RT). 
 
Thymic epithelial cell isolation of K14 TSLP+/- Rag2-/-γc-/- and Rag2-/-γc-/- was 
performed by enzymatic digestion in PBS with 1 Wünsch unit/mL Liberase (Roche), 
0,025 mg/mL DNaseI at 37 ºC. Total cells were used for antibody staining. 
For WT, thymi were isolated and enzymatically digested with 1 Wünsch unit/mL 
Liberase (Roche), 0,025 mg/mL DNaseI at 37 ºC. The enzymatic digests were 
incubated with biotin-conjugated EpCAM (G8.8) followed by anti-biotin magnetic 
microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and enrichment of EpCAM+ 
stromal cells by positive selection on an AutoMACS Pro (Miltenyi).  
 
Isolation of stromal cells from spleen and lymph nodes 
Stromal cell populations were isolated according to the protocol adapted from Link 
et al.109. Briefly, spleen and lymph nodes were opened with needles and digested in 
DMEM (1.2 mM CaCl2, 2% FCS, Pen/Strep) plus Collagenase IV (1mg/mL) and 
DNaseI (0.04 mg/mL) to isolate lymphocytes. In a second digestion step with DMEM, 
Collagenase D (1mg/mL) and DNaseI (0.04 mg/mL), stromal cells were isolated and 
analysed by flow cytometry or further sorted to isolate subpopulations. 
 
4.2.3 Flow cytometry and cell sorting 
Cell suspensions were stained with biotinylated or fluorochrome-conjugated Abs (30’, 
4 ºC) in FACS buffer. Fc receptors were blocked by incubation with anti-mouse 
FcγRII/III mAb (clone 2.4G2). Fluorochrome-conjugated streptavidin was added as a 
second incubation step (30’, 4 ºC) for stainings, which included biotinylated Abs.  
Intracellular RORγt staining was performed using Foxp3 staining buffer set 
(eBioscience) after surface molecule staining according to manufacturer’s protocol. 
For intracellular cytokine staining, cells were stimulated for 4h with PMA (50 ng/mL) 
and Ionomycin (2.5 µg/mL) or IL-23 (20 ng/mL) and incubated with BFA (10 µg/mL) 
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for the last 2h at 37ºC. Cells were washed with FACS buffer and fixed with 4 % PFA 
in PBS for 10min on ice, washed twice with FACS buffer and stained for the 
respective Abs in 0.5 % Saponin in FACS buffer. Intracellular Aire staining was also 
performed in 0.5 % Saponin in FACS buffer after fixation with 4 % PFA in PBS. 
Dead cells were identified using LIVE/DEAD® Fixable Aqua Dead Cell Stain Kit or in 
case of non-fixed cells with DAPI.  
Data were acquired with either FACS Canto II or LSR Fortessa and analysed with 
FlowJo software (Tree Star). Cell sorting was performed with FACS Aria Ilu (BD 
Bioscience, >98 % purity). Absolute cell numbers derived from various organs were 
determined by counting cells with the cell counter CASY INNOVATIS (Roche). 
 
4.2.4 Fetal and re-aggregated thymus organ culture (FTOC and RTOC)  
For FTOCs, fetal thymic lobes were isolated from embryonic day 14.5 (E14.5) WT 
embryos and cultured for 5 days on membranes (Millipore) in the presence of 1.35 
mM 2``- Deoxyguanosine in TOC medium (IMDM, 10% FCS, 10-5 nM β-
mercaptoethanol, 1 % Kanamycin) to deplete hematopoietic cells. Membranes were 
transferred to fresh medium for one day followed by application of RankL (home 
made): 10 µg/mL; TSLP (R&D): 25, 50 or 100 ng/mL) for 5 days. Lobes were 
harvested and disaggregated in FACS buffer, 0,025 mg/mL DNaseI, 1 mg/mL 
Collagenase D for 15’at 37 ºC followed by surface molecular staining. 
For RTOCs, fetal thymic lobes were isolated from WT E14.5, disaggregated in 
TOC medium with 0,025 mg/mL DNaseI, 1 mg/mL Collagenase D for 15’at 37 ºC and 
sorted for CD45- TER119-. Sorted cells were re-aggregated in TOC medium 
(supplemented with 0.25 mg/mL Gentamicin, 10µg/mL Amphoterizin, 4000U 
Pen/Strep, 25 ng/mL IL-7 and 20 ng/mL SCF) in a 1 : 2 ratio with DN3s (sorted for 
CD25+ CD44-) or LPL ILC3s (*Lin-, CD90.2+, CD117+) from Rag2-/- mice for 4 days 
and analysed by flow cytometry. (*CD3ε, CD8α, CD11c, CD19, B220, GR-1, NK1.1) 
 
4.2.5 Phosphoflow  
WT tymic epithelial cells were isolated and stained for surface molecules according to 
manufactured protocol; BM cells were recovered as described. Cells were 
resuspendet in appropriate amount of SF-IMDM 5% FCS and allowed to rest for 2h at 
37ºC in 1.5 mL Eppendorf tubes. Cells were then stimulated for 10min at 37ºC with 
either recombinant TSLP (R&D): 25, 50 or 100 ng/mL or IL-7: 20ng/mL (Peprotech) or 
left unstimulated. Cells were fixed for 15 minutes with 2% PFA (AppliChem) at 37ºC. 
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Permeabilization was done with 100% methanol on ice for 30 min and phospho - 
STAT5 staining was performed at room temperature (RT) for 30 min. 	  
4.2.6 Reconstitution with FL cells and immunization 
Fetal liver (FL) cells from E14.5 TSLPR-/- were isolated. Erythrocytes were lysed with 
erythrolysis buffer (2’ at RT) and 5x106 cells/mouse were injected i.v. into Rag2-/-γc-/- 
or K14 TSLP+/- Rag2-/-γc-/-mice.  
Mice were immunized intraperitoneally (i.p.) with 100 µg alum-precipitated NP-
Ovalbumin (NP (18)-OVA) 6 weeks after FL transfer (day 42) and boosted with 100 
µg alum-precipitated NP-OVA 12 days after the first immunization. Sera were 
collected before immunization (day 42) and 7 days after the second immunization 
(day 61) with NP-OVA. 	  
4.2.7 Antibody detection by ELISA  
To detect NP-OVA-specific Abs in the serum of immunized mice, NUNC 
immunoplate Maxisorb F96 plates were coated with 5 µg/mL NP-OVA (Biosearch 
Technologies Inc.) in 1x PBS at 4ºC o/n. Plates were washed (H2O 0.1% Tween-20) 
and incubated with sera for 1 h at RT. After washing, biotin-conjugated goat anti-
mouse IgG (Caltag Laboratories, 1 h, RT) was added and detected by alkaline-
phosphatase (AKP)-conjugated Streptavidin (Roche, 45’, RT). Plates were 
developed with dinitrophenyl phosphate (dNPP, 1 mg/mL, Sigma) in substrate buffer. 
The reaction was stopped with 1 M NaOH (Fluka). The optical density (OD) was 
determined at 405 nm with an ELISA reader (ASYS Expert plus).  
To detect total IgM and total IgG levels in the serum of reconstituted mice, NUNC 
immunoplate Maxisorb F96 plates were coated with either 5 µg/mL purified anti-
mouse-IgM (unlabeled, clone M41) or purified anti-mouse IgG (clone 15H6) in 1x 
PBS at 4ºC o/n, followed by described protocol. 
 
4.2.8 T cell proliferation assay in vivo 
T cells from spleen and lymph nodes of TSLPR-/- mice were magnetically purified 
with αCD4 - beads (LTR4, Miltenyi Biotec) or stained for αCD8 – PE followed by an 
incubation step with αPE -  beads. CD4+ and CD8+ T cells were pooled (ratio 1:2) 
and labeled with 45 µM carboxyfluorescein succinimidyl ester (CFSE) for 8’ at RT in 
the dark. The reaction was stopped with 80% FCS in Ca2+- and Mg2+- free PBS. 
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Cells were washed, resuspended in PBS and 1x107 cells/mouse were injected i.v. . 
For naïve T cell transfer, a magnetic depletion (Miltenyi Biotech) with B220, CD19, 
CD11c, NK1.1 was performed and naïve T cells were sorted for CD4+ respective 
CD8+, CD62L+ and CD44low/- expression (>98 % purity). Sorted naïve CD4+ and CD8+ 
cells were pooled (ratio 1:2), labeled with 45 µM CFSE as described and 2x106 
cells/mouse (ratio 1:2) were injected i.v.  
 
4.2.9 Immunfluorescence 
Organs were frozen in O.C.T™ (Tissue-Tek®) in liquid N2. Sections were cut on a 
cryostat (8 µm), fixed in acetone and rehydrated in PBS. After blocking with 1 % BSA 
in PBS (30’ at RT) in a wet chamber, sections were incubated with fluorochrome-
conjugated or purified Abs (1 h at RT). Secondary Abs were applied (1h at RT or o/n 
at 4ºC) for stainings including purified Abs after washing twice in PBS (5’ at RT). 
After one wash in PBS, sections were embedded in Fluoromount-G™. 
 
4.2.10 RNA isolation, cDNA synthesis and qRT PCR 
For RNA isolation from tissue, tissue pieces were frozen in liquid nitrogen (LiqN2) in 
1.5 mL Micro tubes PP (Sarstedt) containing Zirconia beads (BioSpec Products). 
Tissue was homogenized in 1mL TRI-Reagent® with a FastPrep-24 instrument (MP 
Biomedicals) for 1’ at 6.5 m/s and RNA was isolated according to manufacturer’s 
protocol. For sorted cells or small tissue quantities, homogenization was performed 
through a 25G needle. RNA was isolated according to manufacturer’s protocol with 
the help of GlycoBlue as a co - precipitant. In case of sorted stromal cells, RNA was 
isolated using the RNeasy Micro Kit (Qiagen) according to manufacturer’s protocol. 
RNA quantification and quality assessment were performed on a Nanodrop 2000c 
(Thermo Scientific Inc.). First strand cDNA was synthesized by using SuperScriptTM 
III Reverse Transcriptase (Invitrogen) according to manufacturer’s instructions. 
Quantitative Real –time (qRT) PCR was performed on a Rotor-Gene RG-3000A 
(Corbett research) using SensiMix SYBR Hi-Rox Kit (Bioline, London, UK). Results 
were normalized to the housekeeping gene TATA box binding protein (TBP) or β-
actin, using the comparative threshold cycle method (ΔCT) for relative quantification. 
Data of mRNA levels in the small intestine were obtained by RNA isolation of 3x1 
cm tissue combined from duodenum, jejunum and ileum of the small intestine. RNA 
was isolated with RNeasy Mini Kit (Qiagen) according to manufacturer’s instructions 
followed by first strand cDNA synthesis with RT2 HT First Strand Kit (Qiagen). 
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Custom arranged RT2 PCR Arrays (Qiagen) were performed by T. Dolowschiak, 
Microbiology ETH Zürich. Results were normalized to the housekeeping gene β-actin, 
using the comparative threshold cycle method (ΔCT) for relative quantification. 
 
4.2.11 Statistical analyses 
Statistical analyses were performed using Mann Whitney U test or unpaired Students 
t-test with Prism software (GraphPad Software, Inc.). P values < 0.05 are considered 
to be statistically different. 
Results 
 
	   48	  
5 Results 	  
5.1 Characterization of Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- 
mice 	  
Primary and secondary lymphoid organs were characterized in Rag2-/- γc-/- and 
K14 TSLP+/- Rag2-/- γc-/- mice with a particular emphasis on the architecture and 
maturation of the thymus stroma as well as LN stromal cells. 	  
 
5.1.1 TSLPtg increases thymus size and thymic cellularity 
 
Macroscopic analysis of 6 - 8 weeks old Rag2-/- γc-/- mice revealed that these mice 
had very small thymi containing cysts compared to K14 TSLP+/- Rag2-/- γc-/- mice and 
WT mice (Fig 8A). Contrary to Rag2-/- γc-/- mice, in which thymocytes accumulate at 
the CD25- CD44+ double negative (DN) 1 stage, K14 TSLP+/- Rag2-/- γc-/- mice 
showed higher thymocyte frequencies in the DN2 and DN3 stage (Fig. 8B). This was 
also reflected by the higher total thymus cellularity (Fig. 8C) as well as the significant 
higher numbers of DN2s and DN3s in K14 TSLP+/- Rag2-/- γc-/- mice (Fig. 8D). These 
results are in line with previous studies demonstrating a role for TSLP on thymocyte 
precursor development180. However, mice with TSLP overexpression do not reach 
DN frequencies of WT controls beyond DN1 (Fig. 8B).  
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Figure 8: TSLPtg increases thymus size and number of DN thymocytes in Rag2-/-γc-/- 
mice. A) Representative photographic picture of thymi from WT (i) Rag2-/- γc-/- (ii) and K14 
TSLP+/- Rag2-/- γc-/- mice (iii). Scale bar represents 1mm. B) Flow cytometry analysis of DN1 
(CD117high CD25- CD44+), DN2 (CD117high CD25+ CD44+) and DN3 (CD25+ CD44-). Numbers 
in dot plots represent frequencies of a representative experiment C) Absolute cell numbers of 
total thymus. D) Absolute cell numbers for DN1, DN2 and DN3; C - D) n = 7 from 2 
independent experiments; median values + interquartile range; n.s. = not significant, 
***P<0.001.  
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5.1.2 TSLPtg expression improves thymic stromal compartment 
 
To investigate whether TSLPtg expression does not only increase the absolute 
number of DN thymocytes but has also an effect on the thymic epithelial 
compartment, WT, Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- thymi were stained with 
αCK5 (medulla marker) and αCK8 (cortical marker). Immunofluorescence analysis of 
WT thymic sections showed a compartimentalization into cortex and medulla (Fig. 9A, 
i and ii), whereas Rag2-/- γc-/- mice showed preferentially CK5 CK8, double positive 
cells and no segregation into compartments (Fig. 9A iii and iv). K14 TSLP+/- Rag2-/- 
γc-/- thymi showed partial segregation of the epithelial cells in CK5 as well as CK8 
single positive cells, beside double positive cells for CK5 and CK8 (Fig. 9A v and vi). 
A feature of medullary thymic epithelial cells (mTECs) is the expression of the 
transcription factor autoimmune regulator (Aire), which is crucial for the 
establishment of central tolerance51. In WT mice, Aire+ cells were confirmed to 
localize in the thymus medulla. No Aire+ cells were detected in Rag2-/-γc-/- mice, and a 
very small number of Aire+ cells were found in the thymi of K14 TSLP+/- Rag2-/-γc-/- 
mice (Fig. 9B). The presence of Aire and the Aire dependent marker xCL1 was 
confirmed by qRT PCR in K14 TSLP+/- Rag2-/-γc-/- mice, whereas these factors were 
undetectable in Rag2-/-γc-/- mice (Fig. 9B). Another marker of mature mTECs is CD80, 
which showed a ~7 times higher expression in K14 TSLP+/- Rag2-/-γc-/- compared to 
Rag2-/-γc-/- mice (Fig. 9B). In summary, the results obtained from histology indicate 
the presence of mTECs in K14 TSLP+/- Rag2-/-γc-/- mice. This observation was 
confirmed by FACS analysis of the thymic epithelial compartment in Rag2-/-γc-/- and 
K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 10).  
In K14 TSLP+/- Rag2-/-γc-/- mice total mTEC numbers were significantly increased 
(~ 200 cells/thymus compared to ~20 cells/thymus in Rag2-/-γc-/- mice). MHC II levels 
were lower in Rag2-/-γc-/- mice compared to WT mice (Fig 10A), indicating an 
immature TEC phenotype. Nevertheless, 38% of mTECs in K14 TSLP+/- Rag2-/-γc-/- 
mice expressed Aire, which argues for mature mTECs. Aire protein expression was 
undetectable in Rag2-/-γc-/- mice (Fig. 10A), which is in line with histology (Fig. 9A iii 
and iv) and qRT PCR data (Fig. 9B). cTEC and fibroblast numbers did not differ 
between Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 10B), indicating that TSLP 
overexpression had no significant effect on these cellular subsets of the thymic 
stromal compartment. 
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Figure 9: TSLPtg improves thymic stromal compartment in Rag2-/-γc-/- mice.	   A) 
Immunohistochemistry was performed on O.C.T™ embedded frozen sections of thymi from 
WT (i and ii), Rag2-/-γc-/- (iii and iv) and K14 TSLP+/- Rag2-/-γc-/- (v and vi) mice and stained for 
Cytokeratin-8 (CK8, green), Cytokeratin-5 (CK5, red) and Aire (blue; Aire was only stained in 
the right panel). Scale bar represents 50µm B) Aire, CD80 and xCL1 expression are shown 
as relative expression to EpCAM; median values + interquartile range; **P<0.01, 
****P<0.0001. 
 	  
	  	  
Figure 10: TSLPtg increases mTEC numbers in Rag2-/- γc-/- mice.	   A) Gating strategy 
for thymic epithelial cells. Numbers in dot plots represent frequencies. B) Absolute cell 
numbers of fibroblasts (CD45- EpCAM- MHC II- Ly51+), cortical epithelial cells (cTECs), and 
medullary epithelial cells (mTECs); n = 9 from 3 independent experiments; median values + 
interquartile range; n.s.= not significant, ****P<0.0001.	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TECs are sources of many different cytokines and chemokines essential for 
recruitment, growth and survival of thymocyte60-64. To investigate whether improved 
thymic stromal patterning in K14 TSLP+/- Rag2-/-γc-/- mice alters cytokine and 
chemokine expression, qRT PCR analysis was performed on total thymus for IL-7, 
stem cell factor (SCF), CCL21, CCL25 and CCL19. Except for CCL21, which was 
significantly downregulated in K14 TSLP+/- Rag2-/-γc-/- mice, none of the factors was 
affected by TSLP overexpression (Fig. 11). 
  
 
 
	  	  
Figure 11: Cytokine and chemokine expression in total thymus normalized to the 
epithelial marker EpCAM. IL-7, SCF, CCL19, CCL21 and CCL25 are shown as relative 
expression to EpCAM; n = 7-11; median values + interquartile range; n.s. = not significant, 
**P<0.01. 	  
Similarly, when mRNA levels were normalized to the fibroblast marker PDGFRα 
instead of EpCAM, there was no difference in transcript level for IL-7, SCF and 
CCL19 between the mouse strains. However, K14 TSLP+/- Rag2-/-γc-/- mice showed a 
9-fold increase in CXCL12, which has a role in thymocyte expansion63 and a 3-fold 
increase in CCL25 (Fig. 12). Also mRNA levels for fibroblast growth factors KGF and 
FGF 10 did not differ between Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 12).  
Taken together, TSLPtg expression in Rag2-/-γc-/- mice increases the number of 
DN thymocytes and promotes Aire expression. However, the improved thymic 
stromal patterning in K14 TSLP+/- Rag2-/-γc-/- mice does not alter growth factor 
expression, but has a significant effect on the upregulation of CXCL12 and CCL25 in 
mesenchymal as well as down modulation of CCL21 in epithelial cells.  
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Figure 12: Cytokine and chemokine expression in total thymus normalized to 
fibroblast marker PDGFRα . IL-7, SCF, CCL19, CXL12, CCL25, KGF and FGF 10 are 
shown as relative expression to PDGFRα; n = 7-11, median values + interquartile range;    
n.s. = not significant, *P<0.05, **P<0.01. 
 	  	  
5.1.3 TSLP has no direct effect on mTEC differentiation and Aire 
expression      	  
mTEC development and Aire expression during embryogenesis is dependent on 
LTi cells and γδ T cell precursors via Rank - RankL interaction75,76, whereas mTEC 
maintenance in adults is mediated by signals from αβ T cells77-81. Since K14 TSLP+/- 
Rag2-/-γc-/- mice are T cell deficient, it was investigated whether TSLP overexpression 
has a direct effect on the development and maintenance of mTECs. 
This question was addressed with fetal thymus organ cultures (FTOC). In WT 
mice, mTECs appear around E16201. Therefore, WT E14.5 thymi before the onset of 
mTEC development were used. Culturing of WT thymic lobes without treatment for 
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11 days showed normal cTEC and mTEC development, the latter also expressing 
Aire (Fig. 13A) due to the presence of LTi cells and normal thymopoiesis. To remove 
developing T cells, thymic lobes were treated with 2’-Deoxyguanosine (dGuo) and 
subsequently cultured for 5 days in the presence of RankL, different concentrations 
of recombinant TSLP or left unstimulated. Analysis by flow cytometry showed that 
treatment with dGuo inhibits mTEC development, whereas subsequent treatment 
with RankL initiates mTECs. Treatment with 25, 50 or 100 ng/mL TSLP did not 
increase the frequency of mTECs (Fig. 13B). Another approach to test whether TECs 
are TSLP responsive was monitoring of STAT5 phosphorylation in response to TSLP 
stimulation in situ. The biological activity of TSLP was assessed on BM cells from 
Rag2-/- mice. After stimulation with 50ng/mL TSLP, 9% of CD19+ B cell precursor 
phosphorylated STAT5. This was 3.5 times lower than with the growth factor IL-7 
(Fig. 13C), but confirmed the biological activity of TSLP at low concentrations. 
WT TECs were isolated and stimulated with 25, 50 and 100 ng/mL TSLP. As there 
was no difference in STAT5 phosphorylation of unstimulated and stimulated TECs 
(Fig. 13D), there is no evidence for a direct effect of TSLP on mTEC development. 
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Figure 13: TSLP has no direct influence on mTEC development: A) Flow cytometry 
analysis of the TEC compartment in FTOCs after 11 days of culture. B) Analysis of the TEC 
compartment in dGuo treated FTOCs cultured in the presence of RankL, different 
concentrations of TSLP or without stimulation for 5 days. A-B) Numbers in dot plots represent 
frequencies of a representative experiment from 5 independent experiments.	   C) Rag2-/- BM 
cells were stimulated with 20 ng/mL IL-7, 50 ng/mL TSLP or left unstimulated. D) WT TECs 
were stimulated with different concentrations of TSLP or left unstimulated. C-D) Levels of 
STAT5 phosphorylation was assessed by flow cytometry analysis; Numbers in dot plots 
represent frequencies of a representative experiment from 2 independent experiments.	  
 
 
It was reported, that in the absence of T cells Rank - RankL interaction plays an 
important role in mTEC development and Aire induction75,76. Therefore, the 
expression of RankL was assessed by qRT PCR on total thymus of K14 TSLP+/- 
Rag2-/-γc-/- and Rag2-/-γc-/- mice. Indeed, RankL transcript levels were significantly 
higher in K14 TSLP+/- Rag2-/-γc-/- compared to Rag2-/-γc-/- mice (Fig. 14A). Possible 
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candidates, which express RankL in an adult T cell deficient thymus, are ILC3s. 
Therefore, K14 TSLP+/- Rag2-/-γc-/-, Rag2-/-γc-/- as well as WT and RORγt-/- mice as 
controls were investigated for the presence of ILC3s in the thymus. (Fig. 7 B). Since 
ILC3s require γc signaling cytokines such as IL-7 for their development and 
survival136, Rag2-/-γc-/- mice are almost devoid of ILC3s. However, TSLP 
overexpression increased ILC3s in the thymus of Rag2-/-γc-/- mice (Fig. 14B-C) as 
already observed for spleen and mLN138. qRT PCR on total thymus demonstrated 
that in line with the increased numbers of ILC3s, K14 TSLP+/- Rag2-/-γc-/- mice 
showed also an elevated level of IL-22 in the thymus (Fig. 14D). Other cellular 
subsets expressing RankL are DN2s and DN3s (Fig. 14E), but to lower extend than 
ILC3s78. Nevertheless DN2s and DN3s could potentially contribute to mTEC 
development in K14 TSLP+/- Rag2-/-γc-/- mice.  
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Figure 14: ILC3s are increased in K14 TSLP+/- Rag2-/- γc-/- mice. A) RankL expression 
on total thymus shown as relative expression to TBP B) Gating strategy for ILC3s in the 
thymus; Lin includes CD3ε, CD8α, CD11c, CD19, B220, TCRαβ, TCRγδ, GR-1 and NK1.1. 
Numbers in dot plots represent frequencies of a representative experiment C) Absolute cell 
numbers of ILC3s in Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- mice D) IL-22 expression on total 
thymus shown as relative expression to TBP; A, C-D) n = 7 - 8; median values + interquartile 
range; **P<0.01, ***P<0.001. E) RankL expression of sorted DN2 (CD3ε-, c-kithigh CD25+ 
CD44+) and DN3s (CD3ε-, CD25+ CD44-) of K14 TSLP+/- Rag2-/- γc-/- mice shown as relative 
expression to TBP; mean values. 	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The notion that not only ILC3 but also DN3 numbers were 16 - fold and 
approximately 450 - fold increased, respectively, raised the question whether DN3s 
and adult ILC3s were able to promote mTEC development in the absence of T cells. 
Therefore, CD45- cells from WT E14.5 thymi were re - aggregated at a 1:2 ratio with 
DN3s or with LP derived ILC3s isolated from Rag2-/- mice. Cells were isolated from 
Rag2-/- mice to ensure that DN3s cannot differentiate beyond DN3s. Furthermore 
have Rag2-/- mice higher ILC3 numbers due to the absence of T and B cells. 
Re - aggregated thymus organ cultures (RTOC) of CD45- TER119- cells + DN3s 
and CD45- TER119- cells + ILC3s were cultured for 4d, disaggregated and analysed 
by flow cytometry. Direct analysis of sorted CD45- TER119- cells showed 95% cTECs, 
as mTEC development has not started at E14.5 (Fig 15 upper row). Re - aggregation 
of total disaggregated thymus (CD45- + CD45+ cells) resulted in the development of 
34% mTEC and 62% cTECs (second row). Re - aggregation of CD45- cells with 
DN3s showed maintenance of ~78% cTECs and development of 11% mTECs 
whereas re - aggregation with LPL ILC3s resulted in a strong commitment of mTECs 
(85%). CD80 expression of mTECs was not affected by DN3s or ILC3s, as the 
frequency of CD80+ mTECs was comparable to the control in the second row (Fig 
15). These data indicate that DN3s are able to induce mTEC development but to 
lesser extend than ILC3s, which might be due to different expression levels of RankL 
or by an additional unknown mechanism.  
In summary, TSLP overexpression does not have a direct effect on mTEC 
development. However, ILC3s and to lesser extent DN3s are able to promote mTEC 
development. 
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Figure 15: DN3s and LP derived ILC3s promote mTEC development: Flow cytometric 
analysis of TEC compartment at E14.5 (upper row), after re - aggregation of disaggregated 
total WT E14.5 thymi in 4d RTOCS and 4d RTOCs of WT E14.5 CD45- cells with either DN3s 
or LP derived ILC3s from Rag2-/- mice. Numbers in dot plots represent frequencies from one 
experiment. 
 
 
 
3.1.4 TSLPtg expression increases myeloid cells in peripheral organs 
 
TSLP increases the number of myeloid cells174. DCs respond to TSLP by 
upregulation of MHC II and co-stimulatory molecules CD40, CD80 and CD86164,202. 
Due to the interaction of OX40+ T cells and OX40L expressed by TSLP conditioned 
DCs, TSLP can polarize CD4+ T cells towards the Th2 lineage87. To address the 
question whether TSLP overexpression in Rag2-/-γc-/- mice has an effect on antigen 
presenting cells (APCs), peripheral organs were analysed in Rag2-/-γc-/- and K14 
TSLP+/- Rag2-/-γc-/- mice for total cell numbers of GR1+ CD11b+ cells, CD11c+ DCs, 
CD11c- MΦ and co-stimulatory molecules by CD11c+ DCs. In the spleen, K14 
TSLP+/- Rag2-/-γc-/- mice had significant higher GR1+ CD11b+ myeloid cells (~3.6x106 
cells in K14 TSLP+/- Rag2-/-γc-/- mice and 1x106 in Rag2-/-γc-/- mice) (Fig. 16A-B), 
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whereas the size of the myeloid compartment in the BM did not differ between    
Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 16A-B). Further characterization of 
the myeloid compartment in the spleen by flow cytometry demonstrated that the 
CD11c+ CD11b+ MHC II+ DC subset was 3 times higher in K14 TSLP+/- Rag2-/-γc-/- 
mice, whereas there was no difference in the CD11c- CD11b+ MΦ subsets  (Fig 16C-
D). Using flow cytometry, the expression of the co - stimulatory molecules CD40, 
CD80 as well as CD86 was analysed in CD11c+ MHC II+ DCs and no difference could 
be detected between Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 16E). 
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Figure 16: TSLPtg increases myeloid cells in the spleen: A) Gating strategy for 
myeloid cells in spleen and BM. B) Absolute cell numbers for GR1+ CD11b+ cells in spleen 
and BM; n = 7 - 11; median values + range; n.s. = not significant, **P<0.01. C) Gating 
strategy for DCs (CD11c+ CD11b+ MHC II+) and MΦ (CD11c- CD11b+). D) Absolute cell 
numbers for DCs and MΦ; n = 7 - 11; median values + range; n.s. = not significant, **P<0.01. 
E) Representative histograms of co - stimulatory molecule expression of CD11c+ CD11b+ 
MHC II+ subset. A+C) Numbers in dot plots represent frequencies of a representative 
experiment. 
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DC and MΦ  numbers as well as the expression of their co - stimulatory molecules 
were also quantified in the small intestine (SI) and colon. K14 TSLP+/- Rag2-/-γc-/- 
mice showed a small but significant increase in the number of MHC II+ CD11c+ DCs 
in the SI as well as in the colon (Fig. 17A-B, Fig. 18A-B). In the colon this was 
associated with an increase in the number of CD103+ DCs (Fig. 18B). The number of 
CD103low DCs and CD11c- MΦ  as well as the expression of co - stimulatory 
molecules CD40, CD80 and CD86 on CD11c+ DCs did not differ between Rag2-/-γc-/- 
and K14 TSLP+/- Rag2-/-γc-/- mice in the SI and colon (Fig. 17C and 18C).  
Altogether, these results indicate that TSLP overexpression promotes the 
accumulation of myeloid cells in the spleen and to lower extend also in the intestine. 
However, TSLP overexpression in Rag2-/-γc-/- mice has no impact on the expression 
of co - stimulatory molecules on DCs. 
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Figure 17: TSLP increases DC numbers in the small intestine: A) Gating strategy for 
DCs (MHC II+ CD11c+), CD103+ DCs, CD103low DCs and MΦ (MHC II+ CD11c- CD11b+); 
Numbers in dot plots represent frequencies of a representative experiment. B) Absolute cell 
numbers for DC subsets and MΦ; n = 6; median values + range; n.s. = not significant, 
*P<0.05. C) Representative histograms of co - stimulatory molecule expression of CD11c+ 
MHC II+ subset. 
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Figure 18: TSLP increases DC numbers in the colon: A) Gating strategy for DCs (MHC 
II+ CD11c+), CD103+ DCs, CD103low DCs and MΦ (MHC II+ CD11c- CD11b+); Numbers in dot 
plots represent frequencies of a representative experiment. B) Absolute cell numbers for DC 
subsets and MΦ; n = 6; median values + range; n.s. = not significant, *P<0.05.  
C) Representative histograms of co-stimulatory molecule expression of CD11c+ MHC II+ 
subset. 
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3.1.5 TSLPtg expression increases ILC numbers in the intestine 
 	  
The intestinal immune system has to keep the balance between tolerating 
commensal bacteria and mounting immune responses against potential pathogens. 
ILC3s in the intestine were reported to give substantial help for the maintenance of 
intestinal immune homeostasis203 by creating an anti - pathological platform146,147,151. 
As a major source of IL-22204, ILC3s can protect intestinal epithelial cells by giving 
survival and proliferation signals159,205 and induce anti - microbial Reg proteins, which 
are targets of IL-22 signaling151. On the other side, NCR- ILC3s are shown to be 
involved in intestinal inflammation by production of IL-17 and IFN-γ 145,206. The role of 
ILC2s under steady state conditions is not clear yet188. However, ILC2s can be 
important Th2 cytokine producers after activation207. To investigate, whether 
increased numbers of ILCs alter the intestinal microenvironment, the intestinal ILC 
subsets and their cytokine profile were analysed.  
Analysis of LP derived ILCs from SI showed that TSLP overexpression resulted in 
a higher frequency of ILC2s and ILC3s in K14 TSLP+/- Rag2-/- γc-/-mice (14% ILC2s, 
67% ILC3s) compared to Rag2-/- γc-/-mice (7% ILC2s, 39% ILC3s) (Fig. 19A). This 
difference in frequencies is also depicted in absolute cell numbers, as K14 TSLP+/- 
Rag2-/- γc-/-mice have an 86-fold increase in ILC2s (Lin- CD90.2+ GATA3+), 18-fold 
increase in NCR- and 36-fold increase in NCR+ ILC3s (Lin- CD90.2+ RORγt+) (Fig. 
19A). In line with higher ILC3 numbers in K14 TSLP+/- Rag2-/- γc-/- mice are qRT PCR 
data on SI tissue, which showed a highly significant increase in RankL (Fig. 19B).  
Approximately 50% of SI - ILC3s showed IL-22 production under steady state 
conditions in both mouse strains. Treatment of ILC3s with IL-23 raised IL-22 
production by at least 20% in Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/-mice (Fig. 19C). 
IL-17 production was lower compared to IL-22 production under steady state 
conditions and did not significantly differ between Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- 
γc-/- mice. However, IL-17 production was upregulated in Rag2-/- γc-/- and K14 TSLP+/- 
Rag2-/-γc-/- mice upon IL-23 treatment (Fig. 19C). ILC3s were also reported to 
produce granulocyte macrophage colony-stimulating factor (GM-CSF), which is an 
important mechanism to promote tolerance in the intestine by increasing DC and 
Treg function152. Upon stimulation with PMA and Ionomycin, ILC3s derived from SI of 
both mouse strains showed GM-CSF and IFN-γ production but did not differ between 
Rag2-/- γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 19D). 
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Figure 19: TSLPtg increases ILC numbers in the SI: A) Gating strategy and 
absolute cell numbers of ILC subsets. Lin includes CD3ε, CD8α, CD11c, B220, NK1.1 and 
GR - 1; numbers in dot plots represent frequencies of a representative experiment; n = 9 - 11; 
median values + interquartile range; ***P<0.001, ****P<0.0001 B) RankL expression is shown 
as relative expression to β-Actin; n = 8; median values, ****P<0.0001. C) Cytokine production 
of ILC3s after 4h stimulation with 20ng/mL IL-23 and incubation with Brefeldin A (10µg/mL) 
for 2h D) Cytokine production of ILC3s after 4h stimulation with 50ng/mL PMA and 2.5µg/mL 
Ionomycin and incubation with Brefeldin A for 2h; C - D) n = 6-8; median values + interquartile 
range; n.s. = not significant. 
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Although ILC3s of K14 TSLP+/- Rag2-/-γc-/- mice did not show a difference in IL-22 
production, the increased number of ILC3s is likely responsible for the significantly 
higher amount of IL-22 transcripts in total SI in K14 TSLP+/- Rag2-/-γc-/- mice (Fig 20A). 
Also the mRNA expression of the natural IL-22 regulator IL-22Rα2 was 39-fold 
increased in SI of K14 TSLP+/- Rag2-/-γc-/- mice as analysed by qRT PCR.  IL-22 is 
known to initiate anti-microbial peptide expression151 and indeed, K14 TSLP+/- Rag2-/-
γc-/- mice showed ~3 fold increase in Reg3β and Reg3γ production in the SI (Fig. 
20B).  
 
 
 
Figure 20: TSLPtg increases IL-22 and anti - microbial peptide expression in 
SI: A) IL-22 and IL-22Rα2 mRNA expression are shown as relative expression to β-Actin; B) 
Reg3β and Reg3γ mRNA expression are shown as relative expression to β-Actin; A-B) n = 8; 
median; **P<0.01, ***P<0.001. 
 
 
 
In the colon, TSLP overexpression favours the increase in frequencies and 
absolute numbers of ILC2s compared to ILC3s. Although there is also an increase in 
the frequency of NCR+ ILC3s, there is no significant difference in absolute cell 
numbers in NCR+ ILC3s and only a minor increase in the NCR- ILC3 compartment 
(Fig. 21A). In Rag2-/-γc-/- mice, there is a prominent cell population, which is Lin- 
CD90.2+ but negative for ILC2 and ILC3 transcription factors GATA3 and RORγt (Fig. 
21A). This cell population could also be observed in the small intestine and might 
indicate an ILC precursor, which has a higher potential to differentiate by TSLP 
overexpression. 
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Taken together, these results demonstrate, that TSLP overexpression in the 
intestine increases the proportion and absolute cell numbers of ILC2s and ILC3s but 
has no effect on IL-22, IL-17, GM-CSF or IFN-γ production. However, increased 
numbers of ILC3s result in higher IL-22 levels and hence, higher amounts of anti-
microbial peptides. 
 
 
 
Figure 21: TSLP increases ILC numbers in the colon: Gating strategy and 
absolute cell numbers for ILC subsets. Lin includes CD3ε, CD8α, CD11c, B220, NK1.1 and 
GR-1. Numbers in dot plots represent frequencies of a representative experiment. n = 6 - 8; 
median + interquartile range; n.s. = not significant, *P<0.05 **P<0.01. 
 
 
 
 
3.1.6 Colonization of BM and spleen in K14 TSLP+/- Rag2-/-γc-/- mice is 
         normal 
 
IL-7 is crucial for the proliferation and differentiation of B-cell lineage cells33,34,206. 
However, in the absence of IL-7, TSLP can rescue the effect of IL-7 and drives 
precursor cells into B cell commitment162,177,178. Due to TSLP overexpression, K14 
TSLP+/- Rag2-/-γc-/- mice accumulate B cell precursors Pro - /Pre - B I (CD19+ 
CD117+) and Pre - B II (CD19+ CD25+) cells in the BM, whereas these cells are 
almost undetectable in Rag2-/-γc-/- mice (Fig. 22A - B). To exclude that some B cell 
precursors had occupied niches for donor HSC in the later transplantation 
experiments, carboxyfluorescein succinimidyl ester	   (CFSE) - labelled TSLPR-/- BM 
cells were injected into Rag2-/-γc-/- and in K14 TSLP+/- Rag2-/-γc-/- mice. After 24h, BM 
cells were harvested and CFSE+ cells were quantified by flow cytometry. There was 
no significant difference in the number of CFSE+ cells in the BM between both mouse 
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strains (Fig. 22C). Also in the spleen, there was no significant difference in CFSE+ 
cell numbers between Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice (Fig 22D). This 
indicates that the recruitment of progenitor cells to the BM and the circulation through 
the spleen is not impaired in K14 TSLP+/- Rag2-/-γc-/- mice.  
 
 
	  
 
Figure 22: Increased numbers of B cell precursors in the BM of K14 TSLP+/- Rag2-/- 
γc-/- mice do not impair recruitment of progenitor cells.	  A) Gating strategy for Pro - /Pre - 
B I and Pre-B II cells; numbers in dot plots represent frequencies of a representative 
experiment. B) Absolute cell numbers of Pro - / Pre - B I and Pre-B II. C) Analysis of CFSE+ 
cells after 24h in the BM and D) spleen; B-D) n = 5 - 7 median values + interquartile range; 
n.s. = not significant, ***P<0.001, ****P<0.0001. 	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5.2 Reconstitution of the adaptive immune system with FL cells 	  
 
To study the previously described effects of TSLPtg expression and the presence 
of LNs on the efficiency of HSCT, Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice were 
reconstituted with FL HSCs. To exclude a direct effect of TSLP on donor cells, 
TSLPR-/- FL HSC were used. The experimental approach included the injection of 
5x106 E14.5 total FL cells and subsequent analysis of the reconstitution kinetics from 
3 - 6 weeks in BM, thymus, spleen, LN and intestine of recipients (Fig. 23). 	  	  
	  	  
Figure 23: Transplantation model: Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice 
were transplanted with E14.5 TSLPR-/- total FL cells.  	  	  	  	  
5.2.1 Efficiency of progenitor cell reconstitution in the BM	  	  
 
As the BM is the primary site for B cell development, several progenitor B cell 
subsets were analysed in reconstituted Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice 3 
to 6 weeks after transplantation. While the total BM cellularity was stable during 
reconstitution and cell numbers did not differ between Rag2-/-γc-/- and K14 TSLP+/- 
Rag2-/-γc-/- mice (Fig. 24A), K14 TSLP+/- Rag2-/-γc-/- mice showed 6 weeks after 
transplantation a significant increase in the myeloid compartment (Fig 24B). In the B 
cell precursor subset was a significant increase in Pro - / Pre - B I and Pre - B II cells 
in K14 TSLP+/- Rag2-/-γc-/- mice 3 weeks after transplantation (Fig. 24C), which is 
likely due to the elevated cell numbers of the recipient. Pre - B II cells did not differ 
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between Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice until a significant decline in 
week 5 in K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 24C). Investigation of B220+ IgM+ B cells, 
which include immature and mature B cells in the BM diminished in K14 TSLP+/- 
Rag2-/-γc-/- mice 5 and 6 weeks after transplantation (Fig. 24C).  
 
 
 
Figure 24: Myeloid and B cell subsets in the BM 3 - 6 weeks after transplantation. A) 
Number of total BM cells. B) Number of GR1+ CD11b+ myeloid cells in the BM. C) Number of 
Pro - / Pre - B I (CD19+ CD117+), Pre - B II (CD19+ CD25+) and B220+ IgM+ B cells in the BM; 
A - C) n = 8 - 13; median values + interquartile range; n.s. = not significant, *P<0.05, **P<0.01, 
***P<0.001. 
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5.2.2 Efficiency of thymocyte development after FL HSCT 	  	  
After transplantation of total FL cells from TSLPR-/- mice, the thymus size 
increased over time in Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice as illustrated in 
Fig. 25A. 
Prior transplantation, K14 TSLP+/- Rag2-/-γc-/- mice had higher numbers of DN 
thymocytes in the thymus compared to Rag2-/-γc-/- mice (Fig. 8D). This could account 
for the higher total cell numbers 3 weeks after transplantation of FL cells (Fig. 25B). 
From week 4 onwards, thymic cellularity of reconstituted mice exceeded the number 
of thymocytes, which indicates the start of T cell development from donor precursors 
(Fig. 25B). 6 weeks after transplantation, there was a 6-fold increase in total 
cellularity, suggesting faster T cell reconstitution in K14 TSLP+/- Rag2-/-γc-/- mice 
compared to Rag2-/-γc-/- mice (Fig. 25B).  
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Figure 25: TSLPtg increases total cellularity in the thymus after HSC transplantation. 
A) Representative photographic picture of thymi from Rag2-/-γc-/- (i) and K14 TSLP+/-         
Rag2-/-γc-/- (ii) mice 3, 4, 5 and 6 weeks after reconstitution. Scale bar represents 1mm. B) 
Absolute cell numbers of total thymus; n = 8 - 13; median values + interquartile range;           
n.s. = not significant, **P<0.01. 
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Flow cytometry analysis of different T cell compartments in the thymi of 
transplanted Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice showed that T cell 
development started between week 3 and 4 and further increased in both Rag2-/-γc-/- 
and K14 TSLP+/- Rag2-/-γc-/- mice. DP T cells were already significantly increased 4 
weeks after transplantation in K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 26A). This was 
followed by a significant increase of CD4+ as well as CD8+ SP T cell subsets 5 weeks 
after transplantation (Fig. 26A). Further discrimination into immature (CD69+) and 
mature (CD69-) CD4+ and CD8+ SP T cells (Fig. 26B-C) showed no specific 
impairment in the regulation of CD69 expression in Rag2-/-γc-/- mice. This indicates 
that the differentiation into mature T cells is possible in both mouse strains but occurs 
more efficiently in K14 TSLP+/- Rag2-/-γc-/- mice. Tregs (TCRβ+ CD4+ CD25+. Foxp3+) 
were detectable in thymi of recipient mice from weeks 3 onwards and were 
significantly higher with TSLP overexpression after week 5 (Fig 26D).  
Together, these data demonstrate that TSLP overexpression in Rag2-/-γc-/- mice 
results in accelerated T cell reconstitution after HSC transplantation compared to 
Rag2-/-γc-/- mice. 
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Figure 26: TSLPtg increases T cell subsets in the thymus after reconstitution: T cell 
subsets 3 - 6 weeks after reconstitution A) Number of double positive (CD4+ CD8+), CD4+ 
(TCRβ+ CD4+ CD8-) and CD8+ (TCRβ+ CD4- CD8+) T cells B) Number of CD4+ immature 
(CD69+) and mature (CD69-) T cells C) Number of CD8+ immature (CD69+) and mature 
(CD69-) T cells D) Number of regulatory T cells (Tregs) (TCRβ+ CD4+ CD25+ Foxp3+); A - D) 
n = 8 - 13; median values + interquartile range; n.s. = not significant, *P<0.05, **P<0.01.	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5.2.3 Reconstitution of the spleen after FL HSCT 	  	  
 
After adoptive transfer of FL HSCs into Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- 
mice spleens increased in size in both mouse strains (Fig. 27A). In line with the 
organ enlargement is the increase in total number of splenocytes. From week 3 to 
week 6 after transplantation, the total number of splenocytes was higher in K14 
TSLP+/- Rag2-/-γc-/- mice compared to Rag2-/-γc-/- mice, reaching statistical significance 
at week 3 and week 6 (Fig. 27B). 	  
	  	  
Figure 27: TSLPtg increases total cellularity in the spleen A) Representative 
photographic picture of spleens from Rag2-/- γc-/- (i) and K14 TSLP+/- Rag2-/- γc-/- (ii) mice 3, 4, 
5 and 6 weeks after transplantation. Scale bar represents 1mm. B) Cell numbers of total 
spleen; n = 8 - 13; median values + interquartile range; n.s. = not significant, *P<0.05. 
 
 
In addition, the total number of natural killer (NK) cells, DCs, GR1+ CD11b+ 
myeloid cells as well as B and T cells was analysed in spleens from Rag2-/-γc-/- and 
K14 TSLP+/- Rag2-/-γc-/- mice after transplantation. While the number of NK cells was 
only significantly increased at 3 weeks after transplantation by TSLP overexpression, 
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the GR1+ CD11b+ myeloid cells reached statistical significance at 5 weeks after HSC 
transplantation in K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 28A). CD11c+ DCs numbers did 
not differ between Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 28A). These 
results demonstrate that NK cells as well as myeloid cells, beside small differences, 
differentiated equally. Hence TSLP overexpression plays no major role in the 
regulation of these cellular subsets. 
In the spleen, B cells can be divided into marginal zone (Mz) and follicular (fol) B 
cells. Mz B cells did not develop earlier than 4 weeks after transplantation. Therefore, 
total CD19+ B cells were compared 3 weeks after transplantation between Rag2-/-γc-/- 
and K14 TSLP+/- Rag2-/-γc-/- mice. The latter had a significant increase in total CD19+ 
cells (Fig. 28B), whereas Mz and fol B cell numbers did not differ between week 4 
and 6 after transplantation in both mouse strains (Fig. 28B). 
In summary, these data suggest that the reconstitution of the B cell compartment 
was equally efficient and not influenced by TSLP overexpression 
 
 
 
Figure 28: Myeloid and B cell subsets in the spleen A) Number of NK cells, CD11c+ 
DCs and GR1+ CD11b+ cells. B) Number of total B cells (week 3) and B cell subsets Mz and 
Fol B cells (weeks 4-6); n = 8 - 13; median values + interquartile range; n.s. = not significant, 
*P<0.05. 
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Although there was no difference beyond 3 weeks of reconstitution in the splenic 
myeloid and B cell compartment of Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice, there 
were significant differences in T cell numbers. 5 weeks after transplantation the 
number of CD4+ and CD8+ T cells was significant higher in spleens of K14 TSLP+/- 
Rag2-/-γc-/- (CD4+: ~ 3.6x107; CD8+: ~ 9.3x107) compared to Rag2-/-γc-/-mice (CD4+: ~ 
0.7x107; CD8+: ~ 1.7x107) (Fig. 29A). Tregs were already detectable 4 weeks after 
reconstitution in both mouse strains with approximately 5-fold increase of Tregs in 
K14 TSLP+/- Rag2-/-γc-/- mice 5 weeks after transplantation (Fig. 29B). Staining for 
Helios, an intracellular transcription factor, which discriminates thymic from 
peripheral induced Tregs94, showed high deviations but no significant difference in 
the frequency of Helios+ Tregs (Fig. 29B). This indicates that Helios- Tregs were 
generated in the periphery of Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice with a 
comparable efficiency (Fig. 29B). Investigation of the memory compartments for 
CD4+ and CD8+ T cells showed no significant difference in the frequency of naïve 
(CD62L+ CD44-) or central memory (CM) (CD62L+ CD44+) T cells and also not in 
CD8+ effector memory (EM) (CD62L- CD44+) T cells. However, a significant decrease 
in the CD4+ EM compartment in the spleen of K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 29C) 
was observed. 
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Figure 29: TSLPtg increases T cells in the spleen after reconstitution. A) Number of 
CD4+ and CD8+ T cells in the spleen of Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice B) 
Number of Tregs and frequency of Helios+ Tregs; C) Frequencies of CD4+ and CD8+ naïve 
(CD62L+ CD44-), central memory (CM) (CD62L+ CD44+) and effector memory (EM) (CD62L- 
CD44+) T cells; n = 6 - 8; median values + interquartile range; n.s. = not significant, *P<0.05, 
**P<0.01, ***P<0.001 ****P<0.0001. 
 
 
 
 
 
 	  
Results 
 
	   81	  
5.2.4 Reconstitution of mesenteric lymph nodes 	  	  
Rag2-/-γc-/- mice have severe defects in LN development due to the lack of LTi 
cells. It was previously described that this defect can be rescued by TSLP 
overexpression138. To investigate the reconstitution of LNs, mLNs were analysed, as 
mLN anlagen are present in most of the Rag2-/-γc-/- mice. mLNs were larger in size 
upon HSC transplantation in both mouse strains (Fig. 30A - B). However, at week 3 
and 4 after transplantation, mLNs showed a significantly higher total cell number in 
K14 TSLP+/- Rag2-/-γc-/- compared to Rag2-/-γc-/- mice (Fig. 30A - B). 
 
	  	  
 
Figure 30: TSLPtg increases total cellularity in mLNs A) Representative photographic 
picture of mLNs from Rag2-/-γc-/- (i) and K14 TSLP+/- Rag2-/-γc-/- (ii) mice 3, 4, 5 and 6 weeks 
after reconstitution. Scale bar represents 1mm. B) Cell numbers of total mLNs; n = 6 - 13; 
median values + interquartile range; n.s. = not significant, **P<0.01, ***P<0.001. 
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Similar to the spleen there was no significant difference in the B cell compartment 
between reconstituted Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 31A). The 
number of CD4+ and CD8+ T cells in mLN increased between week 4 and 6 in both 
mouse strains. However, the rate of this increase appeared to be higher in K14 
TSLP+/- Rag2-/-γc-/- mice (Fig. 31B). Tregs could be found 4 weeks after reconstitution 
and numbers were significantly higher after 5 weeks in K14 TSLP+/- Rag2-/-γc-/- 
(median: 0.47x106 cells) compared to Rag2-/-γc-/- mice (median: 0.064x106 cells). In 
agreement with the observation in the spleen, the frequency of Helios+ cells was 
comparable in both mouse strains (Fig. 31C). Investigation of the memory 
compartment showed neither a difference in CD4+ naïve, CM or EM nor in the CD8+ 
memory subsets (Fig. 31D).  
 
 
Figure 31: TSLPtg increases T cells in the mLN after reconstitution A) Absolute 
number of CD19+ B cells B) Absolute number of CD4+ and CD8+ T cells C) Absolut number of 
Tregs and frequency of Helios+ Tregs; D) Frequencies of CD4+ and CD8+ naïve (CD62L+ 
CD44-), CM (CD62L+ CD44+) and EM (CD62L- CD44+) T cells; n = 6 - 8; median values + 
interquartile range; n.s. = not significant, *P<0.05, **P<0.01, ***P<0.001. 
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5.2.5 Reconstitution of the intestine after FL HSCT  
 
To investigate the effect of TSLPtg expression on the efficiency of lymphocyte 
reconstitution in the intestine, lamina propria lymphocytes (LPLs) were isolated from 
SI and colon 3 - 6 weeks after FL HSC transplantation. Total LPL numbers were 
significantly increased 5 weeks after transplantation in K14 TSLP+/- Rag2-/-γc-/- mice 
compared to Rag2-/-γc-/- mice (Fig. 32A). The difference was also observed in the T 
cells subsets. Here, numbers of CD4+ T cells were approximately 6-fold, CD8+ T cells 
40-fold (Fig. 32B) and Tregs 13-fold (Fig. 32C) increased in K14 TSLP+/- Rag2-/-γc-/- 
mice compared to Rag2-/-γc-/- mice. As seen in other organs, Helios expression did 
not differ between both mouse strains (Fig. 32C). 
In the colon, there was no such difference observed in cell numbers and 
frequency of the different T cell subsets upon HSC transplantation (Fig. 33A - C). 
 
 
	  
 
Figure 32: T cell compartment in lamina propria of SI after HSC transplantation A) 
Absolute number of total LPLs in SI B) Absolute number of CD4+ and CD8+ T cells C) Absolut 
number of Tregs and frequency of Helios+ Tregs; n = 6 - 8; median values + interquartile 
range; n.s. = not significant, *P<0.05 
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Figure 33: T cell compartment in lamina propria of colon after transplantation A) 
Number of total LP - derived cells in colon B) Number of CD4+ and CD8+ T cells C) Number of 
Tregs and frequency of Helios+ Tregs; n = 6 - 8; median values + interquartile range; n.s. = 
not significant. 	  
 
Taken together, TSLP overexpression in Rag2-/-γc-/- mice resulted in faster T cell 
reconstitution in thymus and peripheral organs after FL HSC transplantation from 
TSLPR-/- mice. B cell reconstitution was not significantly different in Rag2-/-γc-/- 
compared to K14 TSLP+/- Rag2-/-γc-/- mice indicating that the reconstitution itself was 
equally efficient.	  	  	  	  
5.2.6 Immunization with T-dependent antigen after FL HSCT 	  
 
The previous described characterization of differences during reconstitution 
showed that the T cell compartment was faster reconstituted in K14 TSLP+/-        
Rag2-/-γc-/- than in Rag2-/-γc-/- mice. To investigate whether these T cells were also 
able to support B cell antibody (Ab) production during an immune response, 
reconstituted Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice were immunized with the T-
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dependent antigen NP-Ovalbumin (NP-(18)-OVA). 6 weeks after transplantation with 
FL HSCs from TSLPR-/- mice, recipient mice were injected intraperitoneally (i.p.) with 
NP-OVA in Alum followed by a second injection 12 days after the initial immunization 
(boost). Total IgM and IgG levels were measured by ELISA in the serum before and 
after immunization. NP-OVA specific IgG was analysed 7 days after second 
immunization (Fig. 34A).  
First, analysis of total IgM and IgG levels 42 days after reconstitution revealed that 
total IgM levels did not differ between Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice 
(Fig. 34A). In contrast, TSLP overexpression led to a higher total IgG level (Fig. 34B). 
As a response to NP-OVA injection both mouse strains generated NP-OVA specific 
IgGs in comparable amounts (Fig. 34C). These data suggest that T cells in both 
Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice could support Ag specific IgG production 
and hence give B cell help during an immune response in similar ranges.  
 
 
 
Figure 34: Immunization with NP-OVA after reconstitution A) Scheme of experimental 
procedure B) Total IgM and IgG titers of Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice 6 weeks 
after reconstitution C) NP-OVA specific IgG titers 7 days after boost with NP-OVA in Alum 
(day 61); n = 6 of one experiment; mean + SEM; 
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5.3 The influence of secondary lymphoid organs on peripheral T 
cell homeostasis  
 
5.3.1 Characterization of stromal cell compartments in secondary 
lymphoid organs  	  
 
Secondary lymphoid organs are important niches for T cells, as they provide 
cytokines and chemokines for migration, proliferation, and survival. Since TSLPR is 
also expressed by LN stromal cells, we asked whether TSLP overexpression had an 
effect on the stromal environment either directly via higher TSLP - TSLPR interaction 
or indirectly by increasing ILC3 numbers. Therefore, stromal compartments of mLNs 
and spleen were analysed for total cell numbers and cytokine expression. The 
stromal compartment of LNs consists of T zone reticular cells (TRCs: CD45- CD31- 
gp38+), lymphatic endothelial cells (LECs: CD45- CD31+ gp38+), blood endothelial 
cells (BECs: CD45- CD31+ gp38-) (Fig. 35A) and double negative stromal cells 
(DNSCs)109. The role of DNSCs is still unrevealed and were not analysed in this 
study. To investigate the stromal compartment of mLNs, mLNs from 3 Rag2-/-γc-/- 
mice were pooled in order to obtain sufficient cell numbers. There was no difference 
in frequencies of TRCs and LECs and only a minor but significant increase in BECs 
in K14 TSLP+/- Rag2-/-γc-/- compared to Rag2-/-γc-/- mice (Fig. 35B). Total numbers of 
TRCs, LECs and BECs were not significantly different in Rag2-/-γc-/- compared to K14 
TSLP+/- Rag2-/-γc-/- mice (Fig. 35A - B). These stromal subsets were also analysed in 
brachial LNs 4 weeks after transplantation, whereby numbers of TRCs and LECs but 
not BECs were significantly increased in K14 TSLP+/- Rag2-/-γc -/- compared to Rag2-/-
γc -/- (Fig. 36A).  
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Figure 35: Characterization of mLN stromal compartment A) Gating strategy for 
stromal subsets B) Frequency and total numbers of TRCs (CD45- Gp38+ CD31-), LECs 
(CD45- Gp38+ CD31+) and BECs (CD45- Gp38- CD31+) in Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- 
γc-/- mice; n = 7 - 9 from 3 independent experiments; median values + interquartile range;     
n.s. = not significant, *P<0.05. 
 
 
 
 
Figure 36: Stromal compartment of brachial LNs 4 weeks after transplantation: 
Frequency and total numbers of TRCs (CD45- Gp38+ CD31-), LECs (CD45- Gp38+ CD31+) 
and BECs (CD45- Gp38- CD31+) in Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- mice; n = 8 from 2 
independent experiments; median values + interquartile range; n.s. = not significant, *P<0.05. 
  
 
 
The stromal compartment of the spleen was also analysed for TRCs and BECs. 
There was no significant difference in numbers of TRCs (median: 827 cells / spleen 
in K14 TSLP+/- Rag2-/-γc-/- compared to 548 cells / spleen in Rag2-/-γc-/- mice) or BECs 
(median: 597 cells / spleen in K14 TSLP+/- Rag2-/-γc-/- compared to 195 cells / spleen 
in Rag2-/-γc-/- mice) comparing Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 37A). 
Results 
 
	   88	  
To test whether splenic TRCs and BECs from both mouse strains differ in their ability 
to produce cytokines for T cell proliferation and survival, TRCs and BECs were 
sorted and analysed for IL-7 and IL-15 transcript levels. There was no difference in 
IL-7 or IL-15 mRNA expression between Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice 
(Fig. 37B). However, IL-7 mRNA levels were 4-fold increased in total spleen of K14 
TSLP+/- Rag2-/-γc-/- compared to Rag2-/-γc-/- mice, whereas there was no difference in 
IL-15 mRNA (Fig. 37C). 
 
 
 
Figure 37: Characterization of splenic stromal compartment: A) Gating strategy and 
total number of TRCs and BECs; n = 7 - 9 from 3 independent experiments B) IL-7 and IL-15 
transcript levels normalized to TBP on sorted TRCs and BECs, n = 2 - 4 from 2 independent 
experiments; n.s. = not significant C) IL-7 and IL-15 transcript levels normalized to TBP in 
total spleen; n = 7 - 8 from 3 independent experiments; median values; n.s. = not significant, 
***P<0.001. 
 
 
The results suggest that the stromal compartment did not contribute to the 
significant increase of IL-7 transcripts in K14 TSLP+/- Rag2-/-γc-/- mice. We further 
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asked, which other cell types could express IL-7 leading to the observed difference in 
IL-7 expression in the spleen of K14 TSLP+/- Rag2-/-γc-/- mice. One cell subset, which 
responds to TSLP overexpression by increasing their number, is the DC subset. qRT 
PCR data suggest no difference in IL-7 mRNA between DCs from Rag2-/-γc-/- and K14 
TSLP+/- Rag2-/-γc-/- mice (Fig 38). However, the increased number of DCs in K14 
TSLP+/- Rag2-/-γc-/- compared to Rag2-/-γc-/- mice may account for the 4-fold increase 
of IL-7 transcripts in the spleen of K14 TSLP+/- Rag2-/-γc-/- mice. 
 
 
 
 
 
Follicular dendritic cells (FDCs) found in secondary lymphoid organs are of 
mesenchymal origin and produce survival factors and chemoattractants for B cells208. 
The development of FDCs requires LTβR signaling, which can be provided by LTαβ+ 
B cells209,210. Previous studies also described the requirement of LTi cells for the 
development of FDC precursors (preFDCs) in the absence of lymphocytes211.    
Rag2-/-γc-/- mice are B cell deficient, but TSLP overexpression increases the number 
of ILC3s, which could provide LTαβ. In line with this, analysis of total ILC3s in the 
spleen showed that NCR- ILC3s but not NCR+ ILC3s were significantly increased in 
K14 TSLP+/- Rag2-/-γc-/- mice (Fig 39A). Investigation of preFDCs (CD45- CD140α+ 
CD21/35- CD54+ CD106+) and mature FDCs (CD45- CD140αlow CD21/35+ CD54+ CD106low) 
in Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 39B - C) did not show significant 
differences in numbers (Fig 39C), indicating that FDC development in Rag2-/-γc-/- 
mice was not controlled by TSLP overexpression or ILC3s.  
Figure 38: TSLPtg does not alter 
IL-7 production of DCs: IL-7 
transcript levels normalized to 
β − actin on sorted CD11c+ MHC II+ 
DCs; n = 5 - 6 from 2 independent 
experiments; median values; n.s. = 
not significant. 
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Taken together, TSLPtg expression has no influence on the absolute cell numbers 
of stromal subsets in LNs and spleen before transplantation. However, 4 weeks after 
transplantation, TRCs and LECs were significantly increased in K14 TSLP+/-      
Rag2-/-γc-/- mice (Fig. 36). This effect is likely due to increased T cell numbers in K14 
TSLP+/- Rag2-/-γc-/- mice, since naïve T cells were reported to be sufficient for the 
induction of TRC expansion212. Whether this is the same mechanism for LEC 
expansion or whether LEC numbers are regulated in a different way by TSLP 
overexpression during reconstitution remains to be tested.   
 	  	  
 
 
Figure 39: FDCs are not affected by TSLPtg expression: A) Total numbers of NCR- 
and NCR+ ILC3s in the spleen; n = 8 - 16 from at least 3 independent experiments; median 
values + interquartile range; n.s. = not significant, *P<0.05. B) Gating strategy for i) FDC 
precursor (preFDC; CD45- CD140α+ CD21/35- CD54+ CD106+) and ii) FDCs (CD45- 
CD140αlow CD21/35+ CD54+ CD106low). C) Total numbers of preFDCs and FDCs in        
Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice; n = 8 - 16 from at least 3 independent 
experiments; median values + interquartile range; n.s. = not significant.  
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5.3.2 TSLPtg increases T cell proliferation in secondary lymphoid 
organs 
Previous experiments showed that TSLP overexpression increases IL-7 
expression in the spleen of Rag2-/- γc-/- mice (Fig. 37C). Since IL-7 promotes T cell 
proliferation and survival, T cell proliferation was investigated in Rag2-/-γc-/- and K14 
TSLP+/- Rag2-/-γc-/- mice. In a first approach, CFSE-labelled CD4+ and CD8+ T cells 
from TSLPR-/- mice were injected i.v. in a 1:2 ratio. Total T cell numbers and CFSE 
proliferation was analysed in the spleen, total LNs and BM 4 and 14 days after T cell 
transfer. 
After 4 days, T cells transferred into K14 TSLP+/- Rag2-/-γc-/- mice showed a higher 
proliferation index in the spleen compared to Rag2-/-γc-/- mice (Fig 40A). While 
approximately 14% CD4+ T cells were CFSE low or negative in Rag2-/-γc-/- mice, 43% 
of CD4+ T cells were CFSElow / neg in TSLP overexpressing mice. CD8+ T cells 
proliferated generally faster than CD4+ T cells. However, also here TSLP 
overexpression further enhanced proliferation, since 82% of CD8+ T cells were 
CFSElow / neg in K14 TSLP+/- Rag2-/-γc-/- mice compared to 38% in Rag2-/-γc-/- mice (Fig. 
40A). In contrast to splenic CD4+ T cells, most of the LN CD4+ T cells were CFSE- 
(K14 TSLP+/- Rag2-/-γc-/- : 71%; Rag2-/-γc-/- : 86%) speaking for a higher proliferation of 
CD4+ T cells in LNs compared to spleen. However, the proliferation of CD4+ T cells 
as well as CD8+ T cells did not differ between Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- 
mice (Fig. 40A). Absolute CD4+ and CD8+ T cell numbers in total LNs were 
significantly higher in K14 TSLP+/- Rag2-/-γc-/- (CD4+: ~ 0.27x106 cells; CD8+: 3.2x106 
cells) compared to Rag2-/-γc-/- mice (CD4+: ~ 0.02x106 cells; CD8+: 0.1x106 cells) (Fig. 
40B). This difference was most likely due to the fact that LN numbers were increased 
in K14 TSLP+/- Rag2-/-γc-/- mice, hence naïve T cells had a higher chance to enter LNs. 
14 days after T cell transfer, all injected T cells became CFSE- in both mouse strains 
(Fig. 40C), indicating that all injected naïve T cells underwent >8 divisions. Analysis 
14 days after T cell transfer showed an increase in T cell numbers in both mouse 
strains compared to the 4 days time point, suggesting ongoing proliferation. However, 
absolute CD4+ and CD8+ T cell numbers in the spleen and LNs were significantly 
higher in K14 TSLP+/- Rag2-/-γc-/- mice compared to Rag2-/-γc-/- mice (Fig. 40D).  
In summary, TSLP overexpression increases proliferation of T cells leading to 
higher T cell numbers in LNs. This effect must be driven indirectly by TSLP, since T 
cells were derived from TSLPR-/- mice. 
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Figure 40: Increased T cell numbers after adoptive T cell transfer by TSLPtg 
expression. 1x107 CFSE - labeled T cells from TSLPR -/- mice were injected into Rag2-/-γc-/- 
and K14 TSLP+/- Rag2-/-γc-/- mice. Mice were analysed 4 days and 14 days after transfer A) 
Representative histograms of CD4+ and CD8+ T cell proliferation in the spleen and LNs 4d 
after T cell transfer. Numbers represent frequencies of CFSElow/- T cells B) Total cell numbers 
of CD4+ and CD8+ T cells in spleen, LNs and BM 4 days after T cell transfer. C) 
Representative histograms of CD4+ and CD8+ T cell proliferation in the spleen and LNs 14 
days after T cell transfer D) Total numbers of CD4+ and CD8+ T cells in spleen, LNs and BM 
14 days after T cell transfer. A-D) n = 5 - 8 from 2 independent experiments; n.s. = not 
significant, *P<0.05, **P<0.01. 
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To investigate proliferation of naïve T cells, 2x106 sorted naïve (CD62L+ CD44 low) 
CD4+ and CD8+ T cells from TSLPR-/- mice were injected i.v. in a 1:2 ratio into    
Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice. Total T cell numbers were analysed in 
spleen, peripheral LNs, BM and thymus 14 or 28 days after T cell transfer. After 14 
days, T cell numbers were higher in LNs of K14 TSLP+/- Rag2-/-γc-/- mice (CD4+: ~ 
5.5x105 cells; CD8+: ~ 1.3x106 cells) compared to Rag2-/-γc-/- mice (CD4+: ~ 0.5x105 
cells; CD8+: 0.1x106 cells) (Fig. 41A). A difference was also observed 28 days after T 
cell transfer but did not reach statistical significance (Fig. 41B). Although, there was 
no difference in CD4+ T cell numbers neither in the spleen and LNs nor in the thymus 
between Rag2-/-γc-/- and K14 TSLP+/- Rag2-/-γc-/- mice (Fig. 41B), TSLP 
overexpression increased CD8+ T cells in the spleen and thymus (Fig. 41B).  
While naïve T cells undergo homeostasis - driven proliferation in lymphopenic 
hosts, they acquire a memory-like phenotype by down regulating CD62L and up 
regulating CD44212. This was seen 28 days after T cell transfer in the spleen. Beside 
significantly elevated frequencies of effector memory (EM) in Rag2-/-γc-/- mice 
compared to K14 TSLP+/- Rag2-/-γc-/- mice, the majority of CD4+ and CD8+ T cells in 
both mice strains had a memory-like phenotype (Fig. 41C). A similar picture was 
seen for the CD4+ compartment in the LNs, whereas approximately 40% of CD8+ T 
cells resembled a naïve phenotype (Fig. 41D). 
Taken together, TSLP overexpression increased naïve T cell numbers in LNs of 
K14 TSLP+/- Rag2-/-γc-/- mice mainly in the early phase of reconstitution. In contrast, 
TSLP overexpression had only a minor effect on the memory T cell compartment in 
peripheral lymphoid organs.  
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Figure 41: Naïve T cell transfer into TSLPtg mice increases T cell numbers. 2x106 
naïve CFSE - labeled T cells from TSLPR -/- mice were injected into Rag2-/-γc-/- and K14 
TSLP+/- Rag2-/-γc-/- mice. Mice were analysed 14 days and 28 days after transfer. A) Total cell 
numbers of CD4+ and CD8+ T cells in spleen, LNs and BM 14 days after naïve T cell (CD62L+ 
CD44low) transfer B) Total cell numbers of CD4+ and CD8+ T cells in spleen, LNs, BM and 
thymus 28d after naïve T cell (CD62L+ CD44low) transfer. Frequencies of CD4+ and CD8+ 
naïve (CD62L+ CD44-), central memory (CM) (CD62L+ CD44+) and effector memory (EM) 
(CD62L- CD44+) T cells in C) spleen and D) LNs, 28d after naïve T cell transfer; A - D) n = 5 - 
7 from 2 independent experiments; n.s. = not significant, *P<0.05, **P<0.01. 
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6 Discussion 
 
Despite advances in improving transplantation conditions for patients suffering 
from immunodeficiency, the re-establishment of a functional immune system after 
HSCT, which is essential for the patient’s life quality and survival, is still a major 
clinical issue. Especially de novo generation of an adequate T cell pool is dependent 
of pretransplantational conditions. For example, cytotoxic drugs and radiotherapy 
before transplantation damage the thymic environment, hence perturbing normal T 
cell development. There are two different strategies to increase T cell numbers after 
HSCT. Firstly, homeostatic proliferation of donor T cells in the periphery and 
secondly improvement of de novo T cell development in the thymus. Increasing 
peripheral T cell numbers after HSCT is achieved by homeostatic proliferation of 
donor T cells which on one hand keep opportunistic and potential pathogens in check 
but on the other hand increase the risk for GVHD. T cell development in the thymus 
requires bilateral communication of the lympho – stromal compartment. This 
interaction ensures correct T cell development and selection as well as development 
and differentiation of TECs.  
ILC3s play an essential role in the development of LNs and have an effect on 
thymic medulla development before birth. I therefore investigated the effect of a 
cytokine - driven increase in ILC3 numbers and LNs on the reconstitution of the 
adaptive immune system after HSCT in immunodeficient mice. To address this 
question I characterized and reconstituted Rag2-/- γc-/- mice with severe defects in LN 
development and K14 TSLP+/- Rag2-/- γc-/- mice, which show almost full LN restoration 
due to increased numbers of ILC3s.  
I could show that TSLP overexpression in Rag2-/- γc-/- mice increased the number 
of DN thymocytes and improved the thymic epithelium architecture with the 
development of Aire+ mTECs in the absence of T cells. Furthermore, T cell 
reconstitution was accelerated in the thymus and in peripheral organs of K14 TSLP+/- 
Rag2-/- γc-/- mice after transplantation with FL cells from TSLPR-/- mice. Moreover, I 
could demonstrate that K14 TSLP+/- Rag2-/- γc-/- mice had higher T cell numbers in 
secondary lymphoid organs compared to Rag2-/- γc-/- mice. T cells from TSLPR-/- mice 
showed a higher proliferation rate in the spleen of K14 TSLP+/- Rag2-/- γc-/- compared 
to Rag2-/- γc-/- mice. This was associated with higher IL-7 mRNA levels in K14 TSLP+/- 
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Rag2-/- γc-/- mice suggesting that IL-7 promoted the relative enrichment of T cells in 
K14 TSLP+/- Rag2-/- γc-/- either through better survival or proliferation.  
 
 
 
6.1 TSLPtg improves thymic stroma and T cell development 
 
Before reconstitution, Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- mice were analysed 
in detail to see the effect of transgenic TSLP overexpression in lymphoid organs.  
The characterization of Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- thymi confirmed 
previous published observations that TSLP overexpression in the absence of IL-7 
signaling leads to an increase of DN2 and DN3s180. DNs are involved in the three-
dimensional patterning of the thymus and promote cTEC proliferation and 
maturation68,213. Immunofluorescence analysis in WT showed compartmentalization 
of the thymus in cortex (CK5- CK8+) and medulla (CK5+ CK8-) containing Aire+ 
mTECs. In Rag2-/- γc-/- mice, I found predominantly CK5+ CK8+ cells. This double 
positive cell type was recently reported to be a precursor, which gives rise to CK5- 
CK8+ progeny in the cortex in the presence of DN2s and DN3s214. These data 
suggest that CK5- CK8+ cells in the thymus of K14 TSLP+/- Rag2-/-γc-/- mice are a 
consequence of elevated numbers of DN2 and DN3s compared to Rag2-/- γc-/- mice. 
Analysis of TECs by flow cytometry indicated a 9-fold increase in mTEC numbers in 
K14 TSLP+/- Rag2-/-γc-/- mice compared to Rag2-/-γc-/- mice. Although mature mTECs 
are defined as MHC IIhigh 215 in WT, K14 TSLP+/- Rag2-/-γc-/- mice showed Aire+ 
mTECs with only intermediate expression levels of MHC II, a phenotype, which might 
be linked to missing T cell interaction. Nevertheless, while approximately 40% of 
mTECs in K14 TSLP+/- Rag2-/- γc-/- mice were Aire+, Aire+ mTECs were undetectable 
in Rag2-/- γc-/- mice, which is line with qRT PCR data. These are interesting results 
because many studies showed the requirement of hematopoietic cells such as 
mature single positive thymocytes for the development and maintenance of mTECs 
in the adult system73,77-79,81,216. To exclude a direct effect of TSLP overexpression on 
mTEC development and differentiation in K14 TSLP+/- Rag2-/- γc-/- mice, I performed 
FTOCs with WT E14.5 thymi. Treatment of FTOCs with RankL could initiate the 
development of mTECs as published by Rossi et al.75, whereas FTOCs treated with 
even high concentrations of TSLP gave no evidence for a direct effect of TSLP on 
mTEC development.  
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RankL provided by ILC3s can promote mTEC development75 and indeed, I 
observed higher ILC3 numbers in the thymus of K14 TSLP+/- Rag2-/- γc-/- compared to 
Rag2-/- γc-/- mice. This is in agreement with higher mRNA levels for RankL in total 
thymi of K14 TSLP+/- Rag2-/- γc-/- mice. However, previous studies78 and also my data 
demonstrated that also DN2 and DN3s expressed RankL. To test whether DN3s or 
adult ILC3s have the capacity to induce mTECs, DN3s and LP - derived ILC3s from 
Rag2-/- mice were re - aggregated with sorted CD45- TER119- cells from E14.5 WT 
thymus. LP - derived ILC3s have high RankL expression (unpublished observation F. 
Lehmann) and revealed a higher potency to promote mTEC development than DN3s, 
likely due to higher RankL expression. While RTOCs with LP ILC3s resulted in the 
generation of 10% cTECs and 85% mTECs, RTOCs with DN3s favoured cTEC 
development and induced only 11% mTECs. There are two possible explanations for 
the lack of cTECs in RTOCs with LP - ILC3s. First of all, although the initial steps of 
cTEC development is independent of thymocyte - derived signals217, later cTEC 
stages require DN1 - 3 as these cells are known to provide signals for 
differentiation213. As DNs are absent in RTOCs with LP - derived ILC3s, cTECs might 
die due to missing signals provided by DNs. The second hypothesis involves an 
additional factor on LP - derived ILC3s, which drives the commitment of common 
TEC precursors or even immature cTECs into mTEC lineage. The latter hypothesis is 
supported with my experiments in FTOCs in which RankL application also favoured 
mTEC development, but showed in addition a clear cTEC population.  
In summary, TSLP overexpression does not have a direct effect on mTEC 
development. However, adult ILC3s and to lesser extent DN3s are able to promote 
mTEC development in situ, whereas DN3s preferentially maintain cTECs. Other 
molecules reported to be involved in the terminal differentiation of mTECS are 
LTαβ/LTβR80. Since the ligand is expressed by ILC3s, future experiments will help to 
answer the question whether this pathway is also involved in the improved 
development of mTECs in RTOCs as well as in the thymus of K14 TSLP+/- Rag2-/- γc-/- 
mice.  
Important factors during T cell development are cytokines and chemokines. They 
mediate survival and migration of thymocytes within the thymus and are produced by 
the epithelial and mesenchymal compartment. IL-7 and SCF are important mediators 
of thymocyte precursor proliferation and differentiation52,218. Nevertheless mRNA 
levels of IL-7 and SCF in total thymus did not differ between Rag2-/- γc-/- and K14 
TSLP+/- Rag2-/- γc-/- mice, when normalized to EpCAM or PDGFRα. In contrast, I 
detected higher levels of CCL25 and CXCL12 in the thymus of                                
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K14 TSLP+/- Rag2-/- γc-/- mice. CCL25 is an important chemoattractant for thymocyte 
precursors from the blood60-62, while CXCL12 also favours the expansion of triple 
negative thymocytes and DP T cells63,64. CCL21 is another chemokine important for 
thymic colonialization. The notion that thymic CCL21 mRNA is decreased in         
K14 TSLP+/- Rag2-/- γc-/- mice indicates that this chemokine has no role in recruiting 
more progenitor cells to the thymus of K14 TSLP+/- Rag2-/- γc-/- mice. In line with this, 
24h after adoptive transfer of CFSE - labeled BM cells, equal numbers of donor cells 
were found in thymi of Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- mice (data not shown). 
CCL21 is also produced by mTECs, which increases the accumulation of positively 
selected thymocytes to the medulla69. A previous study identified CCL21- TECs as an 
immature mTEC precursor, whose differentiation into CCL21+ mTECs might be 
regulated by LTβR and Aire219. Since Aire is present in K14 TSLP+/- Rag2-/- γc-/- mice 
and the ligand LTαβ is expressed by ILC3s129, one would expect higher CCL21 levels 
in thymi of K14 TSLP+/- Rag2-/- γc-/- compared to Rag2-/- γc-/- mice. However, it remains 
to be investigated whether TSLP overexpression has an effect on the CCL21- mTEC 
population, thereby out diluting CCL21 - expressing cells. This could account for the 
significant decrease of CCL21 mRNA in K14 TSLP+/- Rag2-/- γc-/- mice.  
In K14 TSLP+/- Rag2-/- γc-/- mice, I could show increased IL-22 expression in the 
thymus. IL-22 is produced by thymic ILC3s and was reported to promote epithelial 
cell proliferation and survival160. Since IL-22 is exclusively produced by ILC3s in 
lymphopenic mice, the higher IL-22 mRNA level is likely due to the increased number 
of ILC3s in K14 TSLP+/- Rag2-/- γc-/- mice compared to Rag2-/- γc-/- mice and might 
contribute to the improved thymic stromal compartment by acting on TECs as 
proliferation and survival factor. 
Concomitant with the improved thymic architecture, K14 TSLP+/- Rag2-/- γc-/- mice 
had higher numbers of CD4+, CD8+ and naturally occuring Tregs (nTregs) in the 
thymus after HSCT. In addition, K14 TSLP+/- Rag2-/- γc-/- mice had also higher 
expression levels of Aire - dependent xCL1 in the thymus. xCL1 was reported to 
attract tDCs to the medulla. In this study the increasing number of self - antigen 
presenting DCs contributed to nTreg development220. Another mechanism to foster 
nTreg development was described for TSLP by upregulating the co - stimulatory 
molecules CD80 and CD86 on tDCs221,222. In line with this, I found increased mRNA 
levels for CD80 in K14 TSLP+/- Rag2-/- γc-/- mice. However, transcript levels were 
determined on total thymus including not only potential CD80+ tDCs but also CD80+ 
mTECs.  
Discussion 
 
	   100	  
5 weeks after adoptive transfer of fetal liver cells thymocyte numbers were 
increased in the thymus of K14 TSLP+/- Rag2-/- γc-/- compared to Rag2-/- γc-/-mice. This 
indicates an accelerated T cell development in mice with increased availability of 
TSLP. Since donor cells were derived from TSLPR-/- mice, this effect must be indirect. 
The improved thymic microenvironment in K14 TSLP+/- Rag2-/- γc-/- mice before 
transplantation might give a reason for the accelerated T cell reconstitution.  
 	  
6.2 TSLPtg increases T cell reconstitution in secondary 
lymphoid organs 
 
Besides higher thymocyte numbers in reconstituted K14 TSLP+/- Rag2-/- γc-/- mice, 
I could also detect higher T cell numbers in secondary lymphoid organs of K14 
TSLP+/- Rag2-/- γc-/- mice after HSCT as compared to Rag2-/- γc-/- mice. Like in the 
thymus, Treg numbers were increased in the spleen, mLN and small intestine of K14 
TSLP+/- Rag2-/- γc-/- mice.  
Some in vitro studies described a role for TSLP conditioned DCs in the generation 
and proliferation of Tregs, which was associated with upregulation of co - stimulatory 
molecules on DCs221,222. Characterization of CD11c+ DCs in the spleen and intestine 
before transplantation did not show different expression of co - stimulatory molecules 
CD40, CD80 or CD86. Since also Helios expression on Tregs did not differ between 
Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- mice, there is no evidence for a difference in 
peripheral Treg induction between Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- mice. 
Therefore, the increase of Tregs in secondary lymphoid organs of                           
K14 TSLP+/- Rag2-/- γc-/- mice most likely reflects the increase in naturally generating 
Tregs in the thymus. 
Homeostatic proliferation of peripheral donor T cells is an important mechanism to 
restore the T cell compartment directly after HSCT, since de novo T cell development 
in the thymus takes about 3 to 4 weeks223. Analysis of reconstituted mice did not 
allow me to discriminate between expansion of recent thymic emigrants and 
peripheral T cells, which underwent homeostatic proliferation. Therefore, I studied T 
cell proliferation by adoptive transfer of mature TSLPR-/- T cells into Rag2-/- γc-/- and 
K14 TSLP+/- Rag2-/- γc-/- mice. 
It is well accepted, that transferred T cells proliferate in lymphopenic mice224. The 
transfer of CFSE - labelled TSLPR-/- T cells showed a higher proliferation profile of 
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CD4+ and CD8+ T cells in K14 TSLP+/- Rag2-/- γc-/- compared to Rag2-/- γc-/- mice. 
Proliferation of naïve CD4+ T cells in lymphopenic hosts was reported to have two 
different mechanisms of proliferation. While homeostatic proliferation is IL-7 
dependent and T cells divide not more than once every 2 - 4 days, spontaneous 
proliferation is antigen driven, IL-7 independent and faster with more than one 
division per day225. In my adoptive T cell experiments, the majority of injected T cells 
divided >8 times within 14d, indicating that in addition to homeostatic proliferation 
also spontaneous proliferation occurred presumably driven by foreign antigens from 
commensal microbiota226. Homeostatic proliferation of CD4+ T cells is IL-7 dependent. 
Therefore, IL-7 mRNA levels were investigated in Rag2-/- γc-/- and                            
K14 TSLP+/- Rag2-/- γc-/- mice. I could not detect differences in mRNA expression in 
splenic stromal subsets but increased IL-7 mRNA levels in total spleen of               
K14 TSLP+/- Rag2-/- γc-/- mice. Therefore we focused on DCs, since they were 
described as IL-7 producers184,227,228. Sorted CD11c+ MHC II+ DCs from the spleen of 
Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- mice did not differ in IL-7 mRNA, but the        
4 - fold increase in DC numbers in the spleen of K14 TSLP+/- Rag2-/- γc-/- mice may 
account for the higher IL-7 levels and hence for better homeostatic proliferation of    
T cells. 
CD8+ T cell proliferation and survival is dependent on IL-7 and IL-15. However, in 
my studies IL-15 mRNA was not significantly different between Rag2-/- γc-/- and     
K14 TSLP+/- Rag2-/- γc-/- mice, suggesting that IL-7 and not IL-15 may contribute to the 
higher proliferation profile and increased number of CD8+ T cells in the spleen of     
K14 TSLP+/- Rag2-/- γc-/- mice100,229,230. Moreover, homeostatic proliferation was more 
prominent in CD8+ than in CD4+ T cells, which is also reflected in the approximately 
10 times higher CD8+ than CD4+ T cell numbers 4d after adoptive T cell transfer. As 
reported, this effect is not due to differences in IL-7Rα expression or its downstream 
signaling. It results rather of IL-7 mediated downregulation of MHC II molecules on 
IL-7Rα+ DCs, hence reducing TCR / MHC II interactions and proliferation of CD4+ T 
cells 231. 
CD62L is a molecule essential for the migration of mature naïve T cells to LNs. I 
could show in the adoptive T cell transfer experiments, that K14 TSLP+/- Rag2-/- γc-/- 
mice had higher T cell numbers in total LNs compared to Rag2-/- γc-/- mice. Since 
TSLP overexpression could not directly modulate the expression of surface 
molecules on TSLPR-/- T cells, it is unlikely that this difference is due to changes in 
CD62L levels. Probably, the higher absolute T cell numbers in total LNs of K14 
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TSLP+/- Rag2-/- γc-/- mice can be ascribed to increased LN numbers compared to 
Rag2-/- γc-/- mice. 
Adoptive T cell transfer was repeated with sorted naïve T cells. Naïve T cells, 
which undergo homeostatic proliferation, acquire a phenotype with high CD44 
expression levels and functional properties of memory T cells212. Also with this 
approach, K14 TSLP+/- Rag2-/- γc-/- mice had higher T cell numbers after 14d in 
peripheral LNs compared to Rag2-/- γc-/- mice. However, after 28d only a minor but 
significant increase of CD8+ T cells was seen in the spleen. There was also a 
significant increase of CD8+ T cells in the thymus of K14 TSLP+/- Rag2-/- γc-/- mice, 
compared to Rag2-/- γc-/- mice. These recirculating T cells might play a beneficial role 
under transplantation conditions. Donor T cells could support the re - establishment 
of the recipient thymic microenvironment by maintaining mTECs and presenting 
peripheral antigens to developing thymocytes, hence contributing to positive as well 
as negative selection of thymocytes232,233.  
The frequency of naïve and memory T cells in the LNs between Rag2-/- γc-/- and 
K14 TSLP+/- Rag2-/- γc-/- mice after naïve T cell transfer was equal. While in WT mice 
more than 60% of T cells have a CD44- naïve phenotype234,235, reconstituted      
Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- mice showed a higher percentage of memory 
cells, which is reported for T cells undergoing proliferation in lymphopenic hosts212,236. 
In the spleen, there was a significant decrease in the CD4+ effector memory 
compartment of K14 TSLP+/- Rag2-/- γc-/- mice. As there was no difference in naïve or 
central memory T cells, it is likely that TSLP overexpression has an effect on a 
memory compartment, which is not described.  
An increase in T cell survival rate could account for the increase of peripheral T 
cells in K14 TSLP+/- Rag2-/- γc-/- mice after HSCT. T cell survival is influenced by 
signals through TCR / MHC interaction and co - stimulatory molecules or through 
cytokines such as IL-2 and IL-7 237,238. Since IL-7 is produced by DCs, I investigated 
DC numbers after reconstitution in Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- mice. 
However, the number of CD11c+ DCs did not differ between Rag2-/- γc-/- mice and K14 
TSLP+/- Rag2-/- γc-/- mice. This suggests, that TCR / self - antigen driven survival as 
well as increased IL-7 availability due to higher DC numbers do not account for 
higher T cell numbers in secondary lymphoid organs. However, to test directly the T 
cell survival rate, one could consider to inject T cells from a Bcl-2tg mouse on a 
TSLPR-/- background into Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- mice. With this 
approach, all T cell subsets have the same base line of survival and the role of ILC3s 
and secondary lymphoid organs on T cell survival could be investigated. 
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Taken together, the better peripheral T cell reconstitution in K14 TSLP+/-        
Rag2-/- γc-/- mice after HSC transplantation compared to Rag2-/- γc-/- mice is the 
interplay of several mechanisms. Due to an improved state of maturation and 
architecture of the thymus in K14 TSLP+/- Rag2-/- γc-/- mice, the thymus produces 
faster T cells, which leads to a higher thymic output in week 5 and 6 after HSCT. 
Analysis of brachial LNs in Rag2-/- γc-/- mice and K14 TSLP+/- Rag2-/- γc-/- mice 4 weeks 
after HSCT demonstrated that the absolute numbers of TRCs and LECs were higher 
in K14 TSLP+/- Rag2-/- γc-/- mice. As TRC and LECs are important IL-7 producers109, it 
could be assumed that the overall availability of these cytokines is higher in LNs of 
K14 TSLP+/- Rag2-/- γc-/- mice compared to Rag2-/- γc-/- mice and could account for 
better homeostatic proliferation and survival of T cells. 
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6.3 TSLPtg increases ILC3 numbers in the intestine, which 
provide an anti – inflammatory environment 
 
GVHD is a clinical issue and responsible for increased morbidity and mortality 
after HSCT239. During acute GVHD, alloreactive T cells activated against recipient 
antigens attack several organs such as skin, liver and gastrointestinal tract. In this 
setting IL-22 was reported to have beneficial effects on the intestinal mucosa 
protecting epithelial cells and intestinal stem cells from graft - versus - host mediated 
injury after bone marrow transplantation159. In line with this observation, IL-22 was 
further described to play a protective role in infection models with Citrobacter 
rodentium152,240 and Salmonella enterica241 as well as protect intestinal epithelial cells 
during inflammatory bowel disease (IBD) and colitis by providing a signal for 
epithelial cell survival, proliferation, and wound healing242.  
TSLP overexpression increases the total number of ILC3s in the intestine. ILC3s 
were reported to directly regulate immune homeostasis in the intestine. By 
presenting microbiota - derived peptides via MHC II, ILC3s induce apoptotic cell 
death of commensal bacteria - specific T cells similar to negative T cell selection in 
the thymus243. Besides mediating intestinal selection, ILC3s are important cytokine 
producers. They produce IL-22 but are also able to secrete the pro - inflammatory 
cytokine IL-17. Flow cytometric analysis demonstrated that TSLP overexpression 
had no influence on IL-22 or IL-17 production of ILC3s compared to Rag2-/- γc-/- mice. 
However, associated with increased numbers of ILC3s, IL-22 mRNA level was 24 
times higher in K14 TSLP+/- Rag2-/- γc-/- mice compared to Rag2-/- γc-/- mice. IL-22 is 
also required for the induction of anti – microbial peptide expression in epithelial 
cells151, which have anti - bacterial activity. My data showed that K14 TSLP+/-     
Rag2-/- γc-/- mice have a 2.5 and 3 fold increase in Reg3β and Reg3γ, respectively.  
Besides the beneficial aspects on the intestinal epithelium, IL-22 can also act as 
pro - inflammatory mediator in diseases such as psoriasis and rheumatoid 
arthritis244,245. Collectively, the dual nature of IL-22 likely depends on the tissues, the 
cytokine milieu and the amount and duration of IL-22 presence. Therefore, it is 
important to have regulatory mechanisms, which control IL-22 availability. A natural 
regulator of IL-22 is the soluble receptor IL-22Rα2246,247, which is secreted from a 
subset of immature DCs. It is most prominent under steady state conditions and not 
under inflammatory conditions, as mature DCs downregulate IL-22Rα2 expression248. 
Since K14 TSLP+/- Rag2-/- γc-/- mice have elevated numbers of IL-22 producing ILC3s, 
we analysed the mRNA expression of the IL-22 binding protein IL-22Rα2. The        
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39 - fold increase of IL-22Rα2 mRNA expression in K14 TSLP+/- Rag2-/- γc-/- mice is 
associated with higher DC numbers in the small intestine compared to Rag2-/- γc-/- 
mice. This indicates, that IL-22 is also tightly regulated in TSLP overexpressing mice, 
which reduces the risk for immunopathology. Whether levels of IL-22 and IL-22Rα2 
are still significantly increased in K14 TSLP+/- Rag2-/- γc-/- compared to Rag2-/- γc-/- 
mice or alter after reconstitution remains to be investigated. 
Taken together, increased numbers of ILC3s in K14 TSLP+/- Rag2-/- γc-/- mice 
together with higher Treg numbers in the small intestine, as discussed in 6.2, 
provides an anti – inflammatory environment, which could protect the intestinal 
epithelial cells by reducing the risk of GVHD and bacterial pathogens after HSCT. 
 
 
6.4 TSLP as therapeutic treatment? 
 
Treatments to improve T cell reconstitution after HSCT follows two strategies: 
Either by direct targeting of T cell development and proliferation with cytokines like 
IL-7 or IL-2 or by improving the niches mainly by stimulating the proliferation and 
repair of epithelial cells by e.g. KGF and IL-22249. The beneficial effects of cytokines 
are often limited and accompanied by severe side effects. IL-7 for instance is 
implicated in multiple autoimmune diseases250-252 due to enhanced proliferative 
responses to self - antigens during lymphopenia. With this study I show the potential 
of TSLP as an alternative cytokine to improve the thymic microenvironment as well 
as the niches in secondary lymphoid organs without affecting adaptive immune cells 
directly. This raises the question whether TSLP is a candidate for therapeutic 
treatment after HSCT. My study demonstrates clear advantages of TSLP 
overexpression on de novo T cell development and peripheral T cell proliferation. 
However, there are also pathological issues associated with TSLP expression. TSLP 
is preferentially released by epithelial cells of different organs such as lung, intestine 
and skin and multiple studies assessed an important role for TSLP in triggering 
allergic airway diseases and dermatitis in the presence of antigen 189,202,253-256. Naive 
CD4+ T cells, which were primed by TSLP conditioned DCs polarize towards Th2 
phenotype, hence generating Th2 mediated diseases like allergy and asthma. 
Another cell type, which is associated with allergic diseases and promoting 
inflammation in the intestine are ILC2s, which can be activated by TSLP 257-259.     
K14 TSLP+/- Rag2-/- γc-/- mice have also increased numbers of ILC2 in the intestine. 
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This together with Th2 polarized T cells after reconstitution might increase 
inflammatory conditions. Therefore, future experiments are needed to investigate Th 
cell subsets and the cytokine milieu in different organs to exclude that TSLP 
overexpression creates an inflammatory environment. 
In order to avoid polarization of T cells towards Th2 cells one could consider the 
application of TSLP under sterile conditions after cytotoxic treatment and 
radiotherapy in patients before HSCT. This treatment would probably have the 
potential to amplify ILC numbers in patients with a common γ chain deficiency. In 
mice, ILC3 development from the BM transplants takes about 3 - 4 weeks204. It 
remains to be investigated in humans whether this time is sufficient for therapeutic 
TSLP - mediated improvement of thymus, peripheral lymph node and mucosal 
epithelial cell function. 
Translating results from mouse studies into the human system is subjected to 
limitations because of genetic differences e.g. cell marker expression between these 
two species. To be closer to the human system, there are recent advances in the 
development of humanized mouse models. In these models, human genes or human 
HSCs are introduced into mice, which gives the possibility to study the human 
immune system in a small animal model260. In case of studying the role of ILC3s and 
secondary lymphoid organs on the reconstitution of the adaptive immune system, 
one could engraft human HSCs into Rag2-/- γc-/- and K14 TSLP+/- Rag2-/- γc-/- mice. As 
murine and human TSLP share only 43% amino acid identity, it is unlikely that 
human TSLPR+ cells respond directly to murine TSLP. With this approach I could 
study whether the reconstitution of human T cells is also increased due to the 
restoration of lymphoid niches by TSLP overexpression. This would open a new way 
of pre - transplantational treatment to improve the outcome of HSCT. 
References 
 
	   107	  
References 	  
 
1 Parkin, J. & Cohen, B. An overview of the immune system. Lancet 357, 9270, 
1777-1789, (2001). 
2 Luckheeram, R. V., Zhou, R., Verma, A. D. & Xia, B. CD4(+)T cells: 
differentiation and functions. Clin Dev Immunol 2012, 925135, (2012). 
3 Janeway, C. A., Jr. & Medzhitov, R. Innate immune recognition. Annu Rev 
Immunol 20, 197-216, (2002). 
4 Georgopoulos, K., Moore, D. D. & Derfler, B. Ikaros, an early lymphoid-
specific transcription factor and a putative mediator for T cell commitment. 
Science 258, 5083, 808-812, (1992). 
5 Candotti, F., Notarangelo, L., Visconti, R. & O'Shea, J. Molecular aspects of 
primary immunodeficiencies: lessons from cytokine and other signaling 
pathways. Journal of Clinical Investigation 109, 10, 1261-1269, (2002). 
6 Copelan, E. Hematopoietic Stem-Cell Transplantation. N Engl J Med 354, 
1813-1826, (2006). 
7 Passweg, J. R. et al. Hematopoietic stem cell transplantation: a review and 
recommendations for follow-up care for the general practitioner. Swiss Med 
Wkly 142, w13696, (2012). 
8 Koreth J, S. R., Kopecky KJ, Honda S, Sierra J, et al. Allogeneic stem cell 
transplantation for acute myeloid leukemia in first complete remission: 
systematic review and meta-analysis of prospective clinical trials. JAMA 301, 
2349-2361, (2009). 
9 Weinberg, K. I. et al. Hematopoietic stem cell transplantation for severe 
combined immune deficiency. Curr Allergy Asthma Rep 1, 5, 416-420, (2001). 
10 Cavazzana-Calvo M, A.-S. I., Dal Cortivo L, Neven B, & Hacein-Bey-Abina S, 
F. A. Immune reconstitution after haematopoietic stem cell transplantation: 
obstacles and anticipated progress. Curr Opin Immunol 21, 544-548, (2009). 
11 Crooks, G. M., Weinberg, K. & Mackall, C. Immune reconstitution: from stem 
cells to lymphocytes. Biol Blood Marrow Transplant 12, 1 Suppl 1, 42-46, 
(2006). 
12 Seggewiss, R. & Einsele, H. Immune reconstitution after allogeneic 
transplantation and expanding options for immunomodulation: an update. 
Blood 115, 19, 3861-3868, (2010). 
13 Ochs, L. et al. Late infections after allogeneic bone marrow transplantations: 
comparison of incidence in related and unrelated donor transplant recipients. 
Blood 86, 10, 3979-3986, (1995). 
14 Robin, M. et al. Risk factors for late infections after allogeneic hematopoietic 
stem cell transplantation from a matched related donor. Biol Blood Marrow 
Transplant 13, 11, 1304-1312, (2007). 
15 Neven, B. et al. Long-term outcome after hematopoietic stem cell 
transplantation of a single-center cohort of 90 patients with severe combined 
immunodeficiency. Blood 113, 17, 4114-4124, (2009). 
16 Marie-Cardine, A. et al. Transitional B cells in humans: characterization and 
insight from B lymphocyte reconstitution after hematopoietic stem cell 
transplantation. Clin Immunol 127, 1, 14-25, (2008). 
17 Alpdogan, O. et al. Keratinocyte growth factor (KGF) is required for postnatal 
thymic regeneration. Blood 107, 6, 2453-2460, (2006). 
18 Min, D. et al. Protection from thymic epithelial cell injury by keratinocyte 
growth factor: a new approach to improve thymic and peripheral T-cell 
References 
 
	   108	  
reconstitution after bone marrow transplantation. Blood 99, 12, 4592-4600, 
(2002). 
19 Rossi, S. et al. Keratinocyte growth factor preserves normal thymopoiesis and 
thymic microenvironment during experimental graft-versus-host disease. 
Blood 100, 2, 682-691, (2002). 
20 Kennedy-Nasser, A. A. et al. Ultra Low-Dose IL-2 for GVHD Prophylaxis after 
Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of 
Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity. 
Clinical Cancer Research 20, 8, 2215-2225, (2014). 
21 Perales, M. A. et al. Recombinant human interleukin-7 (CYT107) promotes T-
cell recovery after allogeneic stem cell transplantation. Blood 120, 24, 4882-
4891, (2012). 
22 Chen, B. J., Cui, X., Sempowski, G. D. & Chao, N. J. Growth hormone 
accelerates immune recovery following allogeneic T-cell-depleted bone 
marrow transplantation in mice. Exp Hematol 31, 10, 953-958, (2003). 
23 Sutherland, J. S. et al. Enhanced immune system regeneration in humans 
following allogeneic or autologous hemopoietic stem cell transplantation by 
temporary sex steroid blockade. Clin Cancer Res 14, 4, 1138-1149, (2008). 
24 Riddell, S. R., Bleakley, M., Nishida, T., Berger, C. & Warren, E. H. Adoptive 
transfer of allogeneic antigen-specific T cells. Biol Blood Marrow Transplant 
12, 1 Suppl 1, 9-12, (2006). 
25 Le Blanc, K. et al. Transplantation of mesenchymal stem cells to enhance 
engraftment of hematopoietic stem cells. Leukemia 21, 8, 1733-1738, (2007). 
26 Belizário, J. E. Immunodeficient Mouse Models: An Overview. The Open 
Immunology Journal 2, 79-85, (2009). 
27 Seymour, R., Sundberg, J. P. & Hogenesch, H. Abnormal lymphoid organ 
development in immunodeficient mutant mice. Vet Pathol 43, 4, 401-423, 
(2006). 
28 Carsetti, R. The development of B cells in the bone marrow is controlled by 
the balance between cell-autonomous mechanisms and signals from the 
microenvironment. Journal of Experimental Medicine 191, 1, 5-8, (2000). 
29 Carvalho, T. L., Mota-Santos, T., Cumano, A., Demengeot, J. & Vieira, P. 
Arrested B lymphopoiesis and persistence of activated B cells in adult 
interleukin 7(-/-) mice. Journal of Experimental Medicine 194, 8, 1141-1150, 
(2001). 
30 Peschon, J. J. et al. Early Lymphocyte Expansion Is Severely Impaired in 
Interleukin-7 Receptor-Deficient Mice. Journal of Experimental Medicine 180, 
5, 1955-1960, (1994). 
31 Sitnicka, E. et al. Key role of flt3 ligand in regulation of the common lymphoid 
progenitor but not in maintenance of the hematopoietic stem cell pool. 
Immunity 17, 4, 463-472, (2002). 
32 Sudo, T. et al. Interleukin 7 production and function in stromal cell-dependent 
B cell development. J Exp Med 170, 1, 333-338, (1989). 
33 von Freeden jeffry, U. et al. Lymphopenia in Interleukin (Il)-7 Gene-Deleted 
Mice Identifies Il-7 as a Nonredundant Cytokine. Journal of Experimental 
Medicine 181, 4, 1519-1526, (1995). 
34 Waskow, C., Paul, S., Haller, C., Gassmann, M. & Rodewald, H. R. Viable c-
Kit(W/W) mutants reveal pivotal role for c-kit in the maintenance of 
lymphopoiesis. Immunity 17, 3, 277-288, (2002). 
35 Nemazee, D. A. & Burki, K. Clonal deletion of B lymphocytes in a transgenic 
mouse bearing anti-MHC class I antibody genes. Nature 337, 6207, 562-566, 
(1989). 
36 Cambier, J. C., Gauld, S. B., Merrell, K. T. & Vilen, B. J. B-cell anergy: from 
transgenic models to naturally occurring anergic B cells? Nat Rev Immunol 7, 
8, 633-643, (2007). 
References 
 
	   109	  
37 Sukumar, S. & Schlissel, M. S. Receptor Editing as a Mechanism of B Cell 
Tolerance. Journal of Immunology 186, 3, 1301-1302, (2011). 
38 Ceredig, R. & Rolink, T. A positive look at double-negative thymocytes. 
Nature Reviews Immunology 2, 11, 888-896, (2002). 
39 Cerutti, A., Cols, M. & Puga, I. Marginal zone B cells: virtues of innate-like 
antibody-producing lymphocytes. Nature Reviews Immunology 13, 2, 118-132, 
(2013). 
40 Martin, F. & Kearney, J. F. Marginal-zone B cells. Nat Rev Immunol 2, 5, 323-
335, (2002). 
41 Allman, D. & Pillai, S. Peripheral B cell subsets. Curr Opin Immunol 20, 2, 
149-157, (2008). 
42 Ribatti, D., Crivellato, E. & Vacca, A. Miller's seminal studies on the role of 
thymus in immunity. Clin Exp Immunol 144, 3, 371-375, (2006). 
43 Takahama, Y. Journey through the thymus: stromal guides for T-cell 
development and selection. Nature Reviews Immunology 6, 2, 127-135, 
(2006). 
44 Gill, J. et al. Thymic generation and regeneration. Immunol Rev 195, 28-50, 
(2003). 
45 van Ewijk, W. et al. Thymic microenvironments, 3-D versus 2-D? Semin 
Immunol 11, 1, 57-64, (1999). 
46 Klug, D. B., Carter, C., Gimenez-Conti, I. B. & Richie, E. R. Cutting edge: 
thymocyte-independent and thymocyte-dependent phases of epithelial 
patterning in the fetal thymus. J Immunol 169, 6, 2842-2845, (2002). 
47 Lee, E. N. et al. Characterization of the expression of cytokeratins 5, 8, and 
14 in mouse thymic epithelial cells during thymus regeneration following 
acute thymic involution. Anat Cell Biol 44, 1, 14-24, (2011). 
48 Derbinski, J., Schulte, A., Kyewski, B. & Klein, L. Promiscuous gene 
expression in medullary thymic epithelial cells mirrors the peripheral self. Nat 
Immunol 2, 11, 1032-1039, (2001). 
49 Farr, A. G. & Rudensky, A. Medullary thymic epithelium: a mosaic of epithelial 
"self"? J Exp Med 188, 1, 1-4, (1998). 
50 Koble, C. & Kyewski, B. The thymic medulla: a unique microenvironment for 
intercellular self-antigen transfer. J Exp Med 206, 7, 1505-1513, (2009). 
51 Nagamine, K. et al. Positional cloning of the APECED gene. Nat Genet 17, 4, 
393-398, (1997). 
52 Godfrey, D. I., Zlotnik, A. & Suda, T. Phenotypic and Functional-
Characterization of C-Kit Expression during Intrathymic T-Cell Development. 
Journal of Immunology 149, 7, 2281-2285, (1992). 
53 Palmer, E. & Naeher, D. Affinity threshold for thymic selection through a T-
cell receptor-co-receptor zipper. Nature Reviews Immunology 9, 3, 206-212, 
(2009). 
54 Coquet, J. M. et al. Epithelial and dendritic cells in the thymic medulla 
promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 
pathway. J Exp Med 210, 4, 715-728, (2013). 
55 Yui, M. A. & Rothenberg, E. V. Developmental gene networks: a triathlon on 
the course to T cell identity. Nat Rev Immunol 14, 8, 529-545, (2014). 
56 Radtke, F. et al. Deficient T cell fate specification in mice with an induced 
inactivation of Notch1. Immunity 10, 5, 547-558, (1999). 
57 Wolfer A, W. A., Nemir M, MacDonald HR, Radtke F. Inactivation of Notch1 
impairs VDJbeta rearrangement and allows pre-TCR-independent survival of 
early alpha beta Lineage Thymocytes. Immunity 22, 3, 155-160, (2002). 
58 Massa, S., Balciunaite, G., Ceredig, R. & Rolink, A. G. Critical role for c-kit 
(CD117) in T cell lineage commitment and early thymocyte development in 
vitro. Eur J Immunol 36, 3, 526-532, (2006). 
References 
 
	   110	  
59 Rodewald, H. R., Kretzschmar, K., Swat, W. & Takeda, S. Intrathymically 
Expressed C-Kit Ligand (Stem-Cell Factor) Is a Major Factor Driving 
Expansion of Very Immature Thymocytes in-Vivo. Immunity 3, 3, 313-319, 
(1995). 
60 Bleul CC, B. T. Chemokines define distinct microenvironments in the 
developing thymus. Eur J Immunol. 30, 12, 3371-3379, (2000). 
61 Liu, C. L. et al. Coordination between CCR7-and CCR9-mediated chemokine 
signals in prevascular fetal thymus colonization. Blood 108, 8, 2531-2539, 
(2006). 
62 Wurbel, M. A. et al. Mice lacking the CCR9 CC-chemokine receptor show a 
mild impairment of early T- and B-cell development and a reduction in T-cell 
receptor gammadelta(+) gut intraepithelial lymphocytes. Blood 98, 9, 2626-
2632, (2001). 
63 Ara, T. et al. A role of CXC chemokine ligand 12/stromal cell-derived factor-
1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and 
adult T cell development in vivo. J Immunol 170, 9, 4649-4655, (2003). 
64 Plotkin, J., Prockop, S. E., Lepique, A. & Petrie, H. T. Critical role for CXCR4 
signaling in progenitor localization and T cell differentiation in the postnatal 
thymus. J Immunol 171, 9, 4521-4527, (2003). 
65 Lind, E. F., Prockop, S. E., Porritt, H. E. & Petrie, H. T. Mapping precursor 
movement through the postnatal thymus reveals specific microenvironments 
supporting defined stages of early lymphoid development. Journal of 
Experimental Medicine 194, 2, 127-134, (2001). 
66 Ueno, T. et al. CCR7 signals are essential for cortex-medulla migration of 
developing thymocytes. J Exp Med 200, 4, 493-505, (2004). 
67 Ueno, T. et al. Role for CCR7 ligands in the emigration of newly generated T 
lymphocytes from the neonatal thymus. Immunity 16, 2, 205-218, (2002). 
68 Holländer, G. A., Wang, B., Nichogiannopoulou, A., Platenburg, P. P., van 
Ewijk, W., Burakoff, S. J., Gutierrez-Ramos, J. C., and Terhorst, C. 
Developmental control point in induction of thymic cortex regu- lated by a 
subpopulation of prothymocytes. Nature 373, 6512, 350-353, (1995). 
69 Nitta, T., Ohigashi, I., Nakagawa, Y. & Takahama, Y. Cytokine crosstalk for 
thymic medulla formation. Curr Opin Immunol 23, 2, 190-197, (2011). 
70 Shores, E. W., Van Ewijk, W. & Singer, A. Disorganization and restoration of 
thymic medullary epithelial cells in T cell receptor-negative scid mice: 
evidence that receptor-bearing lymphocytes influence maturation of the 
thymic microenvironment. Eur J Immunol 21, 7, 1657-1661, (1991). 
71 Buckley, R. H. Molecular defects in human severe combined 
immunodeficiency and approaches to immune reconstitution. Annual Review 
of Immunology 22, 625-655, (2004). 
72 Lomada, D., Liu, B., Coghlan, L., Hu, Y. & Richie, E. R. Thymus medulla 
formation and central tolerance are restored in IKKalpha-/- mice that express 
an IKKalpha transgene in keratin 5+ thymic epithelial cells. J Immunol 178, 2, 
829-837, (2007). 
73 Boehm, T., Scheu, S., Pfeffer, K. & Bleul, C. C. Thymic medullary epithelial 
cell differentiation, thymocyte emigration, and the control of autoimmunity 
require lympho-epithelial cross talk via LTbetaR. J Exp Med 198, 5, 757-769, 
(2003). 
74 Zhu, M. & Fu, Y. X. Coordinating development of medullary thymic epithelial 
cells. Immunity 29, 3, 386-388, (2008). 
75 Rossi, S. W. et al. RANK signals from CD4(+)3(-) inducer cells regulate 
development of Aire-expressing epithelial cells in the thymic medulla. J Exp 
Med 204, 6, 1267-1272, (2007). 
References 
 
	   111	  
76 Roberts, N. A. et al. Rank signaling links the development of invariant 
gammadelta T cell progenitors and Aire(+) medullary epithelium. Immunity 36, 
3, 427-437, (2012). 
77 Akiyama, T. et al. The tumor necrosis factor family receptors RANK and 
CD40 cooperatively establish the thymic medullary microenvironment and 
self-tolerance. Immunity 29, 3, 423-437, (2008). 
78 Hikosaka, Y. et al. The cytokine RANKL produced by positively selected 
thymocytes fosters medullary thymic epithelial cells that express autoimmune 
regulator. Immunity 29, 3, 438-450, (2008). 
79 Irla, M. et al. Autoantigen-specific interactions with CD4+ thymocytes control 
mature medullary thymic epithelial cell cellularity. Immunity 29, 3, 451-463, 
(2008). 
80 White, A. J. et al. Lymphotoxin signals from positively selected thymocytes 
regulate the terminal differentiation of medullary thymic epithelial cells. J 
Immunol 185, 8, 4769-4776, (2010). 
81 White, A. J. et al. Sequential phases in the development of Aire-expressing 
medullary thymic epithelial cells involve distinct cellular input. Eur J Immunol 
38, 4, 942-947, (2008). 
82 Bettelli, E., Korn, T., Oukka, M. & Kuchroo, V. K. Induction and effector 
functions of T(H)17 cells. Nature 453, 7198, 1051-1057, (2008). 
83 O'garra, A. T-cell differentiation: Commitment factors for T helper cells. 
Current Biology 10, 13, R492-R494, (2000). 
84 Okazawa, A. et al. Th1-mediated intestinal inflammation in Crohn's disease 
may be induced by activation of lamina propria lymphocytes through 
synergistic stimulation of interleukin-12 and interleukin-18 without T cell 
receptor engagement. American Journal of Gastroenterology 97, 12, 3108-
3117, (2002). 
85 Leung, B. P., McInnes, I. B., Esfandiari, E., Wei, X. Q. & Liew, F. Y. 
Combined effects of IL-12 and IL-18 on the induction of collagen-induced 
arthritis. J Immunol 164, 12, 6495-6502, (2000). 
86 Swain, S. L., Weinberg, A. D., English, M. & Huston, G. IL-4 directs the 
development of Th2-like helper effectors. J Immunol 145, 11, 3796-3806, 
(1990). 
87 Ito, T. et al. TSLP-activated dendritic cells induce an inflammatory T helper 
type 2 cell response through OX40 ligand. J Exp Med 202, 9, 1213-1223, 
(2005). 
88 Kitajima, M., Lee, H. C., Nakayama, T. & Ziegler, S. F. TSLP enhances the 
function of helper type 2 cells. Eur J Immunol 41, 7, 1862-1871, (2011). 
89 Finkelman, F. D., Pearce, E. J., Urban, J. F., Jr. & Sher, A. Regulation and 
biological function of helminth-induced cytokine responses. Immunol Today 
12, 3, A62-66, (1991). 
90 Robinson, D. S. et al. Predominant TH2-like bronchoalveolar T-lymphocyte 
population in atopic asthma. N Engl J Med 326, 5, 298-304, (1992). 
91 Zhou, B. H. et al. Thymic stromal lymphopoietin as a key initiator of allergic 
airway inflammation in mice. Nature Immunology 6, 10, 1047-1053, (2005). 
92 Thornton, A. M. et al. Expression of Helios, an Ikaros Transcription Factor 
Family Member, Differentiates Thymic-Derived from Peripherally Induced 
Foxp3(+) T Regulatory Cells. Journal of Immunology 184, 7, 3433-3441, 
(2010). 
93 Weiss, J. M. et al. Neuropilin 1 is expressed on thymus-derived natural 
regulatory T cells, but not mucosa- generated induced Foxp3(+) T reg cells. 
Journal of Experimental Medicine 209, 10, 1723-1742, (2012). 
94 Singh, K., Hjort, M., Thorvaldson, L. & Sandler, S. Concomitant analysis of 
Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T 
cells in naive mice. Sci Rep 5, 7767, (2015). 
References 
 
	   112	  
95 Sprent, J., Cho, J. H., Boyman, O. & Surh, C. D. T cell homeostasis. Immunol 
Cell Biol 86, 4, 312-319, (2008). 
96 Obhrai, J. S. et al. Effector T cell differentiation and memory T cell 
maintenance outside secondary lymphoid organs. J Immunol 176, 7, 4051-
4058, (2006). 
97 Sprent, J. & Tough, D. F. T cell death and memory. Science 293, 5528, 245-
248, (2001). 
98 Schluns, K. S., Kieper, W. C., Jameson, S. C. & Lefrancois, L. Interleukin-7 
mediates the homeostasis of naive and memory CD8 T cells in vivo. Nature 
Immunology 1, 5, 426-432, (2000). 
99 Tan, J. T. et al. IL-7 is critical for homeostatic proliferation and survival of 
naive T cells. P Natl Acad Sci USA 98, 15, 8732-8737, (2001). 
100 Berard, M., Brandt, K., Bulfone-Paus, S. & Tough, D. F. IL-15 promotes the 
survival of naive and memory phenotype CD8+ T cells. J Immunol 170, 10, 
5018-5026, (2003). 
101 Cho, J. H. et al. An intense form of homeostatic proliferation of naive CD8+ 
cells driven by IL-2. J Exp Med 204, 8, 1787-1801, (2007). 
102 Malek, T. R. & Bayer, A. L. Tolerance, not immunity, crucially depends on IL-
2. Nat Rev Immunol 4, 9, 665-674, (2004). 
103 Girard, J. P., Moussion, C. & Forster, R. HEVs, lymphatics and homeostatic 
immune cell trafficking in lymph nodes. Nat Rev Immunol 12, 11, 762-773, 
(2012). 
104 von Andrian, U. H. & Mempel, T. R. Homing and cellular traffic in lymph 
nodes. Nat Rev Immunol 3, 11, 867-878, (2003). 
105 Batista, F. D. & Harwood, N. E. The who, how and where of antigen 
presentation to B cells. Nature Reviews Immunology 9, 1, 15-27, (2009). 
106 Cyster, J. G. et al. Follicular stromal cells and lymphocyte homing to follicles. 
Immunological Reviews 176, 181-193, (2000). 
107 Worbs, T., Mempel, T. R., Bolter, J., von Andrian, U. H. & Forster, R. CCR7 
ligands stimulate the intranodal motility of T lymphocytes in vivo. Journal of 
Experimental Medicine 204, 3, 489-495, (2007). 
108 Marsland, B. J. et al. CCL19 and CCL21 induce a potent proinflammatory 
differentiation program in licensed dendritic cells. Immunity 22, 4, 493-505, 
(2005). 
109 Link, A. et al. Fibroblastic reticular cells in lymph nodes regulate the 
homeostasis of naive T cells. Nature Immunology 8, 11, 1255-1265, (2007). 
110 Surh, C. D. & Sprent, J. Regulation of mature T cell homeostasis. Semin 
Immunol 17, 3, 183-191, (2005). 
111 Onder, L. et al. IL-7-producing stromal cells are critical for lymph node 
remodeling. Blood 120, 24, 4675-4683, (2012). 
112 Luther, S. A., Vogt, T. K. & Siegert, S. Guiding blind T cells and dendritic 
cells: A closer look at fibroblastic reticular cells found within lymph node T 
zones. Immunology Letters 138, 1, 9-11, (2011). 
113 Cui, G. W. et al. Characterization of the IL-15 niche in primary and secondary 
lymphoid organs in vivo. P Natl Acad Sci USA 111, 5, 1915-1920, (2014). 
114 Lee, J. W. et al. Peripheral antigen display by lymph node stroma promotes T 
cell tolerance to intestinal self. Nat Immunol 8, 2, 181-190, (2007). 
115 Magnusson, F. C. et al. Direct presentation of antigen by lymph node stromal 
cells protects against CD8 T-cell-mediated intestinal autoimmunity. 
Gastroenterology 134, 4, 1028-1037, (2008). 
116 Fletcher, A. L. et al. Lymph node fibroblastic reticular cells directly present 
peripheral tissue antigen under steady-state and inflammatory conditions. J 
Exp Med 207, 4, 689-697, (2010). 
References 
 
	   113	  
117 Malhotra, D. et al. Transcriptional profiling of stroma from inflamed and 
resting lymph nodes defines immunological hallmarks. Nat Immunol 13, 5, 
499-510, (2012). 
118 Alimzhanov, M. B. et al. Abnormal development of secondary lymphoid 
tissues in lymphotoxin beta-deficient mice. Proc Natl Acad Sci U S A 94, 17, 
9302-9307, (1997). 
119 Banks, T. A. et al. Lymphotoxin-alpha-deficient mice. Effects on secondary 
lymphoid organ development and humoral immune responsiveness. J 
Immunol 155, 4, 1685-1693, (1995). 
120 Futterer, A., Mink, K., Luz, A., Kosco-Vilbois, M. H. & Pfeffer, K. The 
lymphotoxin beta receptor controls organogenesis and affinity maturation in 
peripheral lymphoid tissues. Immunity 9, 1, 59-70, (1998). 
121 Fukuyama, S. et al. Initiation of NALT organogenesis is independent of the IL-
7R, LTbetaR, and NIK signaling pathways but requires the Id2 gene and 
CD3(-)CD4(+)CD45(+) cells. Immunity 17, 1, 31-40, (2002). 
122 Georgopoulos, K. et al. The Ikaros Gene Is Required for the Development of 
All Lymphoid Lineages. Cell 79, 1, 143-156, (1994). 
123 Kurebayashi, S. et al. Retinoid-related orphan receptor gamma (RORgamma) 
is essential for lymphoid organogenesis and controls apoptosis during 
thymopoiesis. Proc Natl Acad Sci U S A 97, 18, 10132-10137, (2000). 
124 Wang, J. H. et al. Selective defects in the development of the fetal and adult 
lymphoid system in mice with an Ikaros null mutation. Immunity 5, 6, 537-549, 
(1996). 
125 Mebius, R. E., Rennert, P. & Weissman, I. L. Developing lymph nodes collect 
CD4(+)CD3(-) LT beta(+) cells that can differentiate to APC, NK cells, and 
follicular cells but not T or B cells. Immunity 7, 4, 493-504, (1997). 
126 Finke, D., Acha-Orbea, H., Mattis, A., Lipp, M. & Kraehenbuhl, J. CD4+CD3- 
cells induce Peyer's patch development: role of alpha4beta1 integrin 
activation by CXCR5. Immunity 17, 3, 363-373, (2002). 
127 Finke, D. Fate and function of lymphoid tissue inducer cells. Curr Opin 
Immunol 17, 2, 144-150, (2005). 
128 Nishikawa, S., Honda, K., Vieira, P. & Yoshida, H. Organogenesis of 
peripheral lymphoid organs. Immunol Rev 195, 72-80, (2003). 
129 Yoshida H, N. A., Inoue J, Satoh M, Santee-Cooper SM, Ware CF, et al. 
Different cytokines induce surface lymphotoxin-alphabeta on IL-7 receptor- 
alpha cells that differentially engender lymph nodes and Peyer's patches. 
Immunity 17, 6, 823-833, (2002). 
130 Cupedo, T., Jansen, W., Kraal, G. & Mebius, R. E. Induction of secondary 
and tertiary lymphoid structures in the skin. Immunity 21, 5, 655-667, (2004). 
131 Okuda, M., Togawa, A., Wada, H. & Nishikawa, S. Distinct activities of 
stromal cells involved in the organogenesis of lymph nodes and Peyer's 
patches. J Immunol 179, 2, 804-811, (2007). 
132 Vondenhoff, M. F. et al. LTbetaR signaling induces cytokine expression and 
up-regulates lymphangiogenic factors in lymph node anlagen. J Immunol 182, 
9, 5439-5445, (2009). 
133 Mebius, R. E. Organogenesis of lymphoid tissues. Nat Rev Immunol 3, 4, 
292-303, (2003). 
134 Spits, H. & Di Santo, J. P. The expanding family of innate lymphoid cells: 
regulators and effectors of immunity and tissue remodeling. Nat Immunol 12, 
1, 21-27, (2011). 
135 Spits H, A. D., Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate 
lymphoid cells--a proposal for uniform nomenclature. Nature reviews 
Immunology 13, 2, 145-149, (2013). 
136 Artis, D. & Spits, H. The biology of innate lymphoid cells. Nature 517, 7534, 
293-301, (2015). 
References 
 
	   114	  
137 Yokota, Y. et al. Development of peripheral lymphoid organs and natural killer 
cells depends on the helix-loop-helix inhibitor Id2. Nature 397, 6721, 702-706, 
(1999). 
138 Chappaz, S. & Finke, D. The IL-7 signaling pathway regulates lymph node 
development independent of peripheral lymphocytes. J Immunol 184, 7, 
3562-3569, (2010). 
139 Chappaz, S., Gartner, C., Rodewald, H. R. & Finke, D. Kit ligand and Il7 
differentially regulate Peyer's patch and lymph node development. J Immunol 
185, 6, 3514-3519, (2010). 
140 Eberl, G. & Littman, D. R. Thymic origin of intestinal alphabeta T cells 
revealed by fate mapping of RORgammat+ cells. Science 305, 5681, 248-251, 
(2004). 
141 Eberl, G. et al. An essential function for the nuclear receptor RORgamma(t) in 
the generation of fetal lymphoid tissue inducer cells. Nat Immunol 5, 1, 64-73, 
(2004). 
142 Scandella, E. et al. Restoration of lymphoid organ integrity through the 
interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. 
Nature Immunology 9, 6, 667-675, (2008). 
143 Schmutz, S. et al. Cutting Edge: IL-7 Regulates the Peripheral Pool of Adult 
ROR gamma(+) Lymphoid Tissue Inducer Cells. Journal of Immunology 183, 
4, 2217-2221, (2009). 
144 Sonnenberg, G. F., Fouser, L. A. & Artis, D. Border patrol: regulation of 
immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. 
Nat Immunol 12, 5, 383-390, (2011). 
145 Buonocore, S. et al. Innate lymphoid cells drive interleukin-23-dependent 
innate intestinal pathology. Nature 464, 7293, 1371-1375, (2010). 
146 Pantelyushin, S. et al. Rorgammat+ innate lymphocytes and gammadelta T 
cells initiate psoriasiform plaque formation in mice. J Clin Invest 122, 6, 2252-
2256, (2012). 
147 Powell, N. et al. The transcription factor T-bet regulates intestinal 
inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. 
Immunity 37, 4, 674-684, (2012). 
148 Sawa, S. et al. RORgammat+ innate lymphoid cells regulate intestinal 
homeostasis by integrating negative signals from the symbiotic microbiota. 
Nat Immunol 12, 4, 320-326, (2011). 
149 Liang, S. C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells 
and cooperatively enhance expression of antimicrobial peptides. J Exp Med 
203, 10, 2271-2279, (2006). 
150 Satoh-Takayama, N. et al. Microbial flora drives interleukin 22 production in 
intestinal NKp46+ cells that provide innate mucosal immune defense. 
Immunity 29, 6, 958-970, (2008). 
151 Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching 
and effacing bacterial pathogens. Nature Medicine 14, 3, 282-289, (2008). 
152 Sonnenberg, G. F., Monticelli, L. A., Elloso, M. M., Fouser, L. A. & Artis, D. 
CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. 
Immunity 34, 1, 122-134, (2011). 
153 Kruglov, A. A. et al. Nonredundant function of soluble LTalpha3 produced by 
innate lymphoid cells in intestinal homeostasis. Science 342, 6163, 1243-
1246, (2013). 
154 Hepworth, M. R. et al. Innate lymphoid cells regulate CD4+ T-cell responses 
to intestinal commensal bacteria. Nature 498, 7452, 113-117, (2013). 
155 von Burg, N. et al. Activated group 3 innate lymphoid cells promote T-cell-
mediated immune responses. Proc Natl Acad Sci U S A 111, 35, 12835-
12840, (2014). 
References 
 
	   115	  
156 Goto, Y. et al. Innate lymphoid cells regulate intestinal epithelial cell 
glycosylation. Science 345, 6202, 1254009, (2014). 
157 Mortha, A. et al. Microbiota-Dependent Crosstalk Between Macrophages and 
ILC3 Promotes Intestinal Homeostasis. Science 343, 6178, 1477-+, (2014). 
158 Gladiator, A., Wangler, N., Trautwein-Weidner, K. & LeibundGut-Landmann, 
S. Cutting edge: IL-17-secreting innate lymphoid cells are essential for host 
defense against fungal infection. J Immunol 190, 2, 521-525, (2013). 
159 Hanash, A. M. et al. Interleukin-22 Protects Intestinal Stem Cells from 
Immune-Mediated Tissue Damage and Regulates Sensitivity to Graft versus 
Host Disease. Immunity 37, 2, 339-350, (2012). 
160 Dudakov, J. A. et al. Interleukin-22 Drives Endogenous Thymic Regeneration 
in Mice. Science 336, 6077, 91-95, (2012). 
161 Friend, S. L. et al. A thymic stromal cell line supports in vitro development of 
surface IgM+ B cells and produces a novel growth factor affecting B and T 
lineage cells. Exp Hematol 22, 3, 321-328, (1994). 
162 Sims J.E., W. D. E., Morrissey P.J., Garka K., Foxworthe D., Price V., Friend 
S., Farr A.G., Bedell M., Jenkins N.A., Copeland N.G., Grabstein K., Paxton 
R.J. . Molecular cloning and biological characterization of a novel lymphoid 
growth factor. J. Exp. Med. 192, 671–680, (2000). 
163 Quentmeier, H. et al. Cloning of human thymic stromal lymphopoietin (TSLP) 
and signaling mechanisms leading to proliferation. Leukemia 15, 8, 1286-
1292, (2001). 
164 Reche, P. A. et al. Human thymic stromal lymphopoietin preferentially 
stimulates myeloid cells. J Immunol 167, 1, 336-343, (2001). 
165 Liu, Y. J. Thymic stromal lymphopoietin: master switch for allergic 
inflammation. J Exp Med 203, 2, 269-273, (2006). 
166 Saenz, S. A., Taylor, B. C. & Artis, D. Welcome to the neighborhood: 
epithelial cell-derived cytokines license innate and adaptive immune 
responses at mucosal sites. Immunological Reviews 226, 172-190, (2008). 
167 Ziegler, S. F. The role of thymic stromal lymphopoietin (TSLP) in allergic 
disorders. Current Opinion in Immunology 22, 6, 795-799, (2010). 
168 Cosman, D. et al. A new cytokine receptor superfamily. Trends Biochem Sci 
15, 7, 265-270, (1990). 
169 Pandey, A. et al. Cloning of a receptor subunit required for signaling by 
thymic stromal lymphopoietin. Nat Immunol 1, 1, 59-64, (2000). 
170 Zhang, W. et al. Identification of a novel type I cytokine receptor CRL2 
preferentially expressed by human dendritic cells and activated monocytes. 
Biochem Biophys Res Commun 281, 4, 878-883, (2001). 
171 Blagoev, B., Nielsen, M. M., Angrist, M., Chakravarti, A. & Pandey, A. Cloning 
of rat thymic stromal lymphopoietin receptor (TSLPR) and characterization of 
genomic structure of murine Tslpr gene. Gene 284, 1-2, 161-168, (2002). 
172 Park, L. S. et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) 
receptor: Formation of a functional heteromeric complex requires interleukin 7 
receptor. J Exp Med 192, 5, 659-670, (2000). 
173 Isaksen, D. E. et al. Requirement for Stat5 in thymic stromal lymphopoietin-
mediated signal transduction. Journal of Immunology 163, 11, 5971-5977, 
(1999). 
174 Roan, F. et al. The multiple facets of thymic stromal lymphopoietin (TSLP) 
during allergic inflammation and beyond. J Leukocyte Biol 91, 6, 877-886, 
(2012). 
175 Rochman, Y. et al. Thymic stromal lymphopoietin-mediated STAT5 
phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-
7-induced signaling. P Natl Acad Sci USA 107, 45, 19455-19460, (2010). 
176 Ziegler, S. F. et al. The Biology of Thymic Stromal Lymphopoietin (TSLP). 
Immunopharmacology 66, 129-155, (2013). 
References 
 
	   116	  
177 Ray, R. J., Furlonger, C., Williams, D. E. & Paige, C. J. Characterization of 
thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in 
vitro. Eur J Immunol 26, 1, 10-16, (1996). 
178 Levin, S. D. et al. Thymic Stromal Lymphopoietin (TSLP): A cytokine that 
promotes the development of IgM(+) B cells in vitro and signals via a novel 
mechanism. Faseb Journal 13, 4, A322-A322, (1999). 
179 Scheeren, F. A. et al. Thymic stromal lymphopoietin induces early human B-
cell proliferation and differentiation. Eur J Immunol 40, 4, 955-965, (2010). 
180 Chappaz, S., Flueck, L., Farr, A. G., Rolink, A. G. & Finke, D. Increased 
TSLP availability restores T- and B-cell compartments in adult IL-7 deficient 
mice. Blood 110, 12, 3862-3870, (2007). 
181 Al-Shami, A. et al. A role for thymic stromal lymphopoietin in CD4(+) T cell 
development. Journal of Experimental Medicine 200, 2, 159-168, (2004). 
182 Jensen, C. T. et al. FLT3 ligand and not TSLP is the key regulator of IL-7-
independent B-1 and B-2 B lymphopoiesis. Blood 112, 6, 2297-2304, (2008). 
183 Kashyap, M., Rochman, Y., Spolski, R., Samsel, L. & Leonard, W. J. Thymic 
Stromal Lymphopoietin Is Produced by Dendritic Cells. Journal of 
Immunology 187, 3, 1207-1211, (2011). 
184 Spadoni, I., Iliev, I. D., Rossi, G. & Rescigno, M. Dendritic cells produce TSLP 
that limits the differentiation of Th17 cells, fosters Treg development, and 
protects against colitis. Mucosal Immunol 5, 2, 184-193, (2012). 
185 Watanabe, N. et al. Human thymic stromal lymphopoietin promotes dendritic 
cell-mediated CD4+ T cell homeostatic expansion. Nat Immunol 5, 4, 426-434, 
(2004). 
186 Gilliet, M. et al. Human dendritic cells activated by TSLP and CD40L induce 
proallergic cytotoxic T cells. Journal of Experimental Medicine 197, 8, 1059-
1063, (2003). 
187 Lee, H. C. & Ziegler, S. F. Inducible expression of the proallergic cytokine 
thymic stromal lymphopoietin in airway epithelial cells is controlled by 
NFkappaB. Proc Natl Acad Sci U S A 104, 3, 914-919, (2007). 
188 Zaph, F. A. a. C. Another Brick in the Wall: Innate Lymphoid Cells of the 
Intestine. Current Immunology Reviews 9, 111-117, (2013). 
189 Zhang, K. et al. Constitutive and inducible thymic stromal lymphopoietin 
expression in human airway smooth muscle cells: role in chronic obstructive 
pulmonary disease. Am J Physiol Lung Cell Mol Physiol 293, 2, L375-382, 
(2007). 
190 Wang, Y. H. et al. Maintenance and polarization of human TH2 central 
memory T cells by thymic stromal lymphopoietin-activated dendritic cells. 
Immunity 24, 6, 827-838, (2006). 
191 Allakhverdi, Z. et al. Thymic stfomal lymphopoietin is released by human 
epithelial cells in response to microbes, trauma, or inflammation and potently 
activates mast cells. Journal of Experimental Medicine 204, 2, 253-258, 
(2007). 
192 Kato, A., Favoreto, S., Avila, P. C. & Schleimer, R. P. TLR3- and Th2 
cytokine-dependent production of thymic stromal lymphopoietin in human 
airway epithelial cells. Journal of Immunology 179, 2, 1080-1087, (2007). 
193 Li, M. et al. Retinoid X receptor ablation in adult mouse keratinocytes 
generates an atopic dermatitis triggered by thymic stromal lymphopoietin. 
Proc Natl Acad Sci U S A 102, 41, 14795-14800, (2005). 
194 Li, M. et al. Topical vitamin D3 and low-calcemic analogs induce thymic 
stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. 
Proc Natl Acad Sci U S A 103, 31, 11736-11741, (2006). 
195 Li, M. et al. Induction of Thymic Stromal Lymphopoietin Expression in 
Keratinocytes Is Necessary for Generating an Atopic Dermatitis upon 
References 
 
	   117	  
Application of the Active Vitamin D3 Analogue MC903 on Mouse Skin. J 
Invest Dermatol 129, 2, 498-502, (2009). 
196 Lee, H. C., Headley, M. B., Iseki, M., Ikuta, K. & Ziegler, S. F. Cutting edge: 
Inhibition of NF-kappaB-mediated TSLP expression by retinoid X receptor. J 
Immunol 181, 8, 5189-5193, (2008). 
197 Demehri, S. et al. Notch-deficient skin induces a lethal systemic B-
lymphoproliferative disorder by secreting TSLP, a sentinel for epidermal 
integrity. Plos Biology 6, 5, 992-1005, (2008). 
198 Dumortier, A. et al. Atopic dermatitis-like disease and associated lethal 
myeloproliferative disorder arise from loss of Notch signaling in the murine 
skin. PLoS One 5, 2, e9258, (2010). 
199 Sun, Z. et al. Requirement for RORgamma in thymocyte survival and 
lymphoid organ development. Science 288, 5475, 2369-2373, (2000). 
200 Shinkai, Y. et al. RAG-2-deficient mice lack mature lymphocytes owing to 
inability to initiate V(D)J rearrangement. Cell 68, 5, 855-867, (1992). 
201 Gabler, J., Arnold, J. & Kyewski, B. Promiscuous gene expression and the 
developmental dynamics of medullary thymic epithelial cells. Eur J Immunol 
37, 12, 3363-3372, (2007). 
202 Soumelis, V. et al. Human epithelial cells trigger dendritic cell mediated 
allergic inflammation by producing TSLP. Nat Immunol 3, 7, 673-680, (2002). 
203 Sonnenberg, G. F. & Artis, D. Innate lymphoid cell interactions with 
microbiota: implications for intestinal health and disease. Immunity 37, 4, 601-
610, (2012). 
204 Sawa, S. et al. Lineage relationship analysis of RORgammat+ innate 
lymphoid cells. Science 330, 6004, 665-669, (2010). 
205 Lindemans, C. A. et al. IL-22 Is an Intestinal Stem Cell Growth Factor, and IL-
22 Administration in Vivo Reduces Morbidity and Mortality in Murine GvHD. 
Blood 124, 21, (2014). 
206 Geremia, A. et al. IL-23-responsive innate lymphoid cells are increased in 
inflammatory bowel disease. Journal of Experimental Medicine 208, 6, 1127-
1133, (2011). 
207 Walker JA, B. J., McKenzie AN. Innate lymphoid cells-how did we miss them. 
Nat Rev Immunol. 13, 2, 75-87, (2013). 
208 El Shikh, M. E. & Pitzalis, C. Follicular dendritic cells in health and disease. 
Front Immunol 3, 292, (2012). 
209 Fu, Y. X., Huang, G., Wang, Y. & Chaplin, D. D. B lymphocytes induce the 
formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent 
fashion. J Exp Med 187, 7, 1009-1018, (1998). 
210 Tumanov, A. V., Kuprash, D. V., Mach, J. A., Nedospasov, S. A. & 
Chervonsky, A. V. Lymphotoxin and TNF produced by B cells are 
dispensable for maintenance of the follicle-associated epithelium but are 
required for development of lymphoid follicles in the Peyer's patches. J 
Immunol 173, 1, 86-91, (2004). 
211 Krautler, N. J. et al. Follicular dendritic cells emerge from ubiquitous 
perivascular precursors. Cell 150, 1, 194-206, (2012). 
212 Haluszczak, C. et al. The antigen-specific CD8+ T cell repertoire in 
unimmunized mice includes memory phenotype cells bearing markers of 
homeostatic expansion. J Exp Med 206, 2, 435-448, (2009). 
213 Shakib, S. et al. Checkpoints in the development of thymic cortical epithelial 
cells. J Immunol 182, 1, 130-137, (2009). 
214 Klug, D. B. et al. Interdependence of cortical thymic epithelial cell 
differentiation and T-lineage commitment. Proc Natl Acad Sci U S A 95, 20, 
11822-11827, (1998). 
215 Gray, D. H. et al. Developmental kinetics, turnover, and stimulatory capacity 
of thymic epithelial cells. Blood 108, 12, 3777-3785, (2006). 
References 
 
	   118	  
216 Palmer, D. B., Viney, J. L., Ritter, M. A., Hayday, A. C. & Owen, M. J. 
Expression of the Alpha-Beta-T-Cell Receptor Is Necessary for the 
Generation of the Thymic Medulla. Dev Immunol 3, 3, 175-179, (1993). 
217 Jenkinson, E. J., Anderson, G. & Owen, J. J. Studies on T cell maturation on 
defined thymic stromal cell populations in vitro. J Exp Med 176, 3, 845-853, 
(1992). 
218 Fry, T. J. & Mackall, C. L. The many faces of IL-7: From lymphopoiesis to 
peripheral T cell maintenance. Journal of Immunology 174, 11, 6571-6576, 
(2005). 
219 Lkhagvasuren, E., Sakata, M., Ohigashi, I. & Takahama, Y. Lymphotoxin beta 
receptor regulates the development of CCL21-expressing subset of postnatal 
medullary thymic epithelial cells. J Immunol 190, 10, 5110-5117, (2013). 
220 Lei, Y. & Takahama, Y. XCL1 and XCR1 in the immune system. Microbes 
Infect 14, 3, 262-267, (2012). 
221 Watanabe, N. et al. Hassall's corpuscles instruct dendritic cells to induce 
CD4+CD25+ regulatory T cells in human thymus. Nature 436, 7054, 1181-
1185, (2005). 
222 Besin, G., Dupuis, G. & Amrani, A. Protection of NOD mice against diabetes 
by TSLP : conversion of T lymphocytes CD4+CD25-FOXP3-in T lymphocyte 
regulators CD4+CD25+FOXP3+in the presence of dendritic cells cultivated in 
the presence of TSLP. Diabetes Metab 34, A51-A51, (2008). 
223 Foss, D. L., Donskoy, E. & Goldschneider, I. The importation of 
hematogenous precursors by the thymus is a gated phenomenon in normal 
adult mice. Journal of Experimental Medicine 193, 3, 365-374, (2001). 
224 Stockinger, B., Barthlott, T. & Kassiotis, G. The concept of space and 
competition in immune regulation. Immunology 111, 3, 241-247, (2004). 
225 Min, B., Yamane, H., Hu-Li, J. & Paul, W. E. Spontaneous and homeostatic 
proliferation of CD4 T cells are regulated by different mechanisms. Journal of 
Immunology 174, 10, 6039-6044, (2005). 
226 Surh, C. D. & Sprent, J. Homeostasis of Naive and Memory T Cells. Immunity 
29, 6, 848-862, (2008). 
227 de Saint-Vis, B. et al. The cytokine profile expressed by human dendritic cells 
is dependent on cell subtype and mode of activation. Journal of Immunology 
160, 4, 1666-1676, (1998). 
228 Harnaha, J. et al. Interleukin-7 is a survival factor for CD4(+) CD25(+) T-cells 
and is expressed by diabetes-suppressive dendritic cells. Diabetes 55, 1, 
158-170, (2006). 
229 Ku, C. C., Murakami, M., Sakamoto, A., Kappler, J. & Marrack, P. Control of 
homeostasis of CD8+ memory T cells by opposing cytokines. Science 288, 
5466, 675-678, (2000). 
230 Lodolce, J. P. et al. IL-15 receptor maintains lymphoid homeostasis by 
supporting lymphocyte homing and proliferation. Immunity 9, 5, 669-676, 
(1998). 
231 Guimond, M. et al. Interleukin 7 signaling in dendritic cells regulates the 
homeostatic proliferation and niche size of CD4+ T cells. Nat Immunol 10, 2, 
149-157, (2009). 
232 Kirberg, J., Bosco, N., Deloulme, J. C., Ceredig, R. & Agenes, F. Peripheral T 
lymphocytes recirculating back into the thymus can mediate thymocyte 
positive selection. Journal of Immunology 181, 2, 1207-1214, (2008). 
233 Bosco, N., Kirberg, J., Ceredig, R. & Agenes, F. Peripheral T cells in the 
thymus: have they just lost their way or do they do something? Immunology 
and Cell Biology 87, 1, 50-57, (2009). 
234 Raberger, J. et al. The transcriptional regulator PLZF induces the 
development of CD44 high memory phenotype T cells. Proc Natl Acad Sci U 
S A 105, 46, 17919-17924, (2008). 
References 
 
	   119	  
235 Bjorkdahl, O. et al. Characterization of CC-chemokine receptor 7 expression 
on murine T cells in lymphoid tissues. Immunology 110, 2, 170-179, (2003). 
236 Goldrath, A. W., Bogatzki, L. Y. & Bevan, M. J. Naive T cells transiently 
acquire a memory-like phenotype during homeostasis-driven proliferation. J 
Exp Med 192, 4, 557-564, (2000). 
237 Rathmell, J. C., Farkash, E. A., Gao, W. & Thompson, C. B. IL-7 enhances 
the survival and maintains the size of naive T cells. J Immunol 167, 12, 6869-
6876, (2001). 
238 Wang, R., Xie, H., Huang, Z., Shang, W. & Sun, Z. Developing and activated 
T cell survival depends on differential signaling pathways to regulate anti-
apoptotic Bcl-x(L). Clin Dev Immunol 2012, 632837, (2012). 
239 Wingard, J. R. et al. Long-term survival and late deaths after allogeneic 
hematopoietic cell transplantation. J Clin Oncol 29, 16, 2230-2239, (2011). 
240 Tumanov, A. V. et al. Lymphotoxin controls the IL-22 protection pathway in 
gut innate lymphoid cells during mucosal pathogen challenge. Cell Host 
Microbe 10, 1, 44-53, (2011). 
241 Schulz, S. M. et al. Protective immunity to systemic infection with attenuated 
Salmonella enterica serovar enteritidis in the absence of IL-12 is associated 
with IL-23-dependent IL-22, but not IL-17. J Immunol 181, 11, 7891-7901, 
(2008). 
242 Pickert, G. et al. STAT3 links IL-22 signaling in intestinal epithelial cells to 
mucosal wound healing. J Exp Med 206, 7, 1465-1472, (2009). 
243 Hepworth, M. R. et al. Immune tolerance. Group 3 innate lymphoid cells 
mediate intestinal selection of commensal bacteria-specific CD4(+) T cells. 
Science 348, 6238, 1031-1035, (2015). 
244 Ma, H. L. et al. IL-22 is required for Th17 cell-mediated pathology in a mouse 
model of psoriasis-like skin inflammation. Journal of Clinical Investigation 118, 
2, 597-607, (2008). 
245 Zenewicz, L. A. & Flavell, R. A. Recent advances in IL-22 biology. Int 
Immunol 23, 3, 159-163, (2011). 
246 Kotenko, S. V. et al. Identification of the functional interleukin-22 (IL-22) 
receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both 
the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) 
receptor complexes. J Biol Chem 276, 4, 2725-2732, (2001). 
247 Dumoutier, L., Lejeune, D., Colau, D. & Renauld, J. C. Cloning and 
characterization of IL-22 binding protein, a natural antagonist of IL-10-related 
T cell-derived inducible factor/IL-22. J Immunol 166, 12, 7090-7095, (2001). 
248 Martin, J. C. et al. Interleukin-22 binding protein (IL-22BP) is constitutively 
expressed by a subset of conventional dendritic cells and is strongly induced 
by retinoic acid. Mucosal Immunol 7, 1, 101-113, (2014). 
249 Velardi, E., Dudakov, J. A. & van den Brink, M. R. Clinical strategies to 
enhance thymic recovery after allogeneic hematopoietic stem cell 
transplantation. Immunol Lett 155, 1-2, 31-35, (2013). 
250 Uehira, M. et al. The development of dermatitis infiltrated by gamma delta T 
cells in IL-7 transgenic mice. Int Immunol 5, 12, 1619-1627, (1993). 
251 Lundmark, F. et al. Variation in interleukin 7 receptor alpha chain (IL7R) 
influences risk of multiple sclerosis. Nat Genet 39, 9, 1108-1113, (2007). 
252 Totsuka, T. et al. IL-7 is essential for the development and the persistence of 
chronic colitis. Journal of Immunology 178, 8, 4737-4748, (2007). 
253 Al-Shami, A., Spolski, R., Kelly, J., Keane-Myers, A. & Leonard, W. J. A role 
for TSLP in the development of inflammation in an asthma model. Journal of 
Experimental Medicine 202, 6, 829-839, (2005). 
254 Shikotra, A. et al. Increased expression of immunoreactive thymic stromal 
lymphopoietin in patients with severe asthma. J Allergy Clin Immun 129, 1, 
104-U147, (2012). 
References 
 
	   120	  
255 Ying, S. et al. Expression and cellular provenance of thymic stromal 
lymphopoietin and chemokines in patients with severe asthma and chronic 
obstructive pulmonary disease. Journal of Immunology 181, 4, 2790-2798, 
(2008). 
256 Ying, S. et al. Thymic stromal lymphopoietin expression is increased in 
asthmatic airways and correlates with expression of TH2-attracting 
chemokines and disease severity. Journal of Immunology 174, 12, 8183-8190, 
(2005). 
257 Camelo, A. et al. Blocking IL-25 signalling protects against gut inflammation 
in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13. 
Journal of Gastroenterology 47, 11, 1198-1211, (2012). 
258 Halim, T. Y., Krauss, R. H., Sun, A. C. & Takei, F. Lung natural helper cells 
are a critical source of Th2 cell-type cytokines in protease allergen-induced 
airway inflammation. Immunity 36, 3, 451-463, (2012). 
259 Ikutani, M. et al. Identification of Innate IL-5-Producing Cells and Their Role in 
Lung Eosinophil Regulation and Antitumor Immunity. Journal of Immunology 
188, 2, 703-713, (2012). 
260 Ito, R., Takahashi, T., Katano, I. & Ito, M. Current advances in humanized 
mouse models. Cell Mol Immunol 9, 3, 208-214, (2012). 	  
Abbreviations and symbols 	  
 
	   121	  
Appendix 	  
Abbreviations and symbols 	  	  
Ab antibody 
Ag antigen 
Aire autoimmune regulator 
Alum aluminium potassium 
APC antigen presenting cell 
BEC blood endothelial cell 
BM bone marrow 
bp base pair 
CD cluster of differentiation 
CFSE carboxyfluorescein succinimidyl ester 
CK cytokeratin 
CM central memory 
CMJ corticomedullary junction 
CRLF2 cytokine receptor - like factor 2  
cTEC cortical thymic epithelial cell 
DC dendritic cell 
dGuo 2'-Deoxyguanosine 
DN double negative 
DNSC double negative stromal cell 
DP double positive 
E embryonic day 
EM effector memory 
ELISA enzyme linked immunosorbent assay 
EpCAM epithelial cell adhesion molecule 
Fab fragment antigen - binding 
Fc fragment crystallizable  
FDC follicular dendritic cell 
FGF fibroblast growth factor 
Flt3L FMS - like tyrosine kinase 3 ligand 
FL fetal liver 
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fol  follicular 
FoxP3 forkhead box protein P3 
FTOC fetal thymus organ culture 
γc common cytokine gamma chain 
GM-CSF granulocyte macrophage colony stimulating factor 
GVHD graft versus host disease 
HEV high endothelial venule 
HSC hematopoietic stemm cell 
HSCT hematopoietic stemm cell transplantation 
Id2 inhibitor of DNA binding 2  
IFN-γ Interferon-gamma 
Ig Immunoglobulin 
IL interleukin 
ILC innate lymphoid cell 
i.p. intraperitoneal 
i.v. intravenous 
KGF keratinocyte growth factor 
LEC lymphatic endothelial cell 
lin lineage 
LN lymph node 
LP lamina propria 
LT lymphotoxin 
LTi lymphoid tissue inducer 
mLN mesenteric lymph node 
MHC major histocompatibility complex 
mLN mesenteric lymph node 
MΦ macrophage 
mTEC medullary thymic epithelial cell 
MZ marginal zone 
NCR natural cytotoxicity receptor 
NF-κB nuclear factor kappa-light-chain-enhancer of activated B	  cells 
NK natural killer 
NP-OVA  4-Hydroxy-3-nitrophenylacetyl NP- (18)-Ovalbumin 
nTreg naturally occurring Treg 
OD optical density 
OVA Ovalbumin 
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o/n over night 
PDGFRα platelet - derived growth factor receptor α 
PP peyers patch 
preFDC FDC precursor 
pTreg peripheral induced Treg 
RAG recombination activating genes 
Rank receptor activator of NF-κB 
RankL receptor activator of NF-κB ligand 
RegIIIβ/γ regenerating islet - derived protein III beta/ gamma 
RORγt retinoic acid related orphan receptor gamma 
RTOC re - aggregated thymus organ culture 
SCF stem cell factor 
SI small intestine 
SP single positive   
TCR T cell receptor 
TEC thymic epithelial cell 
TD thymus - dependent 
Tg transgenic 
Th T helper 
TI thymus - independent 
TLR Toll - like receptor 
TNF tumor necrosis factor 
TRA tissue restricted antigen 
TRC T zone reticular cell 
Treg regulatory T cell 
TSLP thymic stromal lymphopoietin 
TSLPR thymic stromal lymphopoietin receptor 
UCB umbilical cord blood 
UEA-1 Ulex europaeus agglutinin - 1 
WT wild type 
 
 
% percent 
°C degree celsius 
h hour 
kDA kilo dalton 
Abbreviations and symbols 	  
 
	   124	  
min minutes 
mm milimeter 
ng nanogram 
rpm rounds per minute 
µg microgramm 
µm micromter 
µL microliter 
µM micromol 
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